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1. Abstract:  
The synapse is the major site of neurotransmission in the brain. Even though the synapse has 
been extensively studied, artefact-free imaging tools are still necessary for its correct 
investigation. With the resolution of modern techniques approaching the molecular size, the 
main current limitations are the few available affinity probes targeting synaptic proteins and the 
limited multiplexing abilities of most microscopy techniques. Camelid single-domain antibodies 
(also called nanobodies) are a superior alternative to conventional antibodies for super 
resolution microscopy applications. Nanobodies have a significantly smaller size than 
conventional antibodies; they are monovalent binders, they can reach buried epitopes and can 
be expressed recombinantly in prokaryotic systems. However, nanobodies against just a few 
targets are available and their selection is laborious. In this thesis, I first established a pipeline 
that allows selection, production, and validation of nanobodies against various synaptic proteins. 
Next, I characterized nanobodies binding selectively to primary antibodies (secondary 
nanobodies) and compared them in immunofluorescences performed with conventional 
secondary antibodies. Finally, I also established a protocol for coupling a single-stranded DNA 
to nanobodies using click chemistry. As a proof of principle, I used this procedure to implement 
a triple color super resolution Exchange PAINT with an automated microfluidic setup. 
Altogether, this thesis gives rise to a set of tools that allows the characterization of the neuronal 
































2. General introduction 
2.1 Synapse characterization 
Unraveling the basic principles of brain function is at the center of current scientific research. 
The Human Brain Project, started in 2013 by the European Union, is a billion Euro initiative 
that aims to advance our understanding of the brain. Its American counterpart, the Brain 
Initiative, has already precisely catalogued the cells of the brain and its connectome. The JNPD 
(The EU Joint Programme – Neurodegenerative Disease Research) engages in the eradication 
of neurodegenerative diseases. These are just a few examples of the efforts made in 
understanding the brain, illustrating the imminence of explaining brain mechanisms. To reach 
this goal, the subcellular level of the brain needs to be equally understood. To do so, purified 
hippocampal neurons from rodents are commonly used. This primary cell culture is a simplified 
model to mimic the neural tissue they come from. It is relatively homogenous in its composition, 
forms synaptic networks and shows consistent characteristics from one lab to another (Benson, 
Watkins, Steward, & Banker, 1994). This type of primary neuronal culture has been used for 
the past thirty years because they enable easy manipulations, observation under various 
microscopy techniques, and a variety of labelling and biochemical tools are readily available to 
investigate it. Primary hippocampal neurons are therefore a good simplified model to understand 
basic neuronal functions, communication and how those are altered by neurological 
impairments.  
 
The synapse is the element that allows communication between neurons. In a standard chemical 
synapse, the presynaptic side releases neurotransmitters that bind to receptors on the 
postsynaptic side and trigger a signal in the postsynaptic neuron. This mechanism is mediated 
through synaptic vesicles that store neurotransmitters and release them by fusing to the cell 
plasma membrane at the active zone of the presynapse. Synaptic vesicles, after fusing to the 
plasma membrane, are then retrieved back by endocytosis fused to early endosomes and bud 
once again as synaptic vesicle. This process is known as the synaptic vesicle cycle and it has 
been studied in great detail (Rizzoli, 2014). The study of the synaptic architecture and 
neurotransmitter release mechanism has been performed through a variety of methods. One 




insights such as models of synaptic vesicle recycling (Takei, Mundigl, Daniell, & De Camilli, 
1996), More recently, fluorescent imaging, which exhibit good experimental flexibility with 
sufficient resolution, has been used for example to obtain the quantitative molecular description 
of the synaptic bouton (Wilhelm et al., 2014) and the molecular organization and distribution of 
proteins in chemical synapse (Dani, Huang, Bergan, Dulac, & Zhuang, 2010). 
 
2.2 Detection of proteins of interest  
Proteins are involved in multiple essential functions in the synapse: they provide structural 
stability, transport material and are responsible for a variety of different steps in the synaptic 
vesicle cycle. Endogenous mammalian proteins are per se non-visible to the human eye nor to 
the different light microscopy techniques. In order to image them with fluorescent microscopy, 
they are usually tagged with a detectable element such a recombinant fluorescent protein or an 
organic dye.  
 
2.2.1 Recombinant proteins 
The green fluorescent protein (GFP) was the first naturally-occurring fluorescent protein that 
was discovered back in the nineties (Chalfie, Tu, Euskirchen, Ward, & Prasher, 1994). The so-
called “green revolution” allowed many biological discoveries by enabling the observation of 
location and expression of proteins fused to GFP. However, the original GFP suffered from 
homo-oligomerization, slow folding properties and limited brightness leading to poor signal to 
noise ratio (Shashkova & Leake, 2017). Variants of this original fluorescent protein have been 
discovered and designed to improve brightness and photostability (Thastrup et al., 1995), to 
enhance folding kinetics (Pédelacq et al., 2006), to reduce self-oligomerization and to emit at 
different wavelengths on the light spectrum (Zacharias et al., 2002). Currently, there are more 
than five hundred variants of fluorescent proteins with different characteristics (Lambert, 2019). 
Recently, other types of proteins have been engineered to become fluorescent upon ligand 
binding. Those are the so-called “self-labelling proteins”: SNAP tag (Keppler et al., 2003), 
HALO tag (Los et al., 2008) and CLIP tag (Gautier et al., 2008). They are modified enzymes 
that are fused to the target of interest and will then form a covalent bond with their substrate 




Usually, the use of fused tags, either fluorescent of self-labelling requires the transient 
overexpression of the protein construct. This has been shown to alter the original endogenous 
location and behavior of the targeted protein (T. J. Gibson, Seiler, & Veitia, 2013). To overcome 
these artefacts, stable transfection and direct modification of the endogenous protein with a 
system like CRISPR-Cas (Jinek et al., 2012) could be used.  
  
2.2.2 Standard immunostaining:  
Immunostaining is a common technique that circumvents the modification of the original 
protein and the potential problems suggested above. It is important to point out that with this 
approach, in order to label intracellular targets, permeabilization of the cell is necessary and 
therefore live imaging is difficult.  
 
Conventional immunostaining uses antibodies, mainly immunoglobulin G (IgG), to bind 
specifically to the protein of interest. IgGs are a heterotetratmeric structure, composed of two 
identical heavy chain and two identical light chain connected by disulfide bridges. They have 
two binding identical sites (the paratopes) recognizing a specific sequence of the targeted protein 
(the epitope). The paratope is composed of a combination of a variable domain of a light chain 
(VL) and a variable domain of the heavy chain (VH). Those two domains are not connected and 
therefore the minimal functional antigen binding part contains also constant domains of the light 
and heavy chain (CL and CH1) connected by disulfide bonds. This fragment is referred to as 
antigen binding fragment (Fab) in contract to the rest of the antibody called the fragment 
crystallizable domain (Fc). The Fc domain of IgGs is composed of four constant domains (CH2 
and CH3, for each of the two copy of the heavy chain) and is the site of post-translational 
modification (PTM). The presence of PTM on IgG is a hindrance to cheap fast and simple 
manufacturing of antibody, since it impedes its production in bacterial hosts and requires 
mammalian cells host (Lee & Jeong, 2015). 
 
Since antibodies are also per se non-fluorescent, they have to be directly coupled to a reporter 
(such as an organic dye), in this case the process is called direct immunostaining. Otherwise, in 
a method called indirect immunostaining, a primary antibody raised in a particular animal 




fluorophore) binds in a specie-specific fashion the primary antibody. The indirect variant of 
immunostaining is cheaper and more convenient because secondary antibodies targeting every 
species are commercially available. Another advantage is that multiple secondary antibodies 
bind a single primary antibody, thereby creating an amplification of the signal obtained, which 
might be useful in some applications, for example, when the amount of the targeted protein is 
low.  
 
Antibodies can be either polyclonal or monoclonal. Polyclonal antibodies are produced by 
different B cell lineage within the animal. They are therefore a mixture of different antibodies 
targeting different epitopes, allowing further signal amplification (Lipman, Jackson, Trudel, & 
Weis-Garcia, 2005). In contrast, monoclonal antibodies target a single epitope since they are 
derived from a single B cell which is then proliferated by creating a hybridoma cell line (Köhler 
& Milstein, 1975). The use of monoclonal antibodies minimizes batch-to-batch variation and 
increases consistency in experiments, when compared to the effects of polyclonal antibodies 
(M. Baker, 2015; Bradbury & Plückthun, 2015). However, the majority of the secondary 
antibodies used are polyclonals, due to their faster, less expensive and less technical skills 
required for their production (Lipman et al., 2005).   
 
Standard immunostaining involves a series of limitations. The size of the IgGs (~150 kDa and 
~15 nm for, might even double in case of indirect immunostaining) have been shown to hinder 
the penetration into thick sample and the access to buried epitopes. Their size also increases the 
distance between the targeted protein and the reporter leading to the imaging of a bigger 
structure. The latter is known as linkage error or fluorophore delocalization and has been shown 
to decrease achievable resolution in super resolution microscopy (described below).  The 
bivalency (binding two identical epitopes) and the potential polyclonality of the antibodies 
might cluster the targeted protein, leading to artefacts like probe-induced clustering. Finally, the 
reporter (such as an organic dye) is usually linked to the antibody using N-hydroxysuccinimide 
(NHS) ester coupling chemistry. The reporter reacts with the free secondary amino groups on 
lysines at the surface of the antibody resulting in an uncontrolled labeling strategy, which can 
also alter the epitope recognition site (Mattson et al., 1993). The last disadvantage of indirect 




targets at the same time. In fact, in the same sample, the primary antibodies need to come from 
different species in order that the secondary antibody used does not cross-react on the different 
targets. Despites of the pitfalls of conventional immunostaining, it is a well- and long-
established method and therefore thousands of antibodies are currently commercially available.  
 
 
Figure 2.1: Different affinity binders are used to target proteins in immunostaining. (A) Immunoglobulin 
based affinity binders. Conventional antibodies (IgG) and recombinant antibody fragments (left). Heavy 
chain antibody and recombinant antigen binding domain VHH or nanobody. Blue blocks are constant 
domains; green blocks are variable domains. Light chain is in lighter color. (B) Non immunoglobulin-
based binders. Between brackets the PDB accession number. “N”, “C” are N terminus and C terminus, 
respectively. Adapted from (Helma, Cardoso, Muyldermans, & Leonhardt, 2015).  
 
 
2.2.3 Alternative probes for staining biological samples 
Other types of affinity probes have been developed to overcome some of the limitations of 




get rid of the Fc region. This can be done with the enzyme Pepsin and obtain a Fab2 fragment 
(i.e. the two Fab regions which stays connected by disulfide bonds), or with Papain to obtain a 
Fab fragment, a monovalent probe of around 50 kDa and 9 nm in length (Porter, 1959). Fab 
fragments are composed of four domains (see Fig.2.1): two constant domains CH and CL and 
two variable domains VH and VL where L and C stand for light chain and heavy chain 
respectively. A further attempt to reduce the size of this construct is to form a single chain 
variable fragment (scFv) which consist of the VL and VH connected by an engineered 
polypeptide linker leading to an affinity probe of ~30 kDa and 6 nm in size (Huston et al., 1988). 
Optimization of recombinant scFv is complicated in the design of the short peptide linker that 
needs to maintain the light and heavy chain conformation to be able to recognize the epitope. 
These antibody fragments are definitely reducing the size of the probe, however, their 
expression in recombinant form in bacteria is complicated due to the inability of the disulfide 
bonds to form ensuring proper folding (Vaks & Benhar, 2014).  
 
Other affinity probes not based on immunoglobulin scaffolds have been developed by using 
other naturally existing scaffolds where random mutagenesis is performed on the binding 
surface. For example, Affibodies are binders based on the Z domain of staphylococcal protein 
A (a natural binder to immunoglobulins) and they have a size of 6 kDa and 2 nm (Nord et al., 
1996). These probes have been used in many applications such as in vivo molecular imaging for 
tumor diagnosis (Nilsson & Tolmachev, 2007) and super resolution microscopy (Gomes de 
Castro et al., 2019). Along the same line, Adnectins, also known as Monobodies, were formed 
by the framework of the extracellular domain of human fibronectin III (Koide & Koide, 2007). 
They were modified and used as a FRET sensor for imaging intercellular junctions (Limsakul 
et al., 2018). Other examples are Anticalin (~30 kDa) or DARPins (~14 kDa) both derived from 
modified scaffolds of naturally binding proteins (Plückthun, 2015; Skerra, 2008). Affimers are 
derived from a synthetic protein called the Adhiron scaffold (Tiede et al., 2014) and were used 
to increase the resolution power of single molecule localization microscopy (Schlichthaerle et 
al., 2018). Nucleic acids have also been explored for their ability to be used as affinity probes. 
For instance, aptamers, or their higher affinity binding versions Somamers, are single-stranded 
DNA or RNA based probes, in vitro selected through systematic evolution of ligands by 




through their three-dimensional structure. Thanks to their small size (~15 kDa), they can 
penetrate tissues and bind previously inaccessible epitopes and clearly define cellular structures 
in the context of super resolution microscopy (Opazo et al., 2012; Strauss et al., 2018).  
 
2.2.4 Nanobodies 
One type of alternative small probes that deserves particular attention are the single-domain 
antibodies also known as nanobodies® (trademark by the company Ablynx). Nanobodies are 
derived from a peculiar type of antibodies that are devoid of light chains, thus termed heavy 
chain antibody (hcAb) and can be found in camelid like camels, llamas alpacas and interestingly 
also in sharks (Greenberg et al., 1995; Hamers-Casterman et al., 1993). In camelids, the hcAbs 
coexist with the conventional IgGs that are named IgG1. In the hcAbs, the antigen binding part 
is composed of a single domain, the variable domain of the hcAbs (VHH) and is linked directly 
to the constant domains (to the CH2) by the hinge region. The different length of this hinge 
region gives rise to two isotypes of hcAbs: the IgG2 and the IgG3. Because of the simplicity 
and lack of post-translational modification, the VHH can be expressed as a recombinant protein 
in bacteria (Muyldermans, 2001). In this thesis, the VHH expressed as recombinant binding 
domain will be called nanobody or Nb, as it is also commonly referred to in the literature. 
Nanobodies have a size of 15 kDa and 2-3 nm. They do not have a light chain, which might be 
interpreted as reduction of binding surface and therefore render lower affinity to their targets 
when compared to the conventional antibodies. However, the affinity of the VHH to its cognate 
antigen is not necessarily lower, in fact, affinities in the low picomolar range have been 
measured (Götzke et al., 2019; Soler, Fortuna, de Marco, & Laio, 2018). This is attributed to 
their complementarity determining regions (CDRs) which are in average longer than in a 
classical antibody and thus increasing the interacting surface to the antigen. The CDRs of 
nanobodies form protruding loops that have also been associated with reaching buried or convex 
epitopes, which are inaccessible to conventional IgG. This peculiarity gave a wide range of 
special applications to the nanobodies such as inhibition of enzymes by binding to their catalytic 
site (Chaikuad et al., 2014; Lauwereys et al., 1998), or the inhibition of viral infection by 
competing for the host receptor (Desmyter et al., 2013). In addition, nanobodies have been used 
as crystallization chaperones (Lam, Pardon, Korotkov, Hol, & Steyaert, 2009), in medical 





Nanobodies have also been used in super resolution imaging and have been shown to increase 
the resolution obtained (Maidorn, Olichon, Rizzoli, & Opazo, 2019; Ries, Kaplan, Platonova, 
Eghlidi, & Ewers, 2012). They are easily conjugable to moieties such as fluorophores in a site-
directed manner (Pleiner et al., 2015).   
 
The classical route to generate nanobodies against specific target needs the immunization of a 
camelid with the specific antigen. Naive libraries (obtained from not-immunized animals) and 
synthetic libraries (variability comes from synthetically produced nanobodies with randomized 
sequences on their CDRs) have also been used to screen for target-specific nanobodies 
(Kumaran, MacKenzie, & Arbabi-Ghahroudi, 2012; Yan, Li, Hu, Ou, & Wan, 2014; 
Zimmermann et al., 2018). To identify nanobodies against a specific target, those libraries are 
screened by different display techniques (Liu et al., 2018). Phage display, one of the most used 
screening methods, permits the selection of antigen-specific binding molecules from a library 
of different binders expressed as fusion proteins with a bacteriophage coat protein (Smith, 
1985). This method uses bacteriophages to create a physical linkage between the genotype, the 
encapsulated DNA coding for the binder, and the phenotype, the displayed protein fused to a 
surface phage protein able to bind the intended target. Recently, an alternative method uses next 
generation sequencing (NGS) and mass spectrometry to establish this gene-protein link (Fridy 
et al., 2014).  
 
2.3 Fluorescence imaging and super resolution microscopy  
Fluorescent microscopy is currently the most commonly used method to image cells. It beats its 
competitor methods such as electron microscopy and scanning probe microscopy by its ability 
to introduce molecular targeted contrast and its possibility of live imaging. The resolution of 
fluorescent microscopes (i.e. its ability to separate two different objects) is however limited by 
the diffraction of light. This is described by Abbe (Abbe, 1873) putting the resolution as a 
function of the numerical aperture of the microscope and the wavelength used to excite the 
object. In ideal settings, this number reaches around 200 nm for the visible spectrum in the 
lateral dimension (i.e. in the direction perpendicular to the light propagation) which is bigger 




vesicles are around 40 nm in diameter (Qu, Akbergenova, Hu, & Schikorski, 2009) and therefore 
cannot be resolved by diffraction-limited microscopy.  
 
With the advent of super resolution microscopy that it has been in continues development during 
the last fifteen years, the diffraction limit has been not only overcome, but  subcellular elements 
smaller than 5 nanometers could be imaged (Schermelleh et al., 2019). The super resolution 
microscopy techniques rely on the control or switching “off” and “on” the fluorescence 
emission.  This modulation allows neighboring fluorescent objects to be resolved independently 
of the light diffraction. This control has been exercised mainly in two different ways leading to 
two different categories of super resolution microscopy. One of such categories controls 
spatially the status of the fluorophore. The most commonly used technique that matches this 
category is Stimulated emission depletion (STED) microscopy (Hell & Wichmann, 1994). In 
STED microscopy, the illumination pattern is controlled by scanning the sample with two 
overlapping beams. One beam excites the fluorophore while the other beam has a doughnut 
shape and depletes the emitted fluorescence (STED depletion beam). The fluorescent emission 
of only the center of the doughnut is then recorded (Fig.2.2) 
 
Figure 2.2: The basic principle of STED microscopy. (A) Probability of the fluorophore to emit (Ifluo) 
as a function of the intensity of the STED depletion beam (ISTED). After a certain threshold (Isat) the 
molecule ability to emit is reduced to 50 %. (B) The excitation beam overlaps with a doughnut shaped 
beam that depletes the fluorescence locally. The resulted recorded fluorescence has a narrower 





The second group of techniques controls the status of the emitter temporally. This group of 
techniques falls under the name of single molecule localization microscopy (SMLM). 
Members of this group are Photo-activated localization microscopy (PALM) (Betzig, 2015) and 
stochastic optical reconstruction microscopy (STORM) (Rust, Bates, & Zhuang, 2006). 
Switching the emitter “off” and “on” in a stochastic manner creates a “blinking” pattern that is 
recorded over thousands of frames. The individual, separated localized signals can be fitted with 
a Gaussian and its center position can be precisely calculated. The image is then reconstructed 
from the position of the individual fluorescent molecules. It is worth mentioning a very recently 
developed technique that combines the properties of both STED microscopy and 
PALM/STORM: MINFLUX (Balzarotti et al., 2017). Here, photo switchable fluorophores are 
used and are located through a doughnut-shaped excitation beam. The localization of the emitter 
is determined by the position of the laser, since when located in the center the emission is zero, 
reducing drastically the need of photons required and therefore reaching up to one nanometer 
localization precision (Balzarotti et al., 2017).  
 
The above-mentioned approaches are dependent on the photophysical properties of the 
fluorophores, such as blinking, quantum yield, dark state recovery or bleaching properties. 
Another SMLM technique, termed DNA-points accumulation for imaging in nanoscale 
topography (DNA-PAINT), managed to overcome this dependence (Jungmann et al., 2010). In 
fact, in this approach, the “blinking” pattern is obtained by repetitive transient binding of a 
fluorophore diffusing in the sample solution. A short single-stranded DNA called the imager 
strand carries the fluorophore. The imager strand is complementary to a short single strand DNA 
called the docking strand that is attached to the target (or to an affinity probe binding the target) 
(Jungman et al., 2010) (Fig 2.3). This approach allows 1) overcoming the risk of photobleaching 
of the fluorophore since there is a constant replenishment of fluorophore brought by the 
repetitive binding of the imager strand diffusing freely in the solution 2) fine-tuning of the 
blinking kinetics. The binding duration can be controlled by modulating the stability of the DNA 
duplex formed by imager and docking strand (by modulating GC content, salinity of the imaging 
buffer etc.). While the binding frequency can be controlled by the influx rate of imager strand 
(Schnitzbauer, Strauss, Schlichthaerle, Schueder, & Jungmann, 2017). To overcome the 




the imaging is typically done with a selected plane illumination such as Highly inclined thin 
illumination (HILO), Total internal reflection fluorescence (TIRF), or with a spinning disk 
confocal microscope (Schueder et al., 2017). All of these diffraction unlimited fluorescence 
microscopy techniques enable the localization and study of proteins at high resolution necessary 
for the analysis of synaptic components.  
 
 
Figure 2.3: The principle of DNA-PAINT. The imager strand carrying the fluorophore diffuses in 
solution and bind transiently to the docking strand present on the target. This binding is detected as 
“blinking”: an increase in fluorescence in time. Adapted from (Dai, 2017).  
 
2.4 Multiplexed imaging  
To be able to study the molecular organization of the synapse, there is a need for an imaging 
technique with multiplexing (also known as multicolor) capabilities i.e. imaging several 
different targets of interest in the same sample. This simultaneous detection of targets is 
extremely beneficial because it allows the study of inter-molecular interactions and provides 
contextual information by using markers of structural/functional areas. Limitations of the 
multiplexing capabilities of microscopy techniques lie mainly in the spectral overlaps of 
multiple dyes, the physical limits of the microscope (such as the available filters), and the 
limitations of the affinity probe (Stack, Wang, Roman, & Hoyt, 2014). In the following sections, 
I will outline the fundamentals of these limitations and how they have been partially overcome.  
 
2.4.1 True multicolor imaging 
Organic dyes and fluorescent proteins used in fluorescence microscopy have each of them 




separated in order to unambiguously identify them. Therefore, in fluorescent microscopy, the 
choice of fluorophores is limited to combinations that do not overlap in their emission spectra. 
Most microscopes are able to separate up to 4 different dyes (Stack et al., 2014). To reduce 
overlap of the emission spectra of the different target, quantum dots have been used. Quantum 
dots (QDs), are semiconductor nanocrystals that have a higher brightness and photostability than 
organic dyes (Walling, Novak, & Shepard, 2009). QDs provide the advantage of having a 
narrower emission peak compared to the standard organic dyes enabling better spectral 
separation (Zrazhevskiy & Gao, 2013). However, their cellular toxicity have been the subject of 
debates (Hardman, 2006). Even if the quantum dots are in the nanometer range, they require to 
be conjugated to other molecules in order to target them to the protein or the affinity probe that 
increases their intrinsic size (Weng & Ren, 2006). Spectral overlaps can also be separated thanks 
to spectral imaging and linear unmixing.  This can be done with a standard fluorescent 
microscope equipped with a multispectral camera. The spectra of the fluorophores are registered 
in a library before imaging. The intensity of the fluorophores is then extracted from the 
multispectral data by linear unmixing (Mansfield, Vet Pathology 2014). 
 
Multiplexing is an even more difficult topic when it comes to the super resolution microscopy 
approaches. In fact, PALM/STORM microscopy and derivative techniques that rely on 
switching organic dyes or fluorescent proteins are limited by the requirements of the fluorophore 
(high photon yield and short “on” state to ensure high resolution) and the buffers necessary for 
the blinking. These conditions tend to vary drastically from one fluorophore to another and 
therefore imaging has been limited to 4 super resolved colors in exceptional works (Dempsey 
et al., 2011). STED microscopy suffers from the needs of multiple laser lines to function. For a 
single super-resolved color, both an excitation and a depletion laser are needed, reducing the 
number of available channels for other dyes. STED has been successfully expanded to three 
colors by discriminating the specific lifetime associated to each particular dyes, using dyes with 
a large Stoke shift (emission farther than normal in respect to the excitation wavelength) 





2.4.2 Sequential staining-imaging  
All of the above-mentioned techniques achieve a limited number of targets that can be 
potentially imaged at the same time. To increase this number, cycles of staining and imaging 
have been performed. Between cycles, targeted bleaching, high pH, peroxides, or alkaline 
buffers (Lin et al., 2016) eliminate the fluorescence. The images of the different staining cycles 
are later superimposed. This sequential labelling and imaging strategy are a time-consuming 
methodology. In addition, the sample integrity might be compromised and the inactivation of 
the previous dye might not be completed, leading to artefactual signal cross talk. Recently, a 
protocol has been established to maintain sample integrity and reduce reactive oxygen species 
production, but still guaranteeing proper elution of antibodies (Gut et al., 2018)  
To overcome the sequential staining, other approaches have been developed, where the 
fluorescent moiety is introduced during the imaging process. One example was done by 
Schweller et al., who used dynamic DNA COMPLEXES to sequentially add and remove the 
fluorescence to the targets associated with DNA strands by strand displacement. However, the 
strand displacements required are long reactions, and to “erase” the fluorescence of each target, 
an overnight reaction is needed (Schweller et al., 2012). Another example is an extension of the 
DNA PAINT technique, to what is known as Exchange PAINT (Jungmann et al., 2014). This 
approach relies on the sequential imaging of the different targets by introduction and removal 
of a specific imager strand to the solution. In this way, the different “imager strands” targeting 
the different “docking strands” can carry the same fluorophore. By using the same fluorophore, 
chromatic aberrations can be avoided and the limits due to the availabilities of dyes with 
different emission spectrum can be removed. This expands the targets that can be imaged to 
virtually infinite numbers (Schueder et al., 2017b). This approach has been successfully applied 
for up to 10 targets on a single cell (Agasti et al., 2017). A more recent variant of this technique 
introduced in addition to a DNA sequence barcoding, a kinetic barcoding. Meaning that different 
targets are tagged with different docking strands recognized by the same imager having however 
different frequency and duration of blinking according to the docking strand length of the target. 
In this way, Wade et al. could recognize 124 different DNA origami structure with 97 % 
accuracy (Wade et al., 2019). This method was however not yet applied to a complex sample 






2.5 Aim of this work  
This work primarily aims to establish the basics to study the molecular composition of a 
neuronal synapse in multiplexed super resolution microscopy.  In particular, I aim to 1) bypass 
some of the current limitations of conventional probes used for labeling synaptic targets 2) 
enable the use of alternative probes in highly multiplexed imaging methods.   
To reach these objectives, I first focus on the development of nanobodies targeting the synapse 
and establish a pipeline for their discovery, selection, and validation. To enlarge the number of 
synaptic targets that can be studied, I also aim to characterize systematically the use of secondary 
nanobodies and their advantage over conventional secondary antibodies. Finally, I aim to 
establish a protocol for site targeted conjugation of a single-stranded DNA to nanobodies in 
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Single domain antibodies (also called nanobodies) derive from camelid heavy chain antibodies 
(hcAbs) have been proven a better alternative to conventional antibodies for the detection of 
proteins. However, the current availability and target diversity of nanobodies are limited due to 
the long and laborious production necessary. Here we optimized a pipeline for the production 
of nanobodies targeting different neuronal synaptic proteins. We immunized alpacas with a 
synaptosome preparation enabling potential immune reaction of the alpacas against a wide range 
of synaptic proteins. To assess the generation of hcAbs against a specific protein, we established 
an enzyme-linked immunosorbent assay based protocol. Based on the outcome of this protocol 
we performed phage display selection for those targets. Using this selection approach, we 
successfully generated nanobodies with different binding abilities toward rat Vesicle-associated 
membrane protein 2 (VAMP2), human and mice 2',3'-Cyclic-nucleotide 3'-phosphodiesterase 









3.2 Introduction  
The synapse is an essential component of the nervous system necessary for the transmission of 
signals. To study synapse in depth, we need probes to target their components. Up to now, a 
wide range of probes has been used to target the synaptic proteins. In particular, antibodies 
targeting synaptic proteins keeps enabling different scientific achievement. An example is the 
quantification of synaptic proteins by imaging and biochemical methods (Wilhelm et al., 2014) 
using antibodies. However, antibodies have also been shown to be not ideal probes because of 
their large size, bivalency or limited access to hidden epitopes (Maidorn, Rizzoli, & Opazo, 
2016). Nanobodies are single domain antibodies originating from camelid heavy chain 
antibodies (hcAbs) (Hamers-Casterman et al., 1993) that have been shown to overcomes some 
of the limitations present in conventional antibodies. Thanks to their small size, high solubility 
and monovalent nature nanobodies allow quantitative labeling, lower linkage error and 
consequent higher imaging resolution and decreased probe-induced clustering (Maidorn et al., 
2016; Mikhaylova et al., 2015).  
Nanobodies targeting synaptic proteins were able to reveal a previously unobserved population 
of the Soluble NSF Attachment protein Receptor (SNARE) proteins (Maidorn et al., 2019) and 
were used as tools to inhibit neurotransmitter receptors (Schenck et al., 2017). Due to the scarce 
availability of nanobodies for specific targets, previous studies used nanobodies against 
fluorescent proteins to investigate the neuronal processes. For example, nanobodies against GFP 
were used to measure neurotransmitter receptor dynamics (Modi, Higgs, Sheehan, Griffin, & 
Kittler, 2018) or to study synaptic vesicle redistribution (Seitz & Rizzoli, 2019). However, 
utilizing fluorescent proteins through genetic engineering of cell lines is long and laborious. 
Also, using the fastest transient transfection can impair the endogenous function and localization 
of the protein of interest (Wiedenmann, Oswald, & Nienhaus, 2009).  
To overcome those limitations, we immunized two alpacas (Alp1 and Alp2) with a rat 
synaptosome preparation. This strategy should avoid single immunizations of single purified 
antigens and gives the theoretical potential to generate nanobodies against all synaptic targets 
present in the synaptosomes. When immunizing animals with a complex antigen like 
synaptosomes, it is challenging to predict which proteins present in the synaptosome preparation 




discovery phase. For this reason, we established a protocol based on an enzyme-linked 
immunosorbent assay (ELISA) which assesses the presence or absence of hcAbs (nanobody 
precursor) for specific targets by using the immunized animal serum, before starting the full in 
vitro phage-display process. We termed this assay preELISA and the shortage of available 
nanobodies, and we decided to create a pipeline to identify many different nanobodies against 
different synaptic proteins. To then select nanobodies, we tried a recently published protocol 
claiming to produce a large repertoire of nanobodies against a given antigen by using a 
combination of Next Generation Sequencing (NGS) and Mass spectrometry (MS) (Fridy et al., 
2014). The proof of concept showed by Fridy and colleagues, seemed successful when using a 
single very immunogenic antigen at a time. In fact, they immunized the animal with GFP and 
RFP, which are both very immunogenic proteins not endogenously present in mammals. 
However, we found this approach unsuitable for finding nanobodies in complex immunizations 
like ours using full rat synaptosomes. Several proteins might be too close to the alpacas´ 
endogenous proteins, and therefore they might not produce an immune response to avoid 
generating an auto-immune reaction in the animal. We therefore decided to use the conventional 
approach of phage display. To do so we first generated a nanobody library fused in a customized 
phagemid called here the “minimal phagemid”. This phagemid has a short sequence of 2800 bp 
that guarantees high transformation efficiency and therefore produces nanobody libraries with 
high diversity. We selected nanobodies against rat Vesicle-associated membrane protein 2 
(VAMP2), human and mice 2',3'-Cyclic-nucleotide 3'-phosphodiesterase (CNPase), rat 











3.3 Results  
 
3.3.1 PreELISA for assessment of presence of nanobodies  
Two alpacas were immunized with a synaptosome preparation to allow the selection of 
nanobodies against synaptic proteins. To assess the presence of hcAbs, before starting the 
selection process such as phage display and NGS-MS combination, we established a preELISA. 
As depicted in Fig 3.1 A, the general procedure of preELISA requires a small amount of the 
specific protein of interest, a small amount of serum from the immunized animal, and an 
antibody set coupled to the enzyme horseradish peroxidase (HRP) detecting alpaca antibodies. 
The protein of interest was either immobilized on a 96 well plate in a purified form or by using 
directly the cell lysate of cells expressing the protein of interest. The serum was enriched in 
hcAbs (isoform IgG2 and IgG3) or depleted from the conventional antibodies (isoform IgG1) 
by affinity chromatography. We injected the full serum into a Protein G column. After extensive 
washes, we sequentially eluted the bound fractions with pH 3.5 and pH 2.7 that resulted in two 
distinct peaks, as shown in the chromatogram (Fig. 3.1 B). Those two peaks, according to the 
literature, were expected to contain the majority of IgG3 and IgG1, respectively. We collected 
the flow through and injected it on a Protein A column. Again, a sequential elution at pH 4.0 
and pH 2.7 resulted in two distinct peaks expected to be IgG2 and IgG1, respectively. We then 
ran on ab SDS-PAGE the collected fractions.  The fractions eluted at pH 2.7 showed the 
presence of two bands: a band at 30 kDa that corresponds to the light chain with an expected 
molecular weight (MW) of 25 kDa), and a band at 60 kDa that corresponds to the heavy chain 
with expected MW of 50 kDa. These bands confirm the nature of those fractions as IgG1 
isoforms and where therefore discarded. The fact that the bands in SDS-PAGE showed always 
a higher molecular weight than expected was observed throughout this project and probably 
came from using a ladder displaying expected size not fully optimized to our SDS-PAGE setup. 
The fractions eluted at pH 3.5 and pH 4.0 showed a band running lower than the IgG1 heavy 
chain that corresponds to the heavy chains of IgG3 and IgG2 with and expected MW of 45 and 
43 kDa, respectively confirming the isotype of these fractions (Fig. 3.1 B). In the IgG3 mainly 
enriched fractions, we could observe a light chain contamination, which was further depleted 
by incubation with beads, conjugated to antibody anti llama light chain, however traces of 




Before measuring the actual presence or absence of hcAbs against a specific target, we 
performed a series of negative control experiments. We measured the background signal 
absorbed at 430 nm, which is the wavelength at which the preELISA is revealed, generated by 
the different elements used in the preELISA (Fig. 3.1 C). Then we compared these background 
signals to the absorption at 430 nm of the positive control (PC). The PC consisted of coated cell 
lysate (CL) of cells expressing a control construct detected by an anti-GFP antibody fused to 
HRP. The control construct was composed of the tags, which were fused to the antigens of 
interest: GFP, twin strep-Tag (tst) and HA tag. When analyzing the different negative controls, 
we observed that the incubation on the wells of the anti mouse-HRP alone (NC1) and in 
combination with the mouse anti llama antibody (NC2) displayed low levels of absorption 
compared to the PC. Later during the course of the project, we obtained an antibody anti llama 
directly conjugated to HRP which also showed low background signal compared to the PC (data 
not shown). We also observed that the incubation of CL of cells expressing no exogenous 
proteins or expressing the control construct (NC3 and NC4) displayed low absorption. We also 
tested the stickiness of the enriched serum, to confirm that only the antigen-bound hcAbs will 






Figure 3.1.  preELISA assesses the presence/absence of Nanobody against specific synaptic 
target before starting the selection process. (A)Schematic representation of the preELISA and 
different options (B) HPLC chromatogram of serum enrichment through Protein G and Protein 
A column and elution at different pH depicted in green. FT: Flowthrough i.e. unbound fraction; 
the expected IgG isoform is depicted on the top of the chromatogram peaks. SDS PAGE shows 
that expected isoform are the main component of the collected fractions. (C) preELISA 
preliminary negative controls shows low background absorbance at 430 nm and evident 
difference to positive control.  CL= cell lysate, tst= twin Strep-Tag, HA= HA tag, serum= 
enriched serum, NC= negative control, PC= positive control.  
 
3.3.2 Alternative nanobodies selection through NGS-MS approach  
 
We tested an NGS-MS approach as an alternative to the conventional phage display method to 
select nanobodies. We created a database containing the nanobody sequences from the 
immunized alpacas. To do so we extracted the peripheral blood cells of the animals, isolated 
their mRNA and retrotranscribed the binding domain of the hcAbs (the nanobodies) into cDNA 
by using specific primers. We then performed NGS and in silico translated the data into protein 
sequence database (Fig. 3.2 A upper line). After several NGS runs the database was composed 
of 106 non-redundant nanobodies sequences from the two animals. In parallel, we immobilized 
antigens to select nanobodies able to bind specifically to the antigen of interest; the bound 
fraction was then submitted to MS. (Fig. 3.2 A lower lane). We then determined the sequence 
by matching the peptides revealed by MS to the previously ensemble nanobody database (at the 
protein sequence level).    
We tested this approach for the antigens VAMP2 and Phosphatidylinositol-4-phosphate 3-
kinase C2 domain-containing alpha polypeptide (PIK3C2a) that showed positive preELISA 
(Fig. 3.2B). To reduce the number of non-relevant flying peptides in the MS, which could mask 
the peptides necessary for identification, we digested the hcAbs of the enriched serum with the 
IdeS enzyme. The IdeS enzyme is a cysteine protease which specifically cuts IgGs at their hinge 
region (Von Pawel-Rammingen, Johansson, & Björck, 2002).  The previously observed band at 




a smear of bands ranging between 35 and 15 kDa (Fig. 3.2 C). These bands represent the FC 
domains of the hcAbs and the binding domain with different hinge region lengths. We then 
performed the affinity selection of the nanobodies by incubating the digested hcAbs to 
immobilized antigen. We immobilized on streptactin-coated beads the antigens in two different 
conformations: the native one and the one the antigen is expected to be detected in 
immunostaining i.e. cross-linked by chemical fixation (4% PFA). After binding of the hcAbs to 
the antigen and extensive washing (<2 hours) we eluted the bound nanobodies. For eluting the 
bound nanobodies, we tested different approaches. We eluted either by addition of biotin (EB), 
by denaturation (ED) and in the case of the fixed antigen elution by acidic pH (EA). We 
compared the bands obtained on SDS-PAGE (Fig. 3.2 C). As expected, we observed the band 
representing the antigen when eluting by denaturation of by biotin for the unfixed antigen. The 
elution by denaturation also released the streptactin from the beads leading to a band at around 
10 kDa. The nanobodies are expected to be seen between 35 and 15 kDa however we could see 
just really faint smear or no bands at all (Fig. 3.2 C). This might be due to the low amount of 
target-specific nanobodies present. We cut this particular region and sent it to collaborators to 
be analyzed by MS, and matched the obtained peptides to the nanobody database previously 
created. To ensure the correct matching we established a matching score take took the following 
elements into account:  
1) The number of peptides identified by MS which lead to the identification of a nanobody 
sequence. 
2) The coverage of those peptides to the full nanobody sequence; giving a higher score if the 
peptides covered complementary determining regions (CDRs) of the nanobody.  
3) The uniqueness and the selectivity of the peptide i.e. was the peptide found in the negative 
control or just in the experimental conditions?  
After scoring, manual analysis was performed to narrow down the number of best candidates. 
This was done taking in consideration the similarity of the nanobodies with best scores and their 
amino acids compositions (higher solubility and low amount of cysteine, which would ensure 
proper expression in bacteria).  The DNA sequences of the best ten nanobodies candidates for 
each antigen were then synthetized by a company and cloned into a bacterial expression vector 
containing a 3xFLAG tag for further validation. A high-throughput validation workflow was 




lysate to stain mammalian cells transfected with the target antigen fused to GFP. The presence 
of a binding nanobody to the cell was then revealed by an antibody targeting the 3xFLAG tag. 
A Pearson correlation analysis between the GFP and the 3xFLAG signal was performed. As a 
positive control, an already validated GFP nanobody was expressed in the same vector cassette 
as the nanobody candidates. One of the PIK3C2a Nb candidates, clone 68 gave positive results 
in the established immunostaining workflow validation (Fig. 3.2 D) while VAMP2 did not (data 
not shown).  The clone 68 was therefore analyzed deeply by cloning into a vector containing an 
ectopic cysteine at the carboxyl terminal of the nanobody, by higher scale expression and site 
targeted maleimide labeling to a Cy5 dye. However, in this case the GFP signal and the Cy5 did 
not correlate (Fig. 3.2 E). We then tested the efficiency of the PIK3C2a nanobodies candidates 
to recognize their target in a native conformation by Nb pull down of the target. A Western Blot 
was also performed identifying the bound nanobody through its 3xFLAG tag (Fig. 3.2 F). 
Interestingly clones that did not work in immunostaining, recognized successfully the target in 
this experimental setting. Suggesting that the epitope of these nanobodies might be modified by 
the use of chemical fixatives, which impairs the nanobody binding to the aldehyde fix target 







3.3.3 Synaptosome library generation in minimal phagemid enables higher transformation 
efficiency 
 
Due to the relatively high cost and poor results with the NGS-MS approach, we turned to the phage 
display method to select nanobodies against synaptic targets. We used a nested PCR approach to 
retro transcribe and amplify the nanobody sequences from the total mRNA of the peripheral blood 
mononuclear cells (PBMCs) of the immunized animals (Fig. 3.3 A). Animal´s blood was drawn 
several times after the last boost immunization and the mRNA samples were processed to perform 
the nested PCRs. The PCR product obtained was at the expected base pair size of an average 
nanobody (around 800 bp) (Fig. 3.3 B).  Those PCR were pooled and cloned into a modified 
version of phagemid that contains a truncated version of the pIII coat protein of the M13 
bacteriophage. The reduced size should allow a more efficient transformation efficiency in TG1 
bacteria leading to library with high diversity. The phagemid elements are: a Lac operon, a signal 
peptide to lead the assembly of the phage particles to the periplasm of the bacteria (pelB), a 
3xFLAG tag to facilitate the validation process and a TEV protease site to permit removal of the 
3xFLAG tag and pIII if necessary (Fig. 3.3 C). The phagemid has an antibiotic resistance against 
Trimethoprim (Tmp) which has a shorter sequence than the commonly used Ampicillin (Amp) and 
Kanamycin (Kan) reducing further the plasmid size. The minimal phagemid has a mCherry at the 
site in which the nanobodies should be inserted by cloning, enabling the analysis by eye if the 
proper transformation of the nanobody. By looking at the lack of red color of the plated bacterial 
colonies could estimate that 99% of the transformant have lost the mCherry. It is convention to 
estimate the diversity of the nanobody library created by plating dilution of the transformation and 
counting the number of colonies grown on a selective agar plate. For each transformation we 
obtained around 3x106 clones. We repeated this transformation 20 times and pooled the obtained 






Figure 3.3: (A) Schematic of three step PCR retrotranscribes mRNA, amplify the variable domain 
of the heavy chain antibodies and prepare for cloning in the phagemid. Arrows represent the 
primers. (B) 1.5 % Agarose gel displaying 75 µg DNA. The negative controls (NC) is no starting 
RNA, shows positive signal displaying probable bench contamination. (C) Schematic 
representation of main components of the minimal phagemid 
 
 
3.3.4  Phage display allowed selection of synaptic nanobodies 
 
The proteins tested in preELisa that showed an absorption value at least two-fold higher than the 
negative control was considered antigens with potential possibilities to find specific nanobodies 
(positive preELISA). For those proteins, we performed between two and three panning rounds of 
phage display. We then picked around 90 colonies to confirm the binding ability of those cloned 
by phage ELISA, an ELISA assay detecting the presence of bound phages with an HRP-coupled 
antibody anti M13 phage major coat protein. The positive clones in phage ELISA were then 
sequenced and translated to protein sequences. We manually inspected their sequence, focusing 
mainly on the CDR3 region, the highly diverse region of nanobodies thought to be the most 




with a high content of hydrophilic amino acids and a low number of cysteines to ensure high 
solubility and proper cytosolic bacterial expression. We then validated those nanobodies 
candidates by a first indirect immunostaining using the bacterial lysate and detecting the 3xFLAG 
tag of the phagemid and comparing the localization of this signal to the target of interest fused to 
GFP expressed in a mammalian cell line. If positive, the nanobody candidates were then cloned in 
an optimized vector for nanobody expression in bacteria and transformed in SHuffle competent 
cell, an E. coli strain optimized for promoting the proper disulfide formation on proteins expressed 
in the cytoplasm of the bacterium. The vector also contains an extra cysteine at the carboxy-
terminal of the nanobody to enable site-directed dye conjugation which was performed with 
maleimide-functionalized fluorophores. The nanobodies were then tested on antigen transfected 
mammalian cell lines to confirm their specificity on cells and later in primary neuronal cultures. 
If the nanobody candidates did not perform well in immunostaining after aldehyde fixation of the 
sample they were tested with antigens in native conformation on biochemical assays.  
 
VAMP2 
VAMP2 is one of the SNAREs involved in the vesicle recycling and neurotransmitter release and 
has been shown to modulate the gating of potassium voltage gated channels (Lvov et al., 2009). 
This protein displayed a promising result in the preELISA (Fig. 3.4 A), but lead to no functional 
nanobody candidates by the NGS-MS approach is VAMP2. We decided therefore to select 
nanobodies for this target by phage display. After two pannings of phage display, we performed a 
phage ELISA in which the 17 Nb candidates resulted positive in the phage ELISA (Fig. 3.4 B). 
Alignment of their CDR3 showed different amino acids composition and distribution, showing 
good diversity representation in our results. These nanobody candidates were tested in 
immunofluorescence. To do so in a fast and effective way we used the bacterial lysate of the 
bacteria expressing each nanobody directly as staining material. We verified that the nanobodies 
were expressed in the bacterial lysate by WB revealing the 3xFLAG tag fused to the C terminus 
of the Nb (Fig.4C). We incubated the bacterial lysate on cells transfected with VAMP2 fused to 
GFP. Out of the 17 Nb candidates, 15 did not show specific staining (example clone C3 Fig. 4C), 
while two candidates (clone E2 and G3) showed specific staining to the transfected cells and no 




nanobodies stained specifically the membrane of the cells which is the location where VAMP2 is 
expected to be located, while the GFP signal was also visible in the nucleus. This confirmed us 
that the two candidates E2 and G3 seems to recognize specifically VAMP2. We, therefore, cloned 
these candidates into a bacterial expression vector and coupled it to a Cy5 dye. However, the signal 
from the directly labelled nanobodies (E3 & G3) failed to correlate to the VAMP-GFP signal on 






















Bassoon and Homer1 
Bassoon is a scaffold protein located in the presynaptic active zone and has been shown to be 
involved in processes such as autophagy and protein ubiquitination (Ivanova et al., 2015; Terry-
Lorenzo et al., 2016). Homer1 is a scaffold protein present at the postsynaptic density of the post 
synapse involved in intracellular calcium release (Hayashi et al., 2009). Those two proteins have 
been commonly used as pre and postsynaptic markers. In the preELISA they showed positive 
signal with two-fold higher than the negative control (Fig. 3.5 A). We performed 3 panning rounds 
of phage display for each of the two antigens. We obtained 40 positive clones in the phage ELISA. 
After manual inspection of their sequences, we noticed that most of the sequent obtained were 
redundant or with minor amino acids substitution. Highly represented sequences might indicate 
proper expression of the nanobody and high binding capacities; we selected therefore 16 nanobody 
candidates for Homer1 and 6 for Bassoon.  Those nanobody candidates did not show specific 
signal in indirect immunostaining (data not shown). Therefore, we tested their binding abilities by 
performing an ELISA with different concentration of antigen (between 0 and 100 ng) coated on 
the well of an immunosorbent plate (Fig. 3.4 C). We termed this approach “ramp ELISA” due to 
the increasing amounts of coated antigen on different wells. The Bassoon candidates showed 
binding to the antigen when at least 10 to 100 ng of antigen was coated. Homer1 candidates seemed 
to have higher binding abilities with A1 homer candidate detecting as few as 0.1 ng, showing good 
affinity toward their target in a biochemical assay.   
 
CNPase  
We also screen for nanobodies against two isoforms of CNPase (human and mouse), a myelin-
associated enzymes (Sakamoto, Tanaka, Ichimiya, Kurihara, & Nakamura, 2005). Three panning 
rounds of phage display were performed for each. The phage ELISA performed on coated human 
CNPase gave rise to 10 positive colonies, while the one performed on coated mouse CNPase 
showed all picked colonies positive. Colonies from phage ELISA were sent for sequencing and 





Figure 3.5: Nanobodies recognizes ng amounts of pre and postsynaptic markers. (A)  PreELISA test shows 
presence in the animal serum of hcAbs against Homer and Bassoon. (B) More than 40 Nb candidates were 
positive in phage ELISA after 3 panning rounds of phage display (C) The Nb candidates were able to detect 
low amount of protein coated on an ELISA. x axis displayed in log10 scale for better visibility. 
 
binding ability was tested with a ramp ELISA, coating between 0 and 10 pg of human CNPase or 
mouse CNPase on the well of the immunosorbent plate. The affinity of the nanobodies towards 
their target seemed high, with candidates detecting as few as 0.1 pg. The specificity of the 4 
nanobodies displaying best affinity in the ramp ELISA was then tested in immunofluorescence. 
We coupled these nanobodies to Aberrior Star 635p and stained a sciatic nerve of mouse obtained 
from our collaborator (Dr. Hauke Werner; Max Plank Institute for Experimental Medicine). We 




(MAG) as reference. We could see that the signal of the nanobody was overlapping with the signal 
coming from MAG, showing colocalisation to myelin and therefore specificity to the Schwann 
cells expressing CNPase. We could also observe accumulations of nanobody signal that might 
depict the borders of the nodes of Ranvier (Fig. 3.5 D). We also obtained from our collaborator a 
sciatic nerve preparation of CNPase knock out (KO) mouse (Fig. 3.5 D). The lack of observed 




















Synaptotagmin 1 (Stg1) is another antigen that showed a positive signal in the preELISA (Fig. 3.6 
A). It has a calcium sensing ability that plays a regulatory activity in neurotransmitter release at 
the synapse (Fukuda et al., 2000). After three panning rounds of phage display (Fig. 3.6 B) and 
manual inspection of the sequence of the picked colonies, the nanobodies candidates against Stg1 
were narrowed down to six. We expressed them in SHuffle bacteria, purified and conjugated to 
Aberrior Star 635p. When tested on COS-7 cells transfected with Stg1-GFP, the signal of the 3 
nanobody clones (A9, A5, H1) colocalised with the GFP signal showing specificity (Fig. 3.6 C). 
We therefore stained endogenous Stg1 in neurons. We co-stained with Synaptophysin antibody, a 
protein enriched in synapses, and we observed colocalisation of the two targets and bright signal 
for the clone A5, confirming the specificity of the nanobody (Fig. 3.6 D). Next, we measured the 
affinity of this nanobody to its target with microscale thermophoresis and determined its kD to 0.7 

























Our approach establishes a pipeline to simplify and fasten the selection of nanobodies against 
different targets at the same time. The immunization of the alpacas with a full synaptosome 
preparation, containing several synaptic proteins (Fornasiero et al., 2018) might lead to the 
generation of hcAbs against many different targets at the same time. Single immunizations would 
have required cloning, expression, production, and purification of high amounts of every single 
synaptic protein. In addition, the immunization and boost before drawing the blood of the animals 
can take up to 4-6 months. In our case, we combined these steps by using a synaptosome 
preparation as a complex antigen. This allowed us to overcome the time, cost and effort necessary 
for single immunization of antigen.  However, the complexity of the antigen preparation we used 
for injection cannot guarantee the immunogenicity of every single protein present in the 
synaptosome. In addition, for the production of nanobodies, the immune response needs to be 
hcAbs based. In fact, new world camelid contains ~50 % of hcAbs (IgG2 and IgG3 isoforms) and 
~50 % of conventional IgGs (IgG1) (Hamers-Casterman et al., 1993), which we confirmed by the 
amounts obtained during the serum enrichment in IgG2 and IgG3 (Fig. 3.1 B). This implies that 
the synaptic protein of interest even if immunogenic, might have not triggered the generation of 
hcAbs and it will therefore not be possible to select nanobodies against such target.   
Therefore, we established an assay named preELISA that assesses the presence of hcAbs against 
a specific target of interest in the animal serum.  The preELISA uses a minimal amount of serum 
extracted from the animal and a minimal amount of protein to be investigated. It allows us to give 
an estimate on the success of the in-vitro selection process performed via phage-display (Fig. 3.1).  
We selected nanobodies from these animals following two different approaches. The first consisted 
of the creation of a database of the nanobody sequences obtained from the B cells of immunized 
animals, followed by the antigen-specific identification of nanobodies from the animal serum by 
MS (Fig. 3.2 A). However, we found that this approach was not successful for us for multiple 
reasons. First, it is a method that requires two complicated and costly techniques, MS and NGS, 
which expertise are usually not found in the same laboratory. Therefore, those needs to be 
outsourced either to collaborators, which might become time lengthy, or to professional facilities, 
which becomes costly. Secondly, the identification of the nanobodies is related to the efficiency 




detected nanobodies in MS have a sufficient affinity for our final desired application. On the same 
line, the expression feasibility in bacteria cannot be predicted (NGS from cells, MS from 
circulating hcAbs; the nanobodies never passed through any bacteria expression). These last two 
points increase the probability of selecting nanobodies, which might not fit future purposes: to be 
expressed in bacteria and to have high affinity towards their targets necessary for immunostainings 
protocols. Finally, the already high costs of MS and NGS are further increased in this approach 
since selected nanobodies need to be ordered as synthetic genes to proceed with their subsequent 
validation steps.  
Phage display was a faster, cheaper and amore successful nanobody selection method in our hands.  
The use of a minimal phagemid (Fig. 3.2 C) with a smaller size compared to commonly used 
phagemid, enables theoretically a good transfection efficiency and the creation of a highly diverse 
nanobody library. This diversity was further confirmed by the selection of nanobodies with highly 
diverse CDR sequences. Testing nanobodies in immunofluorescence is laborious since it requires 
cloning the nanobodies in a new expression vector, purifying them and coupling them to a dye. 
For this reason, we established a quick immunostaining by using the bacteria lysate containing the 
nanobody clone and detect its presence by detecting the 3xFLAG Tag fused to the nanobody with 
a fluorescently-labeled monoclonal anti FLAG tag. This strategy saved us time and narrowed down 
the number of nanobodies to be tested in a “cleaner” immunostaining manner. Nanobodies 
candidates against VAMP2 selected by phage display (Fig. 3.4) however worked in bacterial 
lysate-based staining but not when the nanobody was purified and directly conjugated to a dye. 
This problem might come from two different factors: 1) the solubility introduced by the pIII protein 
that is still fused to the nanobody while doing this approach 2) the presence of the pelB signal 
leading the expression of the nanobody in the periplasm, instead of the cytoplasm.  
ELISA is a method of choice for handling of multiple conditions/candidates at the same time. 
Therefore, establishing a “rampELISA” allowed us to observe if the nanobody binding to the 
antigen is dose-dependent, and also to have a draft estimation of the binding strength of the 
nanobody candidate to their targets. For Bassoon and Homer1, the majority of the nanobodies 
candidates did not show good results in the rampELISA and indeed they did not work in final 
immunostainings. (Fig. 3.5). On the other hand, Stg1 nanobodies candidates showed good results 




staining in COS-7 cells and neurons and by binding affinity measurement that resulted in sub-nM 
range (Fig. 3.6 C-E). 
Combination of preELISA, phageELISA and rampELISA and staining method represents an 
optimized pipeline for the selection of nanobodies after a complex immunization of a camelid such 
as the synaptosome preparation. This pipeline will in the future enable a major production of 
nanobodies against different targets in future nanobody discovery projects.  
 
3.5 Material and methods  
 
Cell culture  
COS-7 cells and Rat primary hippocampal neurons were prepared and maintained as described in 
Chapter 5. HEK293FT cells (Invitrogen) were cultured in DMEM high glucose (Lonza), 
supplemented with: 10% fetal bovine serum (FBS), 0.1 mM MEM Non-Essential Amino Acids, 4 
mM L-glutamine, 1 mM MEM Sodium Pyruvate, 0.6% Pen-Strep and 500 μg/ml Geneticin. The 
cells were maintained at 37°C with 5% CO2 and splitted every 2-3 days.  
 
Immunization of alpacas  
The synaptosome preparation was performed as described by Fornasiero et al. (Fornasiero et al., 
2018). Briefly, rat brains were homogenized using a glass-Teflon homogenizer in precooled 
sucrose buffer (320 mM Sucrose, 5mM HEPES, pH 7.4). Centrifugation at 1000 xg for 2 min was 
performed, and the supernatant was further centrifuged at 15’000 xg for 12 min. Next, a 
discontinuous Ficoll density gradient was applied. The fractions at the interface of the 9% Ficoll 
were pooled and washed in sucrose buffer.  Two alpacas (named Alp1 and Alp2) were immunized 
with this preparation. The procedure was performed by Preclinics (Postdam, Germany).    
Six injection were performed weakly with 500 µg of rat synaptosomes (total protein determined 
by BCA assay). Two weeks after the last immunization a single boost with 500 mg synaptosomes 
was performed and 100 ml of blood was taken 3 and 5 days after the boost immunization. PBMCs 
were isolated using Ficoll gradient and Serum was stored at -80°C. Total RNA was extracted using 





Enrichment of hcAbs from complete serum  
Serum from the animal was enriched in IgG2 and IgG3 following the protocol described by 
Hamers-Casterman et al. (Hamers-Casterman et al., 1993) with some modifications. The affinity 
selection steps were done using an Äkta-Prime FPLC system (GE Healthcare). Between 5 and 10 
mL of serum was diluted in PBS in a one to one ratio and filtered through a .45 μm pore size 
Syringe Filters (Stedim Minisart®, Sartorius). The serum was then injected in HiTrap protein G 
HP (GE Healthcare), the flowthrough was collected and injected in HiTrap protein A (GE 
Healthcare). The bound IgGs were eluted from the HiTrap protein G column with first 0.15 M 
NaCl, 0.58% Acetic acid, pH 3.5 to collect mainly IgG3 and then : 0.1 M glycine–HCl, pH 2.7 to 
collect mainly IgG1. The IgG bound to the HiTrap protein A column were eluted with 0.15 M 
NaCl, 0.58% Acetic, pH 4.0 to collect the IgG2. To neutralize the pH of the collected fractions, 1 
M Tris-HCl pH 9.0 was added and the buffer was exchanged to PBS by injection in HiTrap 
Desalting Columns (GE Healthcare). A sample of the collected and desalted fractions were 
analyzed by denaturing (SDS) discontinuous Polyacrylamide Gel Electrophoresis (PAGE) as 
described by Gallagher (Gallagher, 2012). IgG2 and IgG3 fractions were pooled together, and 
residual IgG1 were further removed by incubating the pooled sample with beads conjugated with 
anti-llama light chain (Capralogics).  
 
Nb library generation for phage display  
The mRNA was extracted from the B cells of Alp1 and Alp2 using standard total RNA extraction 
kit (Qiagen). 28 µg of total mRNA diluted in RNAse free water was retrotranscribed to cDNA by 
using Supercript IV (Invitrogen) and the Cal 0002 primer designed originally by Pardon et al. 
(Pardon et al., 2014). Then a first PCR was performed using Cal0001 and Cal0002 (Pardon et al., 
2014) which anneal in conserved regions of the nanobodies, the leader signal sequence and the 
CH2 domain respectively. PCRs were done using KAPA PCR mix high fidelity (KAPA 
Biosystems) and after each PCR, Sera-Mag Select (GE Healthcare) was used to remove primers 
and small fragments. Next, a second PCR was performed to introduce the cloning overhangs for 
further insertion in the phagemid using a variety of degenerated primers described by Pardon et al. 
A final PCR was performed using primers annealing to the cloning overhangs to increase the 
efficiency of cloning. The final PCR product were diluted to 5 ng/µL and 75ng were loaded on a 




were cloned in the phagemid by using Gibson assembly (D. G. Gibson et al., 2009). The phagemid 
used is a modified and smaller version of the pHen2. It contains a pelB leader sequence, an 
mCherry at the position in which the nanobodies should be inserted, truncated version of PIII 
surrounded by cloning overhangs, a TEV cleavage site, a 3x FLAG tag and a gene for 
Trimethoprim (Tmp) resistance. After Gibson cloning, the obtained construct was purified by PCR 
purification kit (Quiagen) and the concentration was measured by Nanodrop (PeqLab). The 
construct was then electroporated in TG1 bacteria (Biocat). For the transformation, 65 ng of DNA 
were added to 50 L of TG1 and this process was repeated 20 times. The reactions were left 1 hour 
at 37°C 300 rmp for initial growth and then pooled together in 400 mL of 2YT medium 
(ThermoFisher) supplemented with 20 µg/mL and let grow overnight at 37°C.  The next day when 
OD600 reached 10, the bacteria were pelleted for 15 min at 4000 xg and resuspended in 25 mL 
LB medium (ThermoFisher) and 25 % Glycerol. The library was aliquoted, snap freezed and stored 
at -80 °C.  
 
ELISA as PRE test 
In order to detect the presence of hcAbs prior the affinity selection process of nanobodies, an 
ELISA was performed in the following way. Purified antigen was immobilized on a 96 well 
immunosorbent plate. All the following steps were done by gentle shaking on a platform shaker. 
The immobilization of the antigen was done either by direct adsorption to the plastic or by using 
streptaviding-biotin interaction. For the first approach, 300 nmol of purified protein diluted in 200 
µL 100 mM Tris, 150 mM NaCl (pH 8) were coated overnight at 4°C on an immunosorbent plate 
(Iba). For the second approach, the cell lysate of transfected cells expressing protein fused to twin-
Strep-Tag was incubated on Strep-Tactin® coated microplate (Iba). The plate was then washed 
with PBS and blocked with 5% (w/v) Milk in PBS either overnight or for 3 hours at RT. After 
rinsing the wells with PBS, the enriched serum prepared as described above, was added to the 
wells in a concentration of 0.5 mg/mL. The serum was let incubated on the wells for 2 hours at 
RT. A series of three washes with PBS for 10 min each was performed to remove the unbound 
IgGs. The presence of bound IgG2 and IgG3 was then revealed with the addition of monoclonal 
mouse anti-Camelid antibody coupled to HRP (Preclinics, clone: P17Ig12) diluted 1:2000 in PBS. 
The antibody was let incubated for 2 hours at RT, then washed 3 times with PBS for 10 min. The 




color was stable (around 5 to 10 min). The reaction was quenched by addition of 100 µL of 1 M 
sulfuric acid. The plate was then imaged at 430 nm with a plate (BioTek Cytation).  
 
Phage Display  
Phage display was performed to select nanobodies against specific target. The procedure was done 
as described in Maidorn PhD Thesis 2017 with some modifications. All steps described below 
were performed under a fume hood to avoid contamination of other bacterial cultures used in the 
lab. To start the process, a 1 mL aliquot of the previously generated nanobody library was diluted 
in 500 mL of 2YT supplemented with 20 µg/mL of Tmp and 4% Glucose and let grow at 37°C  
120 rpm until OD600 reached 0.5. Next, M13KO7 Helper Phages (NEB) were added to the culture. 
The bacteria were let being infected for 45 minutes at 37°C with gentle shaking. Bacteria were 
then pelleted for 10 min at 4000 xg and the pellet was resuspended in 500 mL 2YT medium 
supplemented with 20 µg/mL of Tmp and 50 µg/mL of Kanamycin (Kan) which resistance is 
carried by the helper phage. The infected bacteria were then incubated overnight at 30° C 120 rpm 
to produce the phages. The next day the culture was centrifuged 10 min 4000 xg and the 
supernatant containing the secreted phages was incubated with 4 % (w/v) PEG-8000 to be 
precipitated. The phages were let precipitated on ice for <2 hours. The phages were further pelleted 
by centrifugation at 4°C 4000 xg for 30 minutes. The pellet was resuspended in precooled PBS, 
and 4% PEG was further added to the phages and let on ice for 1 hour to precipitate. The phages 
were again centrifuged 4°C 4000 xg for 30 minutes and the supernatant was collected. Next to 
remove residual bacterial debris, the solution was centrifuged 5 min at 4000 xg and filtered with a 
0.45 µm syringe filter (Sartorius).  
To proceed with the affinity selection of the nanobody targeting specific protein, a phage display 
panning round was performed. The antigens fused to twin Step Tag were immobilized on 
MagStrep XT beads (Iba). Between 3 and 10 nmol of antigen was incubated with 200 µL of beads 
previously equilibrated to PBS. The other antigens not containg the twin Strep Tag were first 
desthiobioninilated by addition of 10-20 molar excess of Desthiobiotin-N-Hydrosuccimide Ester 
(Beryy and Associates) in carbonate buffer for 1 hour at 4°C. The reaction was arrested by addition 
of 0.1 M Tris-HCl. Between 1 and 3 nmol of antigen was bound to 250, 500 or 750 µL of pre-
equilibrated DynabeadsTM MyOne Streptavidin C1 (ThermoFisher) for 1 hour at RT. After 




with 0.01 % (v/v) Tween (PBS-T). Next, the previously produced phages were added to the beads 
and incubated 2 hours at RT with slow shaking. To ensure the high affinity of the selected 
nanobodies, the beads were washed from unbound or loosely bound phages by at least three washes 
10 min with PBS-T and one wash overnight with PBS-T at 4°C. The bound phages were then 
eluted with buffer BXT (Iba) containing 50 mM Biotin. The eluted phages were then used to 
reinfect TG1 cells. To ensure that the TG1 cells express the F’-pilus necessary for infection of 
phages, they were grown on M9 minimal medium (90 mM Na2HPO4, 22 mM KH2PO4, 18 mM 
NH4Cl, 9 mM NaCl, 0.2 & w/v glucose, 1 mM MgSO4, 0.1 mM CaCl2 in 1 L H2O containing 15 
g agar and 1 µg thiamine) for 3 days before infection. From this minimal plate, one colony was 
picked and grow in 50 mL 2YT medium at 37°C. The eluted phages were added to this TG1 culture 
and let infect for 1 hour at 37°C 30 rpm. The bacteria were then pelleted and resuspended in 
selective media to continue with phage production, phage precipitation and panning as described 
above. For each antigen two to three panning rounds were performed. After the panning rounds, 
the infected TG1 culture was pelleted by centrifugation 4000 xg for 20 min and resuspended in 5 
mL 2YT. This concentrated liquate culture was plated on LB agar supplemented with 20 µg/mL 
of Tmp in different dilutions and let grow overnight at 37°C. The next day around 90 colonies 
were picked to be analysed. The picked colonies were dipped in the wells of a 96-well round-bottom 
plate containing 200 μl 2-YT medium supplemented with 20 μg/ml Tmp and let grown overnight at 37°C 
120 rpm to be used for Phage ELISA. The next day, 5 µL of bacteria were transferred to fresh 200 µL 2YT+ 
20 µg/mL Tmp and grown at 37°C 120 rpm for 3 hours. The rest of the culture was supplemented with 25 
% (v/v) glycerol and stored at -80 °C.  
 
Phage ELISA 
In order to screen for the correct binding of the selected nanobodies to their target, an ELISA was 
performed (the phage ELISA).  The bacteria grown in the 96 well plate, were infected with 
MK13KO7 Helper Phages 37°C 30 rpm for 1 hour. The bacteria were then pelleted 4000 xg 15 
min, the pellet was then resuspended in fresh 200 µL 2YT supplemented with 20 µg/mL Tmp and 
50 µg/mL Kan. The culture was incubated overnight at 30°C 120 rpm for phage production. The 
next day, bacteria were pelleted and the supernatant containing the phages was transferred to a 
new plate and stored at 4°C until being used for the Phage ELISA. The antigen was immobilized 




overnight at 4°C with slow shaking. The next day, the wells were washed 3 times 10 min with PBS 
and the wells were blocked using 5% Milk in PBS-T for 3 hours at RT. Next, 25 µL of phages 
produced by the picked colonies were incubated on the well with 75 µL 5% Milk in PBS for 2 
hours at RT. The unbound phages were then washed with PBS-T for 3 times 10 min, and the bound 
phages were detected with anti major coat protein M13-HRP (Santa Cruz) diluted 1:1000 in 100 
µL PBS. The antibody was let for 1 hour at RT and washed away with PBS 3 times 10 min. The 
signal was detected with 100 µL TMB substrate until no drastic change in color could be detected. 
The reaction was stopped by addition of 100 µL of 2M sulfuric acid. The plate was images as 
described before at 430 nm. The “ramp ELISA” used for determining the binding affinity of the 
nanobody candidates toward different amounts of target was performed in the same way as a phage 
ELISA with the difference that logarithmic dilutions of the antigens were coated in different wells.  
 
Protein expression and purification 
Protein expressed in bacteria:  
The DNA constructs were electroporated in different E. coli according to the protein to be 
expressed: SHuffle T7 (Biolabs) for nanobodies and NEB Express (Biolabs) for other type of 
proteins. To express the proteins, bacteria were scraped from a previously made glycerol stock and 
inoculated to 5 mL of Terrific Broth (TB) (Thermofisher) supplemented with appropriate 
antibiotics. The bacteria were let grown overnight at 37°C. The next day the 1 mL of this pre-
culture was diluted in 100 mL of fresh TB with antibiotic. After 3 to 6 hours of incubation at 37°C, 
120 rpm, the expression of the protein was induced by addition of 1 mM Isopropyl-β-D-
thiogalactopyranosid (IPTG) and let overnight at 37°C 120 rpm. The next day 5 mM 
Ethylenediaminetetraacetic acid (EDTA) was added to the culture and the bacteria were harvested 
by centrifugation at 4°C for 30 min 3600 xg. The supernatant was discarded and the pellet was 
resuspended in precooled Buffer 1 (50 mM HEPES, 0.5 M NaCl, 25 mM imidazole, 5 mM MgCl2, 
pH 8) supplemented with 1 mM PMSF, 1 mM DTT, 500 µg/ml lysozyme and 100 µg/ml DNaseI 
(Sigma-Aldrich). The bacteria were then lysed by sonication using three times 10 pulses at 95 % 
in a cell disruptor (Branson Digital) and the cell debris were removed by centrifugation at 4°C for 
1 hour 16000 xg. The supernatant was then added to Ni+-resin beads (Roche) pre-equilibrated in 
Buffer 1. The protein was let to bound to the beads by incubation at RT for 1h with gentle shaking. 




1 supplemented with 500 mM imidazole and adjusted pH 7.5. The eluted protein was then analyzed 
by SDS-PAGE as described above.  
 
Protein expressed in mammalian system.  
Plasmid coding for the antigen was transfected in HEK293FT cells (Invitrogen) using 
polyethylenimine (PEI, Sigma-Aldrich) as transfection method following the protocol by Longo 
et al.(Longo et al., 2013). In brief, 40µg of DNA was diluted in reduced serum medium Opti-MEM 
(Gibco), while PEI was diluted in PEI. The two solution were mixed and incubated for 15 min at 
RT. The mixture was then added dropwise to the cells previously seeded on a 14 cm petri Dish. 
The cells were let expressing the protein for two days at 37°C with 5% CO2.  Two days after 
transfection, the cell media was removed and the cells were washed briefly with prewarmed PBS 
which was then removed. The lysis was then carried on ice by adding 50 mM Tris/HCl, pH 7.5, 
150 mM NaCl, 2 mM EDTA, 0.5% IgePAL, 0.5 % Sodium deoxycholate and freshly added 1:1000 
DNAse 1:1000 Protease inhibitors Aprotinin, Leupeptin, Pepstain A, 1 mM PMSF  1:1000 
protease inhibitor cocktail. The cells were with cell scraper and the lysate was collected into a tube 
and let on ice for 40 min with occasional vortexing. The cells were then sonicated using a cell 
disruptor using one pulse of 45 seconds 70%. The cells debris were then removed by centrifugation 
for 45 min at maximum speed on a table top at 4°C centrifuge. The supernatant then used as a cell 
lysate.   
Nanobody coupling to fluorophore 
In order to label the nanobodies, they were expressed with an additional Cysteine at their C 
terminus. This allow site targeted maleimide coupling without interfering with the nanobody 
conformation and binding capabilities (Pleiner et al., 2015). To reduce the intermolecular disulfide 
bonds, tris(2-carboxyethyl)phosphine TCEP was added in 50 molar excess to the nanobody and 
let for 2 hours on ice. The excess of TCEP was removed by NAP5 columns (GE Healthcare) 
previously equilibrated with PBS. The dye with a maleimide function was added to the nanobody 
in 3-5-fold molar excess and incubated at RT for 2 hours in the dark. The excess of dye was 
removed by using Superdex™ 75 increase 10/300 GL column (GE Healthcare) on Äkta-Prime 





KD measurement  
The affinity of the nanobodies were measure by microscale thermophoresis using the device 
NT.115 Pico (Monolith). Nanobody labelled with Aberrior635p was diluted in MST buffer 
(Nanotemper) supplemented with 0.05 % Tween and incubated with different dilutions of the 
target protein. Measurement were done using the Premium Capillaries (Monolith). For operation 
of the instrument and evaluation of affinity data, the MO.Control and MO.Affinity Analysis 
software (NanoTemper) were used.  
 
Microscopy Setups 
The microscopy setups used in this chapter are the same described in Chapter 5. 
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4.1 Abstract:  
DNA-PAINT is a rapidly developing fluorescence super-resolution technique which allows for 
reaching spatial resolutions below 10 nm. It also enables the imaging of multiple targets in the 
same sample. However, using DNA-PAINT to observe cellular structures at such resolution 
remains challenging. Antibodies, which are commonly used for this purpose, lead to a 
displacement between the target protein and the reporting fluorophore of 20-25 nm, thus limiting 
the resolving power. Here, we used nanobodies to minimize this linkage error to ~4 nm. We 
demonstrate multiplexed imaging by using 3 nanobodies, each able to bind to a different family of 
fluorescent proteins. We couple the nanobodies with single DNA strands via a straight forward 
and stoichiometric chemical conjugation. Additionally, we built a versatile computer-controlled 
microfluidic setup to enable multiplexed DNA-PAINT in an efficient manner. As a proof of 
principle, we labeled and imaged proteins on mitochondria, the Golgi apparatus, and chromatin. 
We obtained super-resolved images of the 3 targets with 20 nm resolution, and within only 35 
minutes acquisition time. 
Keywords: Nanobodies, Super-resolution microscopy, multi-color imaging, fluorescent proteins, 
microfluidics, DNA-PAINT, molecular localization, single domain antibodies (sdAb), 















Super-resolution light microscopy is developing rapidly, and a growing number of cell 
biologists are embracing this technology to study proteins of interest (POI) at the nanoscale. Single 
molecule localization techniques like PALM[1], (d)STORM[2], [3], and others[4] achieve 
resolutions that allows for distinguishing molecules that are separated by only a few nanometers. 
Among these localization techniques, DNA Point Accumulation for Imaging in Nanoscale 
Topography (DNA-PAINT)[5] has demonstrated to achieve a resolution below 5 nm on DNA 
origami structures[6], [7] and offers the possibility to detect multiple POIs within the same 
sample[8]. A special feature of DNA-PAINT is that it is not limited by photobleaching of the 
fluorophore, due to the constant replenishment of fluorophores from solution.  In fact, a target site 
carries one or more single stranded DNA oligonucleotides (commonly referred to as the docking 
strand or handle) instead of a single fluorophore, while a second single stranded DNA molecule 
with a complementary sequence to the docking strand bears a fluorophore (referred to as the imager 
strand). In a DNA-PAINT experiment, the imager strands continuously bind to the docking strands 
and unbind due to thermal fluctuations. The continuous transient binding of the imager strands 
results in sparse “blinking-like” fluorescence detection events. Similar to PALM or STORM, these 
events are then precisely localized to reconstruct a super-resolved image. The localization 
precision depends on the number of photons collected in a single event, whereas the total number 
of events recorded affects the quality of the final super-resolved image. Importantly, DNA-PAINT 
benefits from the orthogonality of DNA hybridization (with different sequences). DNA docking 
strands with different nucleotide sequences can be associated with different targets, thus making 
it easy to obtain multi-target super-resolution images using a single fluorophore. Thereby, 
chromatic aberrations are avoided, resulting in a comparable resolution for all the POIs under 
investigation[9]. For such multiplexed imaging (known as Exchange PAINT[8],[9]), the sequential 
introduction of different imager strands is required. 
However, this methodology imposes several challenges to cell biologists who want to 
optimally image POIs with DNA-PAINT. Usually, primary antibodies that bind to a POI are 
labeled with secondary antibodies which carry the docking strand[10]. But such an approach 
introduces a spatial displacement of up to 25 nm between the target site and the fluorophore[11]–
[13] which seriously limits the resolving power of all single molecule localization super-resolution 




attempt to minimize this “linkage-error”[14] was to use primary antibodies that are directly 
coupled to docking strands[15]. Typically, this has been performed by using undirected coupling 
chemistry via maleimide-peG2-succinimidyl ester or via DBCO-sulfo-NHS-ester cross 
linkers[10]. These non-targeted coupling methods can interfere with the binding ability of the 
primary antibody to the POI by reacting at the paratope of the antibody. Additionally, they result 
in a mixture of antibodies containing a broad distribution of the number of docking strands (even 
including antibodies with none), which results in an inhomogeneous labeling density of the POIs 
and makes single molecule detection non-quantitative.  
To further tackle the “linkage error” of the reporter fluorophores, several small monovalent 
affinity probes are continuously emerging[16]. For instance, small DNA or RNA molecules, 
known as aptamers[17]–[19] or single-domain antibodies (sdAb, or nanobodies)[20] have recently 
gained popularity in the field of super-resolution imaging[21]–[23]. Nanobodies are obtained from 
a special type of immunoglobulins known as heavy chain antibodies (hcAb) and which are found 
in camelids. The recombinant production of the variable domain of these hcAbs result in a 
functional nanobody with only 2-3 nm size[24]. Recently, a significant improvement in spatial 
resolution, as compared to conventional antibody immunofluorescence, was demonstrated by 
using nanobodies for labeling[12], [25]. In addition to their small size, high specificity, and 
monovalent binding affinities, which make them an ideal tool for microscopy, the recombinant 
nature of nanobodies endows them with great flexibility and allows introducing all types of 
modifications in a precise manner. This last feature permits to rationally design and control the 
number and location of desired functional elements on them (e.g. the number and locations of 
fluorophores or docking strands)[22].  
Unfortunately, only few nanobodies able to recognize endogenous mammalian proteins are 
currently available. However, several new nanobodies against different fluorescent protein 
families like GFPs (from Aequorea Victoria), RFPs (from Dicosoma sp.) or mTagBFPs (from 
Entacmaea quadricolor) are now easily accessible. This opens the opportunity to obtain super-
resolution images with a minimal linkage-error on a wide range of biological samples. Fluorescent 
proteins like EGFP[26], mCherry[27] and mTagBFP[28] are widely used in the life-sciences, fused 
to POIs within simple cell lines, large yeast libraries[29], and countless other genetically modified 
organisms (e.g. Arabidopsis thaliana[30], Caenorhabditis elegans[31], Drosophila 




Here, we used a custom-built multi-channel Total Internal Reflection Fluorescence (TIRF) 
microscope and three nanobodies targeting mTagBFP, EGFP and mCherry to perform Exchange 
PAINT experiments on three different targets inside the same cell. For efficient buffer solution 
exchange, a versatile custom-built microfluidics system was developed and implemented. 
Exchange PAINT was performed by sequential introduction of three different imager strands and 
washing in between. Recorded single-molecule localization detection events were subsequently 
analyzed for reconstructing super-resolved images for each of the three targets. We achieved a 
resolution of 20 nm with a localization precision of 14 nm within 35 minutes of acquisition time 
(per target). We envision that nanobody-based DNA-PAINT will provide an efficient solution for 
the protein-DNA linkage problem and will help to exploit the full power of DNA-PAINT for 
cellular imaging, considering the broad availability of many fluorescent proteins.  
4.3. Materials and Methods 
Nanobody coupling to docking oligo  
The unconjugated nanobodies FluoTag®-Q anti-GFP, FluoTag®-Q anti-RFP, and the 
FluoTag®-Q anti-TagBFP (NanoTag Biotechnologies GmbH, Cat. No: N0301, N0401, and N0501, 
respectively) carry one ectopic cysteine at the N-terminus then allowing for chemical couplings 
via a thiol reactive compound. The DNA docking strands (Biomers GmbH, Ulm, Germany) were 
functionalized with an azide group at 5´-end and, in some cases, Atto488 fluorophore at 3`-end. 
The coupling of the docking strands to the nanobodies were performed following procedure from 
Schlichthärle and colleagues [34], with minor modifications. In brief, 15 to 20 nmol of nanobodies 
in phosphate buffer saline (PBS, 127 mM NaCl ,10 mM Na2HPO4, 2.7 mM KCl, 0.2 mM KH2PO4, 
pH7.4) were incubated with a final concentration of 5 mM TCEP (Sigma-Aldrich) for 2 h at 4°C 
to reduce the ectopic cysteine. Afterwards, the excess of TCEP was removed by exchanging the 
buffer to PBS pH 6.5 using spin Amicon filters with a MWCO of 10 kDa (Merck/EMD Millipore, 
Cat. No. UFC501096). The reduced TCEP-free nanobodies were immediately mixed with 50 
molar excess of DBCO-maleimide crosslinker (Sigma-Aldrich, Cat. No. 760668) and incubated 
overnight at 4°C with mild stirring. The excess of DBCO crosslinker in the buffer was exchanged 
to PBS pH 7.4 using Amicon Filters (MWCO 10 kDa) as described previously. Functionalized 
docking strands were added (10 molar excess) to the crosslinker-coupled nanobody, and incubated 




was then removed from the conjugated nanobodies using size exclusion chromatography 
(Superdex 75 Increase 10/300 column, Cat. No: 29148721) and ÄKTA pure 25 system (GE life 
science). The correct fractions of labeled nanobodies were then identified by the SDS-PAGE 
followed by SYBR GOLD staining (Thermo Fisher, Cat No: S11494). The docking strands 
sequences used for the assay were taken from Agasti et al[8]. FluoTag®-Q anti-GFP was coupled 
to P1* sequence (5`-CTAGATGTAT-Atto488-3`), FluoTag®-Q anti-RFP was coupled to P2* (5`-
TATGTAGATC-3`), and the FluoTag®-Q anti-TagBFP was coupled to P3* (5`-GTAATGAAGA-




COS-7 cells were cultured in DMEM medium with 4 mM l‐glutamine and 10% fetal calf 
serum (Thermo Fisher Scientific), supplemented with 60 U/ml of penicillin and 0.06 mg/ml 
streptomycin (Sigma‐Aldrich) at 37°C and 5% CO2. Prior immunostaining and imaging, ca. 20,000 
cells/well, were plated in 8-well chamber (155411PK, ThermoFisher Scientific). In the next day, 
the cells were transfected using 2.5% lipofectamine 2000® and 300 ng of plasmid in Optimem 
medium (Thermo Fisher Scientific). After incubation of ca. 16 h, the cells were fixed using 4% 
paraformaldehyde (PFA) for 30 minutes at room temperature. The remaining aldehydes were 
quenched with 0.1 M glycine in PBS for 30 minutes. Afterwards, cells were permeabilized and 
blocked using 3% bovine serum albumin (BSA) and 0.1% Triton X-100 in PBS for 30 minutes at 
room temperature. Buffer solution containing nanobodies coupled to the docking strand (50 nM) 
was used to stain the cells. For this purpose, we proceeded with incubation of 1 h at room 
temperature, with slow orbital shaking. Finally, the cells were rinsed with PBS and then post-fixed 
with 4% PFA for 30 minutes at the room temperature. As described previously, remaining 
aldehydes were quenched with 0.1 M glycine in PBS. Cells were stored in PBS buffer at 4°C. 
 
Exchange PAINT Experiment  
The imager strands P1 5`-CTAGATGTAT-3`-Atto655, P2 5`-TATGTAGATC-3`-Atto655, 
and P3 5`-GTAATGAAGA-3`-Atto655 (Eurofins Genomics) were aliquoted in TE buffer (Tris 10 
mM, EDTA 1 mM, pH 8.0) at a concentration of 100 μM and stored at -20°C. Prior to the 




500 mM NaCl. A chamber with 8 wells (155411PK, Thermo Fisher Scientific) was fixed on the 
microscope stage with clips. A PDMS layer was used as a chamber cover and supported the inlet 
tubes and a tube for suction. The slide was held on the microscope stage for 0.5 h before the 
acquisition to equilibrate to the room temperature and achieve mechanical stability. Injection of 
fluids and its removal was done using our custom-built microfluidic setup, designed and 
constructed particularly for Exchange PAINT experiment. First, the well was rinsed twice with 
500 µL PBS buffer (pH 8.0, NaCl 500 mM). Then, suitable cells for imaging were selected based 
on the presence of signal from the expressed fluorescent proteins: mTagBFP, mCherry, and EGFP. 
The cells were located by exposing them to the following laser excitation wavelengths and 
detecting the fluorescence in the corresponding emission channel: mTagBFP - 405 nm laser, EGFP 
- 488 nm laser, and mCherry - 561 nm laser. A HILO-illumination scheme was used to excite the 
cells. Laser power was adjusted according to the sample brightness (respectively 0.5 mW, 1 mW 
and 2 mW at the output of optical fiber). Each selection movie of the fluorescent proteins included 
between 200-250 frames (Figure 4.4, A1-A3). Afterwards, we proceeded with Exchange PAINT 
on the selected cell. All the solutions were injected into the cell by applying air pressure in the 
corresponding pressurized tube. First, imager strand P1 (2 nM) in PBS buffer (500 µL) was 
injected into the well and incubated for 10 minutes before the acquisition. Typical DNA-PAINT 
movie included 21,000 frames (corresponds to 35 minutes). The following acquisition settings for 
emCCD camera were used: exposure time 100 ms, pre-amplifier gain 3.0, EM gain 10. The laser 
638 nm was set to 10-15 mW (corresponds to an excitation illumination power density of 0.4-
0.6 kW/cm2). After PAINT movie acquisition, an extensive wash of the well was performed (4-6 
times volume exchange, in total about 3 mL buffer within 5 minutes), in order to remove the 
imager solution from the well completely. Suction was performed by the micro peristaltic pump 
(Makeblock) After the extensive wash, the next imager solution was introduced. We proceeded 
with the same solution exchange procedure also for the imagers P2 and P3 (see comprehensive 
chart in Figure 4.3B). All the experiments were carried out at a constant temperature of 22±1 °C, 
which was crucial for the mechanical stability of the sample (remaining mechanical drifts were 





DNA-PAINT movies analysis 
Raw DNA-PAINT movies were analyzed using the Picasso software package[10]. In the end, 
drift-corrected super-resolution images were reconstructed and the average localization accuracy 
was estimated. For further analysis of the achieved image resolution, the Fourier Ring Correlation 
(FRC)[35] technique was employed. First, localization events were detected using Picasso: 
Localize. For the specific binding-events recognition, the signal box size length was set to 7 pixels 
and the minimum net gradient was limited to the range of 1,700 to 3,500 (depends on the protein 
expression level in a particular cell). Then, the localized bright spots were fitted with the LQ 
Gaussian method to obtain precise fluorophore coordinates. The total number of localization 
events varied from 150,000 to 2,500,000 for the whole movie. The output file with the localization 
coordinates was then loaded into Picasso: Render. Using the Undrift RCC feature (segmentation 
500 frames), movies were corrected for mechanical drift. The final reconstructed super-resolved 
images were exported in PNG format. Finally, all three reconstructed images of different 
organelles were merged together for each imaged cell using ImageJ[36], see Figure 4.4 C1,C2, 
D1-D3. The average localization precision (NeNa[37]) was estimated for each reconstructed 
super-resolved image. For image resolution quantification, Fourier Ring Correlation (FRC)[35] 
was applied using the FIRE ImageJ plugin [38], for detailed numbers see Supplementary 
Information, Table S1. Further image resolution analysis was performed by creating a resolution 
map using SQUIRREL[39] (super-resolution quantitative image rating and reporting of error 

















Optimization of cells transfection and nanobody staining for Exchange DNA-PAINT 
imaging 
 
First, we optimized the transfection of mammalian cells (COS-7) with plasmids encoding for 
proteins present in different organelles fused to various fluorescent proteins. We used TOM70 
fused to EGFP to reveal mitochondria, GalNacT was fused to mCherry to detect the Golgi 
apparatus and histone H2B was fused to mTagBFP to detect the cellular chromatin (nucleus). 
Additionally, we used currently available nanobodies, which bind strongly and specifically to the 
three fluorescent proteins mentioned above. Each type of nanobodies was labelled with a unique 
docking strand, enabling the acquisition of multiple targets using Exchange PAINT, in single cells 






Figure 4.1: Schematic representation of multi-target Exchange PAINT in COS-7 cells. 
Sequential introduction of Imager strands with different sequences reveal multiple targets and 
result in multi-color super-resolution image. (A) DNA-PAINT imaging of   mitochondria with 
Imager P1. (B) DNA-PAINT imaging of the Golgi apparatus with Imager P2. (C) DNA-PAINT 
imaging of nucleus/chromatin. (D) The resulting super-resolved image of a single cell with 3 colors 
overlaid. The cells were stained with (1) nanobody anti-GFP (Nb1) coupled to the DNA strand P1, 
(2) nanobody anti-mCherry (Nb2) coupled to the docking P2, and (3) nanobody anti-mTagBFP 
(Nb3) coupled to the docking strand P3. 
 
All nanobodies had an extra ectopic cysteine at their C-terminus that allowed the conjugation 
of molecules via maleimide chemistry. We used a maleimide-DBCO as a cross-linker to attach the 
single stranded DNA oligo bearing an azide group on its 5´ end (Figure 4. 2A, B). The coupling 
of the docking strand was thus performed in two sequential steps. First, the nanobody was 
incubated with a 50 molar excess of the maleimide-DBCO cross-linker, inducing a thiol-maleimide 
conjugation with the previously reduced single ectopic cysteine at the C-terminus of the 
nanobody[22]. After removing the excess of cross linker, the complex was incubated with a 10 
molar excess of azide functionalized DNA oligo to induce a strain-promoted azide–alkyne 
cycloaddition (copper-free click chemistry[40]).  The separation of the excess of DNA oligo from 
the mixture was performed using a size exclusion chromatography (SEC), resulting typically in 
two obviously separated elution fractions (Figure 4.2C). This is an essential step to avoid 
unspecific signal from the free DNA oligo. As a first routine quality control after SEC, different 
elution fractions were passed through a polyacrylamide gel electrophoresis (PAGE), stained with 
SYBR gold, to report for the presence of the oligonucleotides (Figure 4.2D). Only the fractions 
containing a clean band at the right molecular weight were used subsequently for the 
immunoassays of the transfected COS-7 cells. Due to the large excess of cross-linker and docking 
strands used for each coupling step (see Methods section), we are confident that a major proportion 






Figure 4.2: Click- and thiol-based strategy to conjugate nanobodies to a docking DNA strand 
for DNA-PAINT. (A) Anti-GFP nanobody (blue) bound to EGFP (green). The nanobody is 
modified with a docking stand with a complementary Atto655-labelled Imager strand attached 
(EGFP: nanobody complex extracted from (PDB: 3K1K), DNA strand and Atto655 were 
generated using ChemDraw (CambridgeSoft) and The PyMOL Molecular Graphics System 
(Schrödinger, LLC). Yellow lines represent 3 possible distances (3.1 nm, 3.3 nm and 3.4 nm) of 
the fluorophore to the POI. (B) Scheme representing the orthogonal coupling strategy of docking 
DNA strand to the nanobody. (C) Example of the size-exclusion chromatography (SEC) for the 
separation of DNA-coupled nanobody (#1) from the excess of docking strand (#2). (D) Example 
of the SDS-PAGE of fraction collected from the SEC run, post stained with SYBR gold, which 
reports DNA. Peak #1 collected from SEC shows a prominent band matching the expected 
molecular weight (~15 kDa). Peak #2 lacks the band at the nanobody molecular weight, suggesting 






Microfluidic setup for Exchange DNA-PAINT experiment 
 
Solution exchange inside the sample chamber was done using a custom-built microfluidics 
setup, designed and constructed in particular for the Exchange PAINT experiments. The setup 
allows operation of up to 24 independent inlet channels and is capable of fluid injection/removal 
with an adjustable flow speed in/out of the experimental chamber. 
 
Figure 4.3: Scheme of custom-built microfluidics setup and Exchange PAINT experiment. 
(A) Microfluidics setup: the setup is controlled by a computer software, which includes both 
manual and automated operation modes. Maximum number of the input channels is 24 (only 5 
channels are shown). The peristaltic pump used to remove the solutions from the chamber is also 
computer-controlled. (B) Typical sequence of actions for the Exchange PAINT experiment. The 
tube-shape sketches depict the injection of solutions (P1, P2 or P3) or the imaging buffer (IB) 
(solution volume and injection duration are indicated on top of the objects). Rectangles represent 
movie acquisition with certain laser excitation (laser wavelength and total acquisition time are 
indicated inside the rectangle and on top of the rectangle, respectively). 
 
Magnetic solenoid valves (MH1, Festo) were used to turn on and off the air pressure in the 
channels, which were connected in turn to pressurized tubes. When air pressure is applied to such 
a tube, a liquid flowis created. Flow speed can be adjusted by changing air pressure using a 




gentle flow of solutions. The pressurized air was purified with an air filter (PTA013, Thorlabs). 
Tygon tubing (VERNAAD04103, VWR) was used to guide the solutions from pressurized tubes 
to the experimental chamber. Suction was performed by a micro peristaltic pump DC12.0V 
(Makeblock). For washing, buffer solution for was loaded into a 15 mL test tube (Greiner Bio-
One™ 188271, Fisher Scientific). The tube was equipped with a cap for pressurization 
(FLUIWELL 1C-15, Fluigent). The solutions of imager strands P1, P2 and P3 (concentration 
2 nM, volume 1 mL) were loaded into 2.0 mL tubes (Micrewtube T341-6T, Simport), which were 
then mounted into a holder for four pressurized tubes (FLUIWELL-4C, Fluigent). Both magnetic 
solenoid valves and peristaltic pumps were operated by a custom-written LabView (National 
Instruments) routine, which included both manual and automatic operation modes. A custom-built 




Super-resolution multiplexed DNA-PAINT images of COS-7 cells 
 
We performed Exchange PAINT imaging of COS-7 cells stained with nanobodies, each 
functionalized with a single docking strand. For this purpose, aversatile custom-built optical setup 
was designed and constructed  (see Figure S 4.1). Initially, we checked that all cells to be imaged 
were triple transfected with the plasmids encoding for the TOM70, GalNacT and H2B fused to 
EGFP, mCherry and mTagBFP, respectively. The signal from each fluorescent protein was first 
imaged with a wide-field HILO illumination (see Figure 4.4, A1-A3). Afterwards, we sequentially 
introduced and removed imager strands P1, P2, and P3 as shown in Figure 4.3B. Each DNA 
PAINT movie was acquired during 35 minutes and then analyzed with the Picasso software[10] to 
obtain the super-resolved images (Figure 4.4, B1-B3). The experiment was designed to monitor 
three different proteins that are located in very distinct organelles, in order to simplify the 
evaluation of our Exchange DNA-PAINT images. Clearly, the reconstructed super-resolved DNA-
PAINT images (one for each of the imagers P1, P2, and P3) showed the “patterns” expected for 
the respective organelle, thereby providing additional confirmation of our imaging strategy. For a 




three super-resolved images (from each P-imager movie) were merged together (Figure 4.4, C1). 
The result suggests that every “channel” remains clean, without significant unspecific binding 
events between the different docking-imager partners. The whole imaging cycle for the three target 
molecules, including imager strand injections, incubations, the removal of solutions and the 
acquisition of more than 60,000 frames took in total 2-3 h to be completed. The whole procedure 
worked robustly, and provided high quality super-resolved DNA-PAINT images for nearly every 
imaged cell (selected at the initial wide-field HILO checkup).  
In order to evaluate the image quality in a more quantitative manner, we performed a detailed 
analysis for the average localization accuracy and the actual resolution of the images. For the 
images presented in Figure 4.4,  the average localization accuracy estimated by NeNa[37] was 
19±2 nm (the lowest value was 14 nm, Table S1) and the average resolution, as estimated by 
Fourier Ring Correlation (FRC)[35], was 27±5 nm (the lowest value was 20 nm, Table S1). The 
full list of localization accuracies and FRC resolutions obtained for each organelle in each cell in 
Figure 4.4 can be found in Table S1 in the Supplementary Information. 
Finally, we performed image quality analysis using FRC resolution maps using the 
SQUIRREL software[39]. The resolution values for different images varied between 26-34 nm. 
Moreover, we also compared the super-resolved images as obtained by Picasso and by 








Figure 4.4: Exchange PAINT imaging. A1-A3 Diffraction-limited wide-field images of 
individual target fluorophores: Mitochondria with TOM70-EGFP (A1), Golgi with GalNacT-
mCherry (A2), Chromatin with H2B-mTagBFP (A3). (B1-B3) Single-channel super-resolution 
DNA-PAINT images of respective organelles. The number represents FRC number for resolution 
for the respective image. (C1) Left bottom inset is the full view of the cell imaged in B with all 3-
target Exchange PAINT images merged. Right, zoom of the boxed area I the inset. (C2) One more 
example of Exchange PAINT imaging with the same set of staining as in B and C. (D1-D3) 
Specificity controls were performed by swapping the fluorescent proteins and changing the Golgi 
marker. Now cells were expressing TOM70-mCherry and GM130-EGFP (a different Golgi 





To assess the effectiveness of our method, we performed several controls. First, the targeted 
protein GalNacT that we used to detect the Golgi, was changed to GM130 to ensure that the 
reconstructed organelle is labeled specifically regardless of the target protein used for reporting 
the Golgi apparatus (Figure 4.4, D1-D3). Additionally, we exchanged the fluorescent proteins we 
used for targeting the Golgi and the mitochondria by transfecting cells with plasmids encoding for 
TOM70 fused to mCherry and GM130 fused to EGFP. The same coupled nanobodies were used 
to reveal those targets. Nb1 (nanobody anti GFP) coupled to P1 docking strand, Nb2 (nanobody 
anti-mCherry) coupled to P2, and Nb3 (nanobody anti-mTagBFP) coupled to P3. Therefore, in 
this experiment, the imager P1 revealed the structure of the Golgi apparatus and the imager P2 
revealed the mitochondria. Detailed comparison of NeNa and FRC for both cases can be found in 
Table S1. These control experiments confirmed the efficiency of our system, the specificity of the 
coupled nanobody, and the interchangeability of the targets. Finally, cells transfected with a single 
plasmid coding for TOM70-EGFP were immunostained with anti-GFP nanobodies bearing the P1-
docking DNA and were imaged with imager P3 under the same conditions as before. We observed 
very few binding events (i.e. P3 imager binding P1 docking) without showing any recognizable 
pattern (Figure S 4.3). This extra control suggests a high specificity of the imager to its docking 
strand. Additionally, unspecific binding (e.g. stickiness of the imager to the glass coverslip or 




Conventional antibodies (150 kDa and 12-15 nm in length) are often used for labelling cellular 
targets in DNA-PAINT imaging[5]. This approach has demonstrated to achieve an impressive 
spatial resolution[6], [7], to a level where the size of the primary and secondary antibody sandwich 
(with ~25 nm linkage-error) limits its imaging resolution. It has been demonstrated that small 
camelid single domain antibodies or nanobodies (15 kDa and ~3 nm in length) have the capacity 
to increase the accuracy of super-resolution microscopy for mapping POIs in a cellular 
context[15], [42]. Recently, nanobodies have been coupled to docking oligos to perform DNA-
PAINT [25]. Unfortunately, only few nanobodies are currently available that work efficiently in 




specific fluorescent proteins. In this work, we exploited this property, which makes our method 
highly versatile since many bio-medical researchers typically have their favorite proteins already 
fused to fluorescent proteins[43].  Here, we showcase the use of three specific nanobodies against 
the EGFP family (this nanobody also binds to EYFP, Citrine, mVenus, Cerrulean, Emerald EGFP, 
and more GFP derivatives), mCherry and similar variants (it also binds to mOrange2, tdTomato, 
dsRed1 & 2, mScarlet-I, and other mRFP derivatives), and finally to mTagBFP (it also recognizes 
mTagRFP, mTagRFP657, mKate, and mKate2) for DNA-PAINT super-resolution microscopy. As 
a proof of principle, we used cells expressing three different fluorescent proteins in different 
organelles. The cells were immunostained with anti EGFP, mCherry, and mTagBFP specific 
nanobodies, each coupled to a unique and single DNA-docking strand for performing Exchange 
PAINT on them (Figure 4.4). We achieved an overall resolution of 20 nm, and an average 
localization precision of ~14 nm (in the best case, see Table S1), within only 35 minutes of 
acquisition time per target. We anticipate that, by further experimental and protocol optimizations, 
it will be possible to improve the resolution and acquisition time even further. The set of 
nanobodies presented in this work makes it already possible to investigate three proteins of interest 
within the same cell, all at diffraction-unlimited resolution, with the enhanced precision provided 
by the nanobody monovalency (no clustering of target protein) and small size (minimal linkage-
error) [13], [16]. We hope that our study will motivate other scientists who have their POIs already 
fused to fluorescent proteins to benefit from this technique.  
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4.7 Supplementary Information for 
 
Nanobody Detection of Standard Fluorescent Proteins Enables Multi-Target DNA-
PAINT with High Resolution and Minimal Displacement Errors 
 
Custom-built optical setup description 
Measurements were performed on an in-house-built optical setup. In brief, the excitation part 
included four lasers: 405 nm (CUBE 405-100C, Coherent), 488 nm (PhoxX+ 488-100, Omicron), 
561 nm (MGL-FN-561-100, Changchun), and 638 nm (PhoxX+ 638-150, Omicron). Manual 
shutters were used to easily switch between excitation lasers. The lasers were combined into the 
same optical path using dichroic mirrors DM1 (BrightLine DiO2-R561, Semrock), DM2 
(BrightLine FF495-Di03, Semrock), and DM3 (zt405 RDC, Chroma). Then, the laser beams were 
coupled into a single-mode fiber (P1-460B-FC-2, Thorlabs) with typical coupling efficiency of 
40-50%. After exiting the fiber, the beam was collimated and expanded by a factor of 3.6X using 
telescopic lenses. In order to achieve wide-field illumination, lens L1 (AC508-200-A-ML, 
Thorlabs) focused collimated laser beam on the back focal plane of the high-NA objective 
(UAPON 100x oil, 1.49 NA, Olympus). In order to switch between Epi-, HILO-, or TIRF-
illumination schemes, the translation stage TS (LNR50M, Thorlabs) was used to mechanically 
shift the corresponding optical elements. The translation XY stage (M-406, Newport) ensured 
smooth and stable sample movement during the scan.  
A separate translation stage with a differential micrometer screw (DRV3, Thorlabs) was holding 
the objective and was used for focusing. The emitted fluorescence was separated from the 
excitation laser using the multi-band dichroic mirror DM4 (Di03 R405/488/532/635, Semrock). 
Lens L2 (AC254-200-A-ML, Thorlabs) was used as a tube lens. An adjustable slit (SP60, OWIS) 
was positioned in the image plane and was used to limit the field of view. The multi-band filter 
BP1 (ZET488/561/635m, Chroma) was used to filter out laser remains in the detection path. 
Lenses L3 (AC254-100-A, Thorlabs) and L4 (AC508-150-A-ML, Thorlabs) were used to transfer 
the image plane from the slit to the EMCCD camera (iXon Ultra 897, Andor), thereby providing 




channels according to the experimental requirements. For this purpose, the dichroic mirrors DM5 
(Chroma 550 LPXR) and DM6 (FF648-Di01, Semrock) were positioned on magnetic bases MB 
(KB50/M, Thorlabs). For each channel, additional band-pass filters were used: BP2 (BrightLine 
FF 445/20, Semrock) for the blue channel, BP3 (BrightLine FF 536/40, Semrock) for the green 
channel, and BP4 (BrightLine HC 692/40, Semrock) for the red channel. The overall magnification 
factor of the optical setup was 166.6X, the pixel size was 103.5 nm x 103.5 nm and the full field 
of view was 53 µm X 53 µm. Focus stability was achieved by robust construction of the custom 
microscope body, tightly fixing the 8-well chamber (155411PK, THERMOFISHER SCIENTIFIC) to the 
sample holder and keeping the temperature in the room stable. 
 
Figure S4.1: Schematic drawing of custom wide-field TIRF optical setup. The excitation is 
equipped with four lasers and allows excitation of fluorophores on broad spectral range. Multi-
channel detection enables simultaneous imaging of fluorophores with different emission spectrum 
on the same CCD camera. Number of emission channels can be easily switched between one, two 
and three channels by removing the dichroic mirrors DM5 or/and DM6. The size of region of 









Localization accuracy and resolution estimations 

















Mito GFP P1* 20 21  
Fig 4.4, D1 
Mito RFP P2* 19 22 
Golgi RFP P2* 18 27  Golgi GFP P1* 18 24 
Nucleus BFP P3* 22 32  Nucleus BFP P3* 23 38 
                 
Fig. 4.4, 
C2 
Mito GFP P1* 22 34  
Fig 4.4, D2 
Mito RFP P2* 20 28 
Golgi RFP P2* 16 23  Golgi GFP P1* 19 20 
Nucleus BFP P3* 23 34  Nucleus BFP P3* 19 24 
                 
Fig. 4.4, 
C3 
Mito GFP P1* 19 38  
Fig 4.4, D3 
Mito RFP P2* 14 24 
Golgi RFP P2* 16 28  Golgi GFP P1* 18 27 
Nucleus BFP P3* 22 31  Nucleus BFP P3* 17 26 
Table S1. Average localization precision (NeNa) and resolution estimation using FRC 
technique for each of the reconstructed images presented in Figure 4. Cell names appear 











DNA-PAINT analysis toolkits comparison: Picasso vs. Rapidstorm 
Verification of Picasso analysis was done by analysing same image with RapidStorm.1 Recorded 
DNA-PAINT movie was loaded into RapidStorm. Blinking event were identified by setting the 
intensity threshold to 60 % of a total brightness. Resolution (both X and Y direction) was set to 10 
nm/pixel. The comparison between reconstructed images shown on Figure S 4.2. The achieved 
resolution was estimating by exporting the localization file output and then running it into 
SQUIRREL ImageJ plugin2. Resulting numbers and comparison to Picasso output shown on Table 
S1. We saw good agreement between Picasso and RapidStorm results.  
 
Figure S 4.2: Comparison between Picasso and RapidStorm software packages. (A) Wide-
field (WF) diffraction-limited image of GFP protein. (B) Reconstructed super-resolution image 











Figure S 4.3: Control experiment for the nanobody specificity and the stickiness of the 
imager strand inside fixed COS-7 cell transfected with TOM70-GFP-P1*. (A) wide-field 
image of TOM70 GFP. (B) Super-resolution image from a DNA-PAINT movie taken in presence 
of P3 imager. Only few random localization events detected in presence of the imager P3 (C) 
Super-resolution image of the same region of interest, taken in presence of P1 imager (after 

















DNA-PAINT Fourier Ring Correlation resolution maps 
For NanoJ-SQUIRREL analysis stack of two statistically independent super-resolution images of 
the same structure were reconstructed using Picasso and RapidStorm software. Then using 
‘Calculate FRC Map’ feature (block per pixel value 25 and pixel size 10 nm) the FRC map was 
made and overlaid with respective super-resolution image. Average FRC resolution value was 
obtained by finding the mean value from the area with high localization density. For this purpose, 
obtained super-resolution image was cropped and whole procedure was repeated for this area. The 
average resolutions obtained are 26 nm for Picasso and 30 nm for RapidStorm. 
 
Figure S4.4. Resolution estimation using Fourier Ring Correlation maps realized by 
SQUIRREL ImageJ plugin2.  Comparison between Picasso and RapidStorm analysis tools. (A1-
3) Super-resolution DNA-PAINT images of COS-7 cell organelles reconstructed by Picasso. (B1-
3) FRC map overlaid with the corresponding super-resolution images, as reconstructed by Picasso 
toolkit. (C1-3) FRC map overlaid with the corresponding super-resolution images, as reconstructed 




object region. The colors on B and C indicated resolution, according to scale shown on the right-
hand side.  
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A standard procedure to study cellular elements is via immunostaining followed by optical 
imaging. This methodology typically requires target-specific primary antibodies (1.Abs), which 
are revealed by secondary antibodies (2.Abs). Unfortunately, the antibody bivalency, 
polyclonality, and large size can result in a series of artefacts. Alternatively, small, monovalent 
probes, such as single-domain antibodies (nanobodies) have been suggested to minimize these 
limitations. The discovery and validation of nanobodies against specific targets are challenging, 
thus only a minimal amount of them are currently available. Here,  we used STED, DNA-PAINT, 
and light-sheet microscopy, to demonstrate that secondary nanobodies 1) increase localization 
accuracy compared to 2.Abs; 2) allow direct pre-mixing with 1.Abs before staining, reducing 
experimental time, and enabling the use of multiple 1.Abs from the same species; 3) penetrate 
thick tissues more efficiently; and 4) avoid probe-induced clustering of target molecules observed 
with conventional 2.Abs in living or poorly fixed samples. Altogether, we show how secondary 
nanobodies are a valuable alternative to 2.Abs. 
 





5.2 Introduction  
Standard immunodetection approaches use typically a primary antibody (1.Ab) which binds the 
protein of interest (POI) and a secondary antibody (2.Ab) that binds to the 1.Ab and carries a 
detection element. In fluorescent microscopy techniques, the detection element is a fluorophore1,2 
or a single strand of DNA. The latter is used in DNA Point Accumulation for Imaging in Nanoscale 
Topography (DNA-PAINT), a single molecule localization microscopy technique reaching <5 nm 
resolution by transiently binding of single stranded DNA bearing a fluorophore to their 
complementary strand on the target of interest3. The complex formed by the primary antibody and 
the secondary antibody (1.Ab-2.Ab) is widely used because it is a cost effective and flexible 
approach since only the 2.Abs need to be coupled to the detection element. However, the use of 
this complex carries some relevant limitations. First, the 1.Ab-2.Ab can measure up to 30 nm, 
leading to a large distance between the targeted molecule and the detection element, causing the 
so called “linkage” or “displacement” error4. While this might not influence the results in some 
applications (e.g. epifluorescence, ELISA or FACS), it is of major relevance for super-resolution 
microscopy techniques where the localization precision can be as high as 1 nm5. The linkage error 
can be reduced by using directly labelled small affinity probes like camelid single domain 
antibodies (sdAbs) also known as nanobodies (Nbs)4,6, affibodies7, aptamers8,9 or affimers10, which 
all have sizes below 3 nm. Unfortunately, such small probes exist only for a handful of targets11 
due to their rather laborious selection and validation process, while conventional 1.Abs are readily 
available for a large number of POIs. An alternative to the standard 2.Abs was recently developed: 
monovalent recombinant secondary nanobodies (2.Nbs)12. Secondly, the large size of the 1.Ab-
2.Ab complex makes them to perform poorly in crowded cellular environments or when the 
epitopes are abundant and densely arranged. In this respect, smaller probes such as aptamers or 
nanobodies are more efficient in the detection of the POI8,13,14. Moreover, sample penetration of 
full antibodies is a problem when staining thick biological specimen such as tissues, biopsies or 
whole organisms13,15. For the optimal labelling of these thick samples, protocols have been 
established, but they are often laborious and require time-consuming incubations of weeks16 or 
need artefact-prone epitope retrieval protocols17. Smaller probes are expected to shorten some of 
these long incubations. Third, in a multiplex immunostaining, i.e. when multiple targets are stained 
in the same sample, scientists are typically constrained to use 1.Abs coming from different species. 




incubated on the sample, washed off and only then 2.Abs are incubated. Therefore, 1.Abs should 
be raised in different species and 2.Abs should recognize one species specifically, limiting the 
choice of antibodies for a multiplexing staining. It has been shown that by pre-mixing 1.Abs with 
2.Nbs in a tube prior staining, one could circumvent this species limitation and use on a sample 
1.Abs from the same species12. Finally, conventional antibodies used commonly for 
immunodetections are bivalent binders, i.e. each antibody molecule can bind two POIs/epitopes 
simultaneously. In the case of polyclonal antibodies, they are not only bivalent binders, but they 
also contain an unknown number of different antibodies able to bind the POI. This is the case of 
the vast majority of 2.Abs used for detection of 1.Ab in immunofluorescence applications. The 
bivalency and polyclonality of 2.Abs combined have been proposed as characteristics that induce 
clustering of the POI and their interactors, which can have a strong impact in the conclusions 
obtained from such experiments18,19. The use of monovalent secondary probes should minimize 
the potential of secondary probe induced clustering effects.   
In this work, we tested and thoroughly validated the use of 2.Nbs for several microscopy 
applications. We first confirmed that the usage of 2.Nbs decreases linkage error by using them in 
STED microscopy and DNA-PAINT. We then exploited the ability of these probes to allow the 
simultaneous use of several 1.Abs from the same species by using them in Exchange-PAINT 
multiplexed super-resolution microscopy. This technique enables to image a virtually infinite 
number of targets in high resolution in the same sample20,21. Additionally, we observed that pre-
mixing 1.Ab and 2.Nb can save time in staining thick biological samples imaged under light-sheet 
microscopy, ensuring also a better sample penetration and homogenous staining. Finally, we 
systematically compared the probe-induced clustering of the target protein either using directly-
labelled monovalent probes, like affibodies and single Fab’ fragments, and conventional 1.Abs 
detected by polyclonal and bivalent 2.Abs or by monovalent 2.Nbs. We observed that 2.Nbs 
drastically reduced the clustering of the target in both live and fixed sample. This makes 2.Nbs a 
real alternative to conventional 2.Abs by minimizing experimental time, expanding the 
multiplexing ability of immunostainings, improving the tagging precision and signal linearity, and 





Secondary nanobodies provide higher staining accuracy than secondary antibodies 
First, we investigated the accuracy of 2.Abs or 2.Nbs in revealing their 1.Ab target. To do so, we 
imaged (using a two-color STED microscopy setup) COS-7 cells fixed with cold methanol to 
ensure a strong immobilisation of the POI22, then stained with a monoclonal 1.Ab anti-alpha 
tubulin directly conjugated to the fluorAbberiorStar635P. The primary antibody was subsequently 
recognized by either a polyclonal 2.Ab or a monovalent 2.Nb, both carrying the fluorophore 
AbberiorStar580. An autocorrelation analysis was performed on these images to evaluate the 
staining accuracy of the secondary probes by comparing them with the directly labelled primaries. 
Initially, the autocorrelation of the images with the fluorescent 1.Ab provided an idea of the 
distribution or density of the 1.Ab on microtubule filaments. The autocorrelation curve obtained 
from the signal of the 2.Nb followed the tendency of the autocorrelation obtained for the anti-alpha 
tubulin primary antibody, which proposes that the 2.Nb signal accurately follows the fluorescent 
signal from the 1.Ab. In contrast, when performing the same analysis on the staining performed 
with the polyclonal 2.Abs, the correlation curve was shifted to the right. This suggests that the 
2.Ab inaccurately reveals the location of the 1.Ab anti-alpha tubulin (Fig. 5.1A). To confirm this, 
we decided to analyse paraformaldehyde (PFA) fixed peroxisomes within primary hippocampal 
neurons. We compared the diameter of these small organelles when imaged with STED 
microscopy after using a 1.Ab anti-pmp70 (a peroxisomal membrane protein) revealed by a 2.Ab 
or a 2.Nb. We observed a significant shift to smaller diameters of 1.Ab-2.Nb labelled 
organelles after comparing 3020 peroxisomes stained with 1.Ab-2.Ab and 3109 
peroxisomes stained with 1.Ab-2.Nb (Fig. 5.1B). To evaluate more precisely if the 2.Nbs 
decrease the linkage error, we needed a technique providing higher spatial resolution. For 
this purpose, we used DNA-PAINT that has achieved sub-10-nm resolution3. As DNA-
PAINT uses affinity reagents attached to short DNA oligonucleotides, we coupled the 
2.Nbs site-specifically to a single stranded DNA oligo (termed docking strand) as described 
previously23. We performed an assay which has been used as gold standard in the field to 
assess linkage error24. We immunostained the microtubule network of fibroblast cells with 
a monoclonal 1.Ab against alpha tubulin, and detected it by either a 2.Ab or a 2.Nb coupled 
to docking strands (Fig. 5.2). After analysing the diameter of ~80 microtubules for each 




2.Ab and 38.3±9.34 nm when using a 2.Nb (Fig. 5.2 G, I). A similar gain in precision was 
observed previously using dSTORM12. Additionally, we performed an autocorrelation 
analysis on single microtubules to corroborate their difference in size, and we observed a 
significantly faster loss in autocorrelation for microtubules stained with 2.Nb (Fig. 5.2H). 
 
 
Figure 5.1. 2.Nbs minimize the linkage error caused by 2.Abs and increase detection accuracy. (A) Two-color 
STED imaging of microtubules stained with 1.Ab directly labelled with AbberiorStar635P dye and secondary reagents 
(either 2.Ab or 2.Nb) labelled with AbberiorStar580. Fixation conditions were the same for both conditions (methanol 
fixation, see Methods). Example images and schematic representation of the experimental procedure. Scale bar 2.5 
µm. Autocorrelation analysis on signal obtained from either the 1.Ab or the secondary probe microtubules. N=51 line 
profiles for 2.Nb, N= 70 for 2.Ab and N=121 for 1.Ab. One-way ANOVA p=1.061x10-6 F=14.58 followed by post 
hoc Bonferroni tests indicates that the 2.Ab is different with p<0.01 from the 1.Ab and 2.Nb which themselves are 
indistinguishable. (B) Primary hippocampal neurons were fixed for 30 minutes with 4% PFA, and stained against the 
peroxisome protein (pmp70) with 1.Ab-2.Ab or 1.Ab-2.Nb. Exemplary STED images. Scale bars 10 µm (overview) 
and 100 nm (zoom). Size distribution analysis of peroxisomes. N=3109 peroxisomes were analysed when stained with 
2.Nb and N= 3020 stained with 2.Ab. Error bars correspond to the standard error of the mean from 4 independent 
experiments. Paired t-test shows that the apparent size of peroxisomes stained with 2.Nb is on average smaller with 






Premixing secondary nanobodies bypasses the primary antibody animal-species limitations 
In standard immunoassays, 1.Abs are first incubated with the sample followed by washes 
to remove unbound excess of primary antibodies. Only at this point, labelled-2.Abs are 
incubated for a period of time with the sample followed by washes to eliminate the non-
bound excess of 2.Abs before imaging the specimen. Pre-mixing the 1.Ab with the 2.Ab 
before adding them to the sample would shorten protocols and save considerable amount 
of time and costs (e.g. in clinical pathology laboratories). However, this is not possible due 
to the polyclonality and bivalency of 2.Abs that result in agglutination or aggregation of 
the 1.Abs-2.Abs complexes and thus in a failure to stain the intended target in the sample 
(Supp. Fig. 5.1). If the secondary probe binds to the 1.Ab in a monovalent fashion, pre-
mixing primary and secondary probes would be possible. The pre-mixing of 2.Nbs with a 
Figure 5.2: DNA-PAINT imaging using secondary antibodies or secondary nanobodies shows differences in 
microtubule´s diameter size. (A) Overview DNA-PAINT image of COS-7 cells fixed with cold methanol and stained 
with 1.Ab targeting alpha tubulin and 2.Ab coupled to a DNA-PAINT docking strand. (B) Zoom-in image of the 
region highlighted in A. (C) Cross-sectional histogram example of the region highlighted in B, showing a microtubule 
filament diameter of ~50 nm. (D) Overview DNA-PAINT image of alpha tubulin stained with 1.Ab and 2.Nb (E) 
Zoom-in image of the region highlighted in D. (F) Cross-sectional histogram example of the region highlighted in E, 
showing a microtubule filament diameter of ~30 nm. Scalebars: 5 m (A, D), 500 nm (B, E). (G) Histogram analysis 
for the microtubules diameter distribution (86 cross-sections for 2.Ab and 78 for 2.Nb). (I) Box & Whiskers graph of 
G. Whiskers represent 10 & 90 percentiles. Two-tailed unpaired t-test results in p < 0.0001 (****). (H) 
Autocorrelation analyses with N=57 line profiles for each condition; 2.Nb display a significantly faster loss of 




mouse monoclonal 1.Ab anti-alpha tubulin for 15 minutes resulted in properly stained 
filaments (Supp. Fig. 5.1) and single bands detected in a fluorescent Western blot assay 
(Supp. Fig. 5.2 A). Bypassing this limitation by pre-mixing with monovalent secondary 
probes open a new possibility in immunoassays, i.e. it allows to use several 1.Abs against 
different targets raised in the same species. To detect two or more POIs it was typically 
required that each 1.Ab comes from a different animal (e.g. mouse, rabbit and chicken for 
the detection of 3 POIs on the same specimen). This strict requisite is necessary to ensure 
the indirect detection of the POIs with species-specific 2.Abs. This restriction provides a 
limitation for the choice of 1.Ab and it can reduce the multiplexing capability of 
immunoassays. Here we chose three different monoclonal 1.Abs raised all in mouse 
directed against alpha-tubulin, GM130 (Golgi), and FXFG repeats in nucleoporins (nuclear 
pore complex; NPC). Each was pre-mixed with anti-mouse kappa-light chain 2.Nbs 
carrying different fluorophores (Fig. 5.3A, B). COS-7 cells were imaged under scanning 
confocal microscopy, and they clearly displayed the three stained structures (microtubules, 
Golgi and NPC) with minimal background and negligible cross-talk between the channels. 
This multiplexing assay requires that the 2.Nb stays bound to its primary antibody without 
swapping to another primary during the staining incubation, which would result in the 
cross-contamination of signals.  To asses this potential problem, we performed a control 
experiment where mouse 1.Ab anti-GM130 was pre-mixed with excess of fluorescently 
labelled 2.Nb anti mouse antibody (2.Nb-Star635p). In parallel, mouse 1.Ab anti-alpha 
tubulin was premixed with excess of non-fluorescent 2.Nb anti mouse antibody. Finally, 
these individual pre-mixtures were added simultaneously to methanol-fixed cells and were 
incubated for 1 hour, 3 hours or overnight. We were not able to observe the distinctive 
microtubule pattern in any of the conditions, which demonstrates that no cross-
contamination from the fluorescent 2.Nbs pre-mixed with the 1.Ab anti-GM130 onto the 
1.Ab anti-tubulin occurred (Fig. 5.3 C-G; Supp. Fig 5.3). Similarly, this pre-mixing 
capability could be applied for the detection of 2 different POIs in fluorescent Western blots 
assays (Supp. Fig. 5.2 B). The option of pre-mixing primary antibodies with secondary 
nanobody is ideal for techniques that allow the detection of multiple targets (multiplexing). 
Therefore, we turned once again to DNA-PAINT, this time we used an extension termed 




sample with a few nanometer precision20,23. We stained primary hippocampal neurons with 
two mouse monoclonal 1.Abs and each was pre-mixed with 2.Nbs conjugated to DNA 
docking strands with orthogonal sequences. We performed Exchange-PAINT on synapses 
stained against bassoon, a protein highly enriched at the pre-synaptic active zone25, and the 
scaffold protein homer that is concentrated at the post-synaptic density26 (Fig. 5.3 H, I). 
Notably, we obtained a super-resolved view of single neuronal synapses using two primary 
antibodies from the same species. We measured a distance of 129.5±10.9 nm (Fig. 5.3 J-
K) between bassoon (pre-synaptic) and homer (post-synaptic), reproducing previous results 
obtained with other advanced microscopy techniques such as dSTORM27 and X10 
expansion microscopy28. The presence of localisations of homer in the pre-synaptic area is 
most likely due to unspecific background staining caused by the respective 1.Ab (Supp. 
Fig. 5.4).   
Secondary nanobodies enhance sample penetration in shorter incubation time 
We used the time advantage of pre-mixing 1.Abs with the 2.Nbs to stain a complex thick sample 
that requires long incubation with the probes to ensure proper sample staining. We used cochleae 
extracted from three weeks old mice and stained parvalbumin-α, a calcium buffering protein 
present in inner hair cells and type I spiral ganglion neurons (Fig. 5.4). We compared how long 
the 1.Ab-2.Nb and 1.Ab-2.Ab needed to be incubated to result in a homogenous staining 
throughout the sample. In order to image the entire volume, we used light-sheet microscopy after 
decalcification and clearing. Two cochleae obtained from the same animal were stained either with 
1.Abs and sequentially with 2.Abs or with 1.Abs pre-mixed with 2.Nbs for comparable amount of 
time. The cochleae stained with 1.Ab-2.Ab for a total of 6 days (3 days 1.Ab, 3 days 2.Ab) showed 
insufficient penetration of the staining, with signals accumulated in the outer bone surface and in 
the edges exposed to the solution (Fig. 5.4 A). The cochlea stained with the same antibody for 14 
days (7 days 1.Ab, 7 days 2.Ab) showed a better staining performance, revealing hair cells and 
neurons. However, the ganglion displayed a staining gradient with stronger signals on the edges, 
indicating insufficient detection of target molecules deep in the tissue (Fig. 5.4 A, area depicted 
with white discontinuous lines). On the other hand, the cochleae stained with pre-mixed 1.Ab-
2.Nb for 6 and 14 days revealed a homogenous staining of neurons in an analogue area. No 
apparent difference in term of signal homogeneity between the two incubation times was observed 































Figure 5.3. Pre-mixing 1.Abs with 2.Nbs allows to use same animal-species 1.Ab for several target proteins on the same 
sample. (A) Scheme of pre-mixing: different 1.Abs were pre-mixed with 2.Nbs each carrying different fluorophores and 
subsequently incubated on cells. (B) Example of confocal images performed on COS-7 cells stained with the pre-mixing 
methods. Cyan: mouse anti-tubulin 1.Ab pre-mixed with 2.Nb-CF633. Green: mouse anti-GM130 1.Ab pre-mixed with 2.Nb-
Alexa488. Magenta: mouse anti-NPC 1.Ab pre-mixed with 2.Nb-Alexa 546. Scale bar represents 10 µm. (C) Scheme of the 
experimental procedure:  a mouse monoclonal anti-tubulin antibody was pre-mixed with unconjugated 2.Nbs. A monoclonal 
anti-GM130 antibody was pre-mixed with 2.Nb conjugated to Star635p. (D) Epifluorescence example image of cells co-
incubated with both mixtures simultaneously for 1h. (E) Control where only the anti-GM130 premixed with 2.Nb-Star635p was 
used. (F) Control sample stained only with anti -Tubulin premixed with 2.Nb-Star635p. (G) Control where 2.Nb conjugated to 
Star635p was used without 1.Ab. All images displayed in D-G are equally scaled, for direct comparison. Scalebar represents 10 
µm (H) Exchange-PAINT overview image of primary rat hippocampal neurons. Yellow arrows indicate evident mature synapses 
where the pre-synaptic active zone (mouse 1.Ab anti-bassoon) and post-synaptic density (mouse 1.Ab anti-homer) are in front 
of each other. (I) Higher magnification of a selected synapse where a synaptic cleft is recognized. (J) Exemplary histogram 
analysis of the selected synapses displaying the length of the synaptic cleft. (K) Distance analysis of 8 different synapses 




A custom written analysis quantifying the signal intensity throughout the ganglion of the cochleae 
(Fig. 5.4 C, Supp. Figs 5.5 and 5.6) showed how the signal coming from cochleae stained with 
1.Ab-2.Nb displayed a plateau phase meaning homogenous staining, while the ones stained with 







Figure 5.4: Pre-mixing decreases the incubation time necessary to obtain homogenous staining of the cochlea. Mice intact 
cochleae were stained with a parvalbumin- antibody, either pre-mixed with 2.Nb (A) or sequentially incubated with 2.Ab (B) for 
the time indicated. In each panel, the maximal intensity z-projection (MIP) and an exemplary light-sheet microscopy slice of an 
intact cochlea (Slice) are depicted. Scale bar: 200 µm. Ganglion outlined by dotted line (C) Mean pixel line profile from radii 
crossing the ganglion distributed along the centerline of the ganglion. See Supp. Fig. 5.5 for schematic analysis explanation and 
Supp. Fig. 5.6 for raw data.  N=2 cochlea per condition. Note: the plateau profile depicted by the samples stained with 2.Nb, as 
opposed to the relatively pronounced peak profile in the samples stained with 2.Ab for 7 days or to the flat profile in the samples 




Secondary nanobodies reduce probe-induced clusters of target proteins on living cells 
To test if the 2.Nbs have an effect in the probe-induced clustering of target molecules, we 
decided to analyse the surface distribution of IgM containing B cell receptors (IgM-BCRs) 
on a human B cell line (Ramos cells). This cellular model allows simple visual inspection 
and numerical analysis because the POIs are evenly distributed in the cellular surface of 
these resting B cells29. Cells were first stained and then chemically fixed with aldehydes to 
be imaged under stimulation emission depletion (STED) microscopy. Initially, the surface 
IgM-BCRs on living Ramos cells were stained using fluorescent-monovalent probes: a 
monoclonal affibody29 or a polyclonal single Fab fragment (polyFab) (Fig. 5.5).  In this 
case a smooth continuous plasma membrane signal from the surface IgM-BCRs distribution 
was observed at the optically sliced equator of the cells. However, when cells were stained 
using a 1.Ab-2.Ab, a sparse clustered signal was clearly identified (Fig. 5.5). Finally, we 
tested if the 2.Nbs elicit a similar clustering effect observed using 1.Ab-2.Ab detection 
system. Interestingly, a considerably milder effect was observed when using the same 1.Ab 
detected by a 2.Nbs, partially rescuing the distribution pattern observed when stained with 
the monovalent affibody or polyFab that bind directly to the IgM-BCRs (Fig. 5.5). These 
results suggest that although the bivalency of the monoclonal 1.Ab still deviates slightly 
from the signal distribution obtained with fluorescent monovalent primary probes, the 
major cluster-inducing element is contributed by the conventional 2.Abs. A Pearson´s 
autocorrelation analysis30 was used to quantify the probe-induced clustering. The custom-
written analysis consists of collecting the STED image intensity along the membrane and 
correlating it to itself for different rotation angles. We then plotted the autocorrelation 
curves, which start with a perfect correlation (r = 1) at zero rotation and decrease at higher 
rotations (Fig. 5.5 B, with rotation angle converted to corresponding membrane distance). 
The major empirical effect between the different conditions was observed at membrane 
distances between 0.7 to 1 µm. Therefore, the correlations measured throughout this 
interval were then averaged with the value obtained from each cell corresponding to a spot 
on the scatter plot (Fig. 5.5 C). With this method we determined an average autocorrelation 
of 0.34±0.19 (mean±SD) for cells stained with the monovalent polyFab and 0.29±0.16 for 
cells stained with the monovalent affibody, while it was only 0.07±0.12 for the cells stained 




using super-resolution microscopy, but it was also observed in diffraction limited scanning 
confocal microscopy images (Supp. Fig. 5.7). As expected by the more continuous pattern 
observed, the average autocorrelation of cells stained with 1.Ab-2.Nb was 0.21±0.17 
indicating a significant decrease (rescue) of the probe-induced clustering artefact caused by 






Figure 5.5: Live staining of IgM-BCRs on Ramos cells shows different pattern according to the probe used. (A) STED 
images of a B cell stained with fluorescent polyclonal single Fab’ fragment (polyFab); affibody; primary antibody revealed by a 
fluorescent secondary antibody (1.Ab-2.Ab); primary antibody revealed by a secondary nanobody (1.Ab-2.Nb). All fluorescent 
probes were conjugated to AbberiorStar635P fluorophores. Scale bars = 5 µm. (B) Autocorrelation analysis along the 
circumference of cells. We analysed three independent experiments with N≥ 10 cells for each conditions (C) Box-dot plots show 
the average autocorrelation from 0.7 µm to 1.0 µm circumference (grey zones shown in the graphs in B). Boxes show the 
interquartile range (IQR). Lines signify medians, and whiskers extend to 1.5 times the IQR. Lower box represents higher 
clustering. The autocorrelation observed in 1.Ab-2.Ab differs from the monovalent probes (polyFab and affibody) by p ≤ 0.0001 
and from 1.Ab-2.Nb by p ≤ 0.001. P values were calculated with one-way ANOVA followed by Tukey Multiple Comparison 




Probes induce clusters of target proteins in aldehyde-fixed cells 
It has been noticed that conventional fixations times with 4% paraformaldehyde (PFA) does not 
necessarily prevent protein movement34. Also, other variables like blocking reagents and 
temperature need to be taken into consideration and tested case-by-case depending on the imaged 
target31. A more efficient fixative such as glutaraldehyde (GLU) could be used, but it generates 
unwanted autofluorescence and only few affinity molecules bind their target epitopes after GLU 
crosslinking. A recently described di-aldehyde alternative that seems to alleviate some of these 
problems caused by PFA and GLU is glyoxal32. However, glyoxal implementation is very recent 
and the vast majority of researchers still use PFA-fixation for conventional immunofluorescence. 
Therefore, we tested and compared the probe-induced clustering after exposing the Ramos cells 
for 10 and 30 minutes with 4% PFA or 30 minutes with a combination of 4% PFA and 0.1% GLU 
(Fig. 5.6 and Supp. Fig. 5.8). We compared these fixative conditions and live staining using the 
classical 1.Ab-2.Ab complexes or the 1.Ab-2.Nb imaged under STED microscopy. Our 
observations suggest that applying 4% PFA for 10 minutes is not enough to avoid the artefactual 
formation of clusters induced by 1.Ab-2.Ab (autocorrelation of 0.14±0.11 not significantly 
different from the live staining condition 0.07±0.12). However, 4% PFA fixation for 30 minutes 
seems to be sufficient to rescue to a great degree the clustering artefact caused by the 2.Ab 
(0.23±0.18 different from the live staining condition with p value P ≤ 0.001; see also Fig.5.2 A). 
Using the 2.Nbs had no significant change between live, 10 or 30 minutes of fixation with 4% PFA 
(0.21±0.17, 0.20±0.17 and 0.21±0.18 respectively; Fig. 5.6 B). As expected, similar non-clustering 
effects are observed for a primary monovalent probe like the monovalent polyFab directed against 
human IgM-BCRs (Supp. Fig. 5.8). In addition, when observing the staining pattern created by the 
combination of 4% PFA and 0.1% GLU for 30 minutes, the stained rim of the cells is not a thin 
layer as observed by PFA fixation, but it displays a texture-like surface. From studies in electron 
microscopy, it is expected that GLU fixation results in a better ultrastructure preservation. Due to 
the uneven texture-like surface when fixing with PFA and GLU, and therefore a reduced 
homogeneity at the investigated spatial scale, the Pearson´s correlation analysis has the tendency 






In this study we have systematically studied how secondary nanobodies detecting primary 
antibodies can be used to overcome several limitations and artefacts caused by conventional 
polyclonal secondary antibodies. Additionally, problems with polyclonal secondary antibodies 
have been repeatedly attributed to the poor reproducibility provided by polyclonal serums, which 
can be highly heterogeneous37. Therefore, we propose that using recombinantly produced 
monoclonal and monovalent secondary reagents, like the nanobodies characterized here, not only 
eliminates the ethically controversial use of animals for conventional 2.Abs (e.g. from donkey, 
goat, sheep, etc.), but importantly also minimizes artefacts, linkage errors and increases the 
reproducibility of biomedical experiments. 
 
Figure 5.6: Probe-induced clustering on aldehyde fixed B cells. (A) and (B) STED images showing the effect of 
fixation on clustering induced by 1.Ab-2.Ab or 1.Ab-2.Nb. Scale bars represent 5 µm. Box-dot plots show the average 
autocorrelation from 0.7 µm to 1.0 µm circumference (grey zones shown in the Supp. Fig. 9). Boxes show the interquartile 
range (IQR). Lines signify medians, and whiskers extend to 1.5 times the IQR. Lower box represents higher clustering. 





Smaller size of the secondary probe decreases linkage error and increases staining accuracy 
Although it has been already demonstrated that small primary affinity probes are able to minimize 
the linkage error4,8,12, there was just one indication performed in dSTORM that secondary 
nanobodies can increase the labelling precision12. Here we show, in addition to the resolution 
improvement by using 2.Nbs on DNA-PAINT and STED microscopy, that bulky secondary 
antibodies not accurately represent the distribution of the primaries, due to a combination of their 
polyclonal nature and large size (Fig. 5.1 A). We show that the 1.Abs directly labelled with a 
fluorophore decorates microtubules with a certain periodicity that can be followed when revealed 
with a 2.Nb but not with a conventional 2.Ab, suggesting that the 2.Ab blurs the localization of 
the 1.Ab. This inaccuracy of the polyclonal 2.Abs can have major consequences in one of the main 
application of fluorescence microscopy, namely co-localization studies. 
 
Pre-mixing overcomes the species limitation for multiplexing microscopy  
Mixing the primary and the secondary reagents prior to incubating them with the sample (pre-
mixing) is a desired feature as it saves experimental time. This cannot be performed with 
conventional bivalent polyclonal 2.Abs (Supp. Fig. 5.1), however, pre-mixing has been shown to 
work when using monovalent binders against 1.Abs12. This feature eliminates the animal-species 
limitation of the primaries when detecting two or more POIs. We first showed that it is possible to 
use 2 mouse 1.Abs in a simpler Western-blot assay (Supp. Fig. 5.2), and then we tried 3 different 
mouse 1.Abs in immunofluorescence under conventional scanning confocal microscopy. 
Nevertheless, pre-mixing needs to be carefully tested and well validated for every application and 
for each set of 1.Abs, since the 2.Nbs are not covalently bound to the 1.Abs. However, our control 
experiments (Fig. 5.3 C & Supp. Fig. 5.3), suggest that no significant movement between primaries 
can be observed if incubation with pre-mixed primary and secondary nanobodies is for 1 and 3 
hours, even overnight incubations did not show signs of cross-contamination when using two 
primaries of the same species. To ensure the permanence of the secondary nanobody on its primary 
antibody in demanding applications like DNA-PAINT, we decided to perform a short post fixation 
between the applications of the different pre-mixed pairs. Here we showcased the proof-of-
principle of pre-mixing with 2.Nbs and multiplexing using Exchange-PAINT super-resolution 
microscopy. We determined the distance between the pre- and post-synapses with high accuracy 




methods27. Exchange-PAINT not only provides high spatial resolution, but it also eliminates the 
limit on the number of POIs that can be imaged in the same sample. This makes the combination 
of pre-mixing using 2.Nbs with Exchange-PAINT a very powerful approach for multiplexing. 
 
Pre-mixing shortens experimental time and allows a better penetration of probes in thick 
tissue  
Immunostaining protocols of complex thick tissue samples typically require days to weeks16,17. 
This is because it takes time for the antibody to penetrate into the tissue, for thoroughly washing  
unbound binders, and also because the 1.Abs and 2.Abs have to be performed sequentially. This 
may be a problem even in cell monolayers, where it has been suggested that primary and 
conventional secondary antibodies have difficulties penetrating in crowded areas and revealing all 
epitopes8,13.  
Pre-mixing the primary antibodies and the secondary nanobodies reduces the experimental time of 
immunostainings and becomes a very important time-saver when used in samples that require long 
staining protocols. Here we used cleared mouse cochlea imaged with light sheet microscopy to 
compare the staining pattern of primaries pre-mixed with 2.Nbs or using conventional secondary 
antibodies. Our observation suggest that pre-mixing shorten the conventional protocol by at least 
half the time (i.e. 6 days of staining; Fig. 5.4). We did not test shorter times for pre-mixing, but 
the fact that no clear difference in intensity or signal distribution between pre-mixed stainings for 
6 or 14 days were observed, suggests that optimal incubation time might be even shorter.  
 
Antigen clustering on cells rescued by the use of secondary nanobodies 
Our results on probe-induced clustering of the POI show strong indications of conventional 
polyclonal 2.Abs as the major clustering element.  We first demonstrated that these probe-induced 
artefacts can be minimized using monovalent probes as secondary reagents (e.g. 2.Nbs). The 
staining of living Ramos cells show how the distribution of BCRs at the plasma membrane went 
from a smooth to a clustered pattern when using 1.Ab-2.Ab, which was rescued by the use of 2.Nb 
(Fig. 5.6). This result suggests that monoclonal bivalent 1.Ab has some minor effect on probe-
induced clustering compared to the major clusters of the POI observed when using polyclonal 




aldehyde fixation was performed. Sample fixation with 4% paraformaldehyde for 10 minutes is a 
widespread practice in biology laboratories, but seems to be insufficient to fully immobilize 
cellular elements, in agreement with previous work22,32. We complemented the previous 
observations by demonstrating that polyclonal 2.Abs drastically enhance the clustering of the POIs 
if samples are poorly fixed (Fig. 5.6). The artificial aggregation of POIs even after chemical 
fixation can lead to several misleading conclusions when studying for example co-localization of 




Small, monovalent, and monoclonal probes specific to the endogenous targets are clearly the ideal 
probes to reveal POIs. Unfortunately, their availability is limited to a handful of targets. On the 
other hand, a large amount of well validated monoclonal antibodies is available. Our data suggests 
that the localization of primary antibodies with recombinant secondary nanobodies or probably 
other small monovalent binder such as Protein A33, can minimize the probe-induced clustering of 
targets, increase the localization accuracy in super-resolution microscopy, lower steric hindrance 
for detecting more target molecules, enhance the sample penetration, remove the species-limitation 
by pre-mixing allowing high multiplexing capabilities, and finally, increase the reproducibility of 




5.4 Material and Methods  
 
Cell culture  
Cells were cultured at 37°C, 5% CO2 in a humified incubator. The human Burkitt lymphoma B 
cell lines DG75 and COS-7 fibroblast were obtained from the Leibniz Institute DSMZ—German 
Collection of Microorganisms and Cell Culture (DSMZ Braunschweig, Germany). For 
maintenance, cell lines were kept on petri dishes. For experiments cells were plated on poly‐L‐
lysine (PLL)‐coated coverslips. DG75 cells were splitted every 3 days using fresh complete 
medium (RPMI medium supplemented with 10% Fetal Bovine Serum (FBS), 4 mM L-glutamine 
and 100 U/ml penicillin and streptomycin). COS-7 fibroblast cells were cultured in complete 
Dulbecco’s MEM with the addition of 10% FBS, 4 mM L-glutamine, 0.6% penicillin and 
streptomycin. A549 cells (ATCC, Cat. No. CRL-1651) were maintained in DMEM (Thermo 
Fisher Scientific, Cat. No. 10566016), supplemented with 10% Fetal Bovine Serum (Thermo 
Fisher Scientific, Cat. No. 10500-064) and 1% Penicilin/Streptomycin (Thermo Fisher Scientific, 
Cat. No. 15140-122). 
Rat primary hippocampal neuron cultures were prepared as described before by Opazo et al.33  In 
brief, the brains of P1-2 were extracted and placed in cold HBSS (ThermoFisher, Waltham, 
Massachusetts, USA). The hippocampi were extracted and placed in a solution containing 10 mL 
DMEM (Thermo Fisher), 1.6 mM cystein, 1 mM CaCl2, 0.5 mM ethylenediaminetetraacetic acid 
(EDTA), 25 units of papain per mL of solution, with CO2 bubbling, at 37°C for 1 h. The solution 
was removed and the hippocampi were incubated in 10% FBS‐DMEM, 73 µM albumin for 15 
minutes. The hippocampi were triturated using a 10 mL pipette in complete‐neurobasal medium 
[Neurobasal A (Thermo Fisher), containing 2% B27 (Thermo Fisher) and 1% Glutamax‐I (Thermo 
Fisher). Neurons were plated (12‐well plate) on poly‐L‐lysin‐hydrochloride (Sigma‐Aldrich, St. 
Louis, Missouri, United States) coated coverslips in plating medium (500 mL MEM, 50 mL horse 
serum, 5 mL glutamine, 330 mg glucose. After 2 h the plating medium was replaced with 1.25 ml 







Staining of BCRs  
For the staining of BCRs on living cells the staining was performed on ice to avoid the 
internalization of BCRs. Cells (~200,000 cells/sample) were pelleted by centrifuging at 1000 x g, 
resuspended in 50 µL of ice-cold complete medium (see above) containing the investigated affinity 
probe (see Supp.Table 1) and incubated for 10 minutes on ice. Cells were centrifuged at 400 x g 
at 4°C in a table top centrifuge and the excess of probe was removed. Cells were washed by 
resuspension in 1 ml of ice-cold Dulbecco’s Phosphate Buffered Saline (DPBS) followed by 
incubation on ice for 3 minutes and centrifugation at 400 x g at 4°C. The washing step was repeated 
3 times to remove most of the excess of the fluorescent probes. When a secondary probe was used 
(see Supp. Table 1), the cells were further incubated with 50 µL ice-cold complete medium 
containing the secondary reagent and incubated for another 30 minutes on ice (staining controls 
without secondary probes were left for the same time on DPBS only). Washing was performed as 
described for the primary probe. After staining, cells were resuspended in 1 ml of cold DPBS and 
transferred to a 12 well plate (containing PLL coated coverslips). The plate was centrifuged at 500 
rpm for 5 minutes at 4°C. The DPBS was carefully discarded and cells were fixed with 1 mL of 
4% paraformaldehyde and 0.1% GLU in PBS for 10 minutes on ice followed by 30 minutes at 
room temperature. The fixative was removed and quenched by adding 1 mL of 0.1 M Glycine in 
DPBS and incubated at room temperature for additional 20 minutes. Finally, cells were rinsed with 
1 mL DPBS and mounted on a glass slide using Mowiol (6 g glycerol, 6 ml deionized water, 12 
ml 0.2 M Tris buffer pH 8.5, 2.4 g Mowiol 4–88, Merck Millipore). The staining of BCRs of fixed 
Ramos cells, around 200,000 cells/sample were pelleted by centrifuging at 1000 x g, resuspended 
in 1 mL DPBS and transferred to a single well on a 12 well plate containing PLL coated coverslips. 
The cells were let to sediment on the coverslips at 37°C for 1 h. DPBS was removed and cells were 
fixed with one of the following conditions: 10 minutes with 4% PFA, 30 minutes with 4% PFA or 
30 minutes with 4% PFA and 0.1% GLU. For all fixation conditions the first 5 minutes incubation 
were performed on ice and the remaining fixation time at room temperature. After fixation, the 
quenching of reactive aldehydes was performed as described above. Cells were finally rinsed and 
staining was done in 1 mL DPBS containing the different probes. After staining, cells were washed 






Imaging and Analysis of BCRs 
Cells were imaged with multicolor confocal STED microscope (Abberior Instruments, Göttingen, 
Germany) described below. Imaging was performed using a 640 nm excitation laser and a 775 nm 
depletion laser. The final raw STED images were obtained after the summation of 3 successive 
scans. STED images of cells were analyzed using custom written MATLAB scripts (MATLAB 
Release 2014b, The MathWorks, Inc., Natick, Massachusetts, United States). For each cell center, 
the radii of two circles were manually adjusted so that the area between the circles contained all 
of the cell membrane. From this area, pixels were grouped by their angle to the cell center (in 360 
bins of 1°) and maximum-projected to obtain the angle-dependent intensity 𝑦𝑖along the membrane. 
The self-similarity of this function was then assessed by calculating its normalized autocorrelation 
𝑎𝑖 = 𝐹
−1{𝐹(𝑦𝑖) ∙ 𝑐𝑜𝑛𝑗(𝐹(𝑦𝑖))}          (1) 





           (2) 
the mean value 𝑦, the complex conjugate conj and the fast Fourier transform F. It gives a measure 
of how similar the intensity of two points are on the membrane depending on their angular distance. 
As the effect of different labeling homogeneities was best observed at a range of 8-12°, the 
autocorrelation from this area was then averaged for each cell (and translated to the perimeter in 
µm in the figures by approximating the cell diameters to 10 µm).  
 
Peroxisome size  
Primary neurons from rat hippocampi were fixed with 4% PFA 30 minutes followed by 30 minutes 
at room temperature. The neurons were incubated in a blocking and permeabilizing solutions 
containing 5% bovine serum albumin (BSA) and 0.1% Triton X-100 for 20 minutes at room 
temperature. The rabbit polyclonal anti Pmp70 antibody (Abcam, Cat No: ab85550) was added on 
the cells in a 1:300 dilution in PBS containing 2.5% BSA 0.05% for 1 h at room temperature. The 
cells were washed 3 time for 10 minutes each in PBS and incubated with either secondary goat 
anti rabbit conjugated to AbberiorStar635P (Abberior GmbH, Cat. No: 2-0012-007-2) or the 2.Nb 
FluoTag-X2 anti rabbit also conjugated to AbberiorStar635P (NanoTag Biotechnologies, Cat. No: 




room temperature. The cells were washed 3 times for 10 minutes in PBS and finally mounted in 
Mowiol. The peroxisomes on neurons were imaged with the STED setup described above using a 
640 nm excitation laser and 775 nm depletion laser.  
For determining the peroxisome diameter, the images were filtered using a bandpass filter, in 
MATLAB, to remove background noise, and peroxisome regions of interest were identified using 
an empiric threshold. The smallest ellipse diameter that fitted each peroxisome region of interest 
was then obtained by using the self-written MATLAB routine. 
 
Autocorrelation on Microtubule stainings  
COS-7 cells were fixed with -20°C pre-cooled methanol for 20 minutes at -20°C. Methanol was 
removed and cells were blocked with 3% BSA for 20 minutes at room temperature. The cells were 
incubated with primary mouse monoclonal antibody anti-tubulin (SySy, Cat No: 302 211) directly 
coupled to Atto647N fluorophore and diluted at 1:25 in 1.5 % BSA for 1 h at room temperature. 
The cells were washed 3 times, 5 minutes each with PBS. Cells were then incubated with either 
secondary nanobody FluoTag-X2 anti mouse conjugated to AbberiorStar580 (NanoTag 
Biotechnologies, Cat No: N1202) or secondary full antibody anti mouse coupled to 
AbberiorStar580 (Abberior, Cat. No: 2-0002-005-1) diluted at 1:100 in 1.5% BSA for 1 h at room 
temperature. Finally, cells were washed as described above and mounted in Mowiol. Images of 
microtubules were taken using the Abberior Expert line STED system. A 640 nm excitation laser 
and 775 nm depletion laser were used for imaging the 1.Ab (AbberiorStar635P) while a 561 nm 
excitation laser and 775 nm depletion laser were used for imaging the fluorophore on the secondary 
probes (AbberiorStar580).  The correlation of the STED signal provided by the secondary probe 
to the primary probe was analyzed as follows. Lines were drawn following the stained 
microtubules using a self-written routine in MATLAB. The Pearson´s correlation between the 
directly labeled 1.Ab and the secondary probes were measured at the drawn lines. The 








Pre-mixing experiment Immunostaining 
COS-7 cells were fixed in -20°C pre-cooled methanol for 20 minutes at -20°C. The cells were 
blocked by addition of 3% BSA in PBS for 30 minutes at room temperature. In the meantime, the 
1.Abs were pre-mixed for 30 minutes with two molar excess of fluorescently-labeled 2.Nbs in PBS 
containing 1.5% of BSA (see Supp. Table 2). The pre-mixed complexes were then incubated on 
the fixed cells sequentially. In between each round of pre-mixed complex, the cells were washed 
3 times for 5 minute each with PBS and post-fixed with 4% PFA for 10 minutes. The excess of 
fixative was quenched with 0.1 M glycine in PBS for 10 minutes. The cells were mounted in 
Mowiol and imaged using a multicolor laser scanning confocal microscope (the STED system 
described before). ). For the immunostaining of Fig. 3D-G and Supp. Fig. 3, COS-7 cells were 
stained and blocked as described above. The 1.Abs were premixed with approximately two-fold 
molar excess of the 2.Nbs (either fluorescently labelled or unconjugated) for 30 minutes. The 
premixed complexes were in this case incubated simultaneously on the cells for the amount of time 
indicated. The cells were then washed three times for 5 min with PBS. Hoechst was added and 
rinsed after 5 minutes before they were mounted in Mowiol and imaged with STED microscopy. 
 
Pre-mixing experiment Western Blot  
A confluent plate of COS-7 cells was briefly washed with ice-cold PBS before lysing the cells on 
the plate sitting on ice with pre-chilled Lysis buffer (50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 2 
mM EDTA, 0.5% IgePAL, 0.5 % Sodium deoxycholate 33and freshly added DNAse, 1 mM PMSF 
and protease inhibitor cocktail (Roche). Cells were scrapped and passed through a syringe with 
needle gauge 26 several times avoiding foam. After max. speed centrifugation at 4°C in a table-
top centrifuge for 15 minutes. Supernatant was taken and mixed with 2x loading dye (50 mM Tris-
HCl, 4% sodium dodecyl sulfate (SDS), 0.01% Serva Blue G, 12% glycerol, pH 6.8, 50 mM DTT) 
and heated at 95°C for 10 minutes. Boiled samples were then loaded in  10% SDS-PAGE. Proteins 
in the gel were then transferred to a nitrocellulose membrane in wet trans-blot cell (Biorad). The 
membranes were blocked in blocking buffer (5% Nonfat Dried Milk in PBS + 0.1% Tween-20) 




for 10 minutes and then added together on the blocked nitrocellulose membranes for 60 minutes 
at room temperature. Membranes were washed 5 times with large volumes of PBS for 5 minutes 
each and read with a LiCor Sytem Odyssey Clx. 
 
Conjugating secondary nanobodies to ssDNA or fluorophores 
Secondary nanobodies (obtained from NanoTag Biotechnologies GmbH) were coupled to docking 
oligonucleotide strands (Biomers GmbH, Ulm, Germany) functionalized with an azide group at 
the 5′-end and an Atto488 fluorophore at the 3′-end following the protocol described by Sograte-
Idrissi et al23. In brief, the nanobody containing an extra C-terminal cysteine was reduced with 5 
mM TCEP (Sigma-Aldrich, Cat. No. C4706) for 2 h on ice. TCEP was removed via 10 kDa 
molecular weight cut-off (MWCO) Amicon spin filters (Merck, Cat. No. UFC500324) and the 
nanobody was coupled through maleimide conjugation chemistry to a maleimide-DBCO 
crosslinker (Sigma-Aldrich, Cat. No. 760668). After removal of excess crosslinker through 10 kDa 
MWCO Amicon spin filters, the nanobody was coupled to the docking oligo containing an azide 
group at its 5´-end (Biomers) through a strain promoted azide-alkyne cycloaddition reaction. To 
avoid background signal, the excess of docking oligo was removed by a size exclusion 
chromatography column (Superdex® Increase 75, GE Healthcare) on an Äkta pure 25 system (GE 
Healthcare). The docking strand sequences were obtained from Agasti el al.20 and can be found in 
Supp. Table 5.2.  
Nanobodies bearing ectopic cysteines were first reduced with 10 mM of TCEP for 1-2h. After 
removing TCEP with a Nap5 column (GE Healthcare), reduced nanobodies were immediately 
exposed to ~3 molar excess of maleimide-functionalized fluorophore (e.g. CF633, Alexa488, 
Alexa546, Star635p) for 2 hours. Subsequently, the excess of dye was removed using a size 
exclusion chromatography column (Superdex® Increase 75, GE Healthcare) on an ÄKTA pure 25 
system (GE Healthcare). 
 
DNA-coupling of antibody 
Donkey anti-mouse secondary antibody (Jackson Immunosearch, Cat. No. 715-005-151) was 
labelled with a DNA strand via a DBCO-sulfo-NHS ester linker according to the protocol as 




NHS ester cross-linker (Jena Bioscience, Cat. No. CLK-A124-10) for two hours at 4°C. Unreacted 
cross linker was then removed using a Zeba desalting column (40 kDa MWCO, Thermo-Fisher 
Scientific, Cat. No. 87766). The antibody-DBCO conjugate was then attached to a DNA strand 
functionalized with an azide group at the 5’-end via copper-free click chemistry. Excess DNA-
strands were removed using 100 kDa MWCO Amicon spin filters (Merck Millipore, Cat. No. 
UFC510096). Docking strand sequences were obtained from Agasti el al.20 and can be found in 
Supp. Table 2. 
 
Stainings for DNA-PAINT 
Cells for DNA PAINT imaging were plated on an 8-well chamber coverglass II (Sarstedt, Cat No: 
94.6190.802 or ibidi, Cat. No. 80827 ibidi, Cat. No. 80827) and grown overnight. The next day, 
cells were fixed. COS-7 cells were fixed with pre-cooled methanol for 20 minutes at -20°C. The 
cells were then blocked with 3% (w/v) BSA for 20 minutes at room temperature and incubated 
with a primary mouse monoclonal anti-alpha tubulin antibody directly labelled with Atto647N 
(SySy, Cat No: 302 211) and diluted 1:25 in 1.5% BSA for 1 h at room temperature. Unbound 
1.Ab was removed by washing the cells 3 times with PBS for 5 minutes each. They were then 
incubated with the 2.Nb or 2.Ab coupled to DNA-PAINT docking sequences. The cells were 
washed 3 times for 5 minutes with PBS. 
Rat primary hippocampal neuron, were fixed by adding 4% PFA for 30 minutes on ice and 4% 
PFA for 30 additional minutes at room temperature. The neurons were blocked and permeabilized 
with 3% (w/v) BSA + 0.1% (v/v) Triton X-100 for 20 minutes at room temperature. The mouse 
monoclonal anti Bassoon (Enzo, Cat No: ADI-VAM-PS003-F) and the mouse monoclonal anti 
Homer (SySy, Cat No: 1600111) were pre-mixed in a 1:5 molar ratio with 2.Nb anti mouse coupled 
to P1 (5´- TTATACATCTATTTT-Atto488-3´) and P5 (5´-TTTCAATGTATTTTT-Atto488-3`) 
respectively. The pre-mixed anti Homer 1.Ab and its 2.Nb were added on the cells for 1 h with 
slow orbital shaking. The cells were then washed 3x 5 minutes each with PBS and 1x 5 minutes 
with PBS supplemented with 0.1 M NaCl. The 1.Ab-2Nb complex were briefly fixed by adding 
4% PFA for 5 minutes. The fixative was removed and the remained quenched with 0.1 M glycine 
for 5 minutes. The pre-mixed anti Bassoon 1.Ab with its 2.Nb was added to the cells for 1 h at 




incubated with a 1:10 dilution of 90 nm gold particles (cytodiagnostics, Cat. No. G-90-100) for 10 
minutes, rinsed 4x with PBS and stored at 4°C until imaging was performed. 
 
DNA-PAINT Imaging  
The correspondent imager strand to the DNA-PAINT docking sites used on the nanobodies (Supp. 
Table 5.3), were equipped with a Cy3b fluorophore at their 3´-end. Imager strands were diluted in 
PBS supplemented with 500 mM NaCl and 1x Trolox (Sigma-Aldrich, Cat. No. 238813-1G). 
Imager strands were used at concentrations between 0.5 nM and 2 nM to optimize the number of 
binding events per time (see Supp. Table 4). The focal plane was found by searching in the 488 
nm channel. Cells were then imaged in the 561 nm channel with a 100-200 ms exposure time per 
frame for 30.000-60.000 frames. When exchange of imager was performed, the chamber was 
washed 10 times with PBS supplemented with 0.5 M NaCl until no residual blinking was observed 
anymore. The reconstruction of the raw data and the drift correction with cross correlation and 
gold particles as fiducial markers was performed with Picasso Sotware3. Microtubule filament 
sizes were measured via exported regions and Gaussian fits in Origin on the localizations. Images 
were acquired as described below and raw data movies were reconstructed with the Picasso 
software suite. Drift correction and multicolor alignment was performed via redundant cross-
correlation and 90 nm gold particles as fiducial markers. The Picasso software suite was also used 
to detect the localisation frequency events in Supp. Fig. 5.4A. 
 
Cochlear staining 
Mice C75Bl6/J of 3 weeks of age were euthanized by decapitation. Cochleae were harvested and 
fixed in 4% PFA for 45 minutes at room temperature. Afterwards, they were processed following 
the cochlea-adapted version of the iDISCO+ protocol (Keppeler and Duque-Afonso et al., in 
preparation). Briefly, they were decalcified in 10% EDTA in PBS, pH 8, for 2 days and treated 
with 25% N,N,N′,N′-Tetrakis(2-Hydroxypropyl)ethylenediamine in PBS for another 2 days, in 
order to remove endogenous fluorescence34 at room temperature under constant rotation. The 
samples underwent the methanol-free pre-treatment of the iDISCO+ protocol35, followed by the 
regular procedure for immunostaining and clearing. The pre-treatment consisted in subsequent 
incubations at 37°C under constant shaking of the following solutions:  0.2% Triton X-100 in PBS 




Tween-20/0.1% Deoxycholate/0.1% IGEPAL CA-630 in PBS (1 day), Triton X-100 in PBS 
(2x1h). The immunostaining continued at 37°C, under constant shaking, with the incubation of the 
tissue in a Permeabilization solution (0.16%TritonX-100/20%DMSO/2.3% Glycine (0.3M) in 
PBS, 2 days) and in a Blocking Solution (0.16% TritonX-100/10%DMSO/3%BSA in PBS, 2 
days). The 1.Ab (Guinea Pig antiserum anti-parvalbumin- α, 195 004, Synaptic System) was pre-
mixed with the 2.Nb (Nanobody anti-guinea pig Alexa 546) using a molar ratio of 1:3 or 45 min, 
under constant rotation, at room temperature. The PTwH buffer contained 0.2% Tween-20/0.001% 
Heparin in PBS. The primary antibody was diluted in a solution containing 5%DMSO/1.5%BSA 
in PTwH with a concentration of 1:300. The 2.Ab (Goat-Anti Guinea pig 568, Invitrogen, A11075, 
1:500) and the 1.Ab pre-mixed with the 2.Nb were diluted in a solution containing only 1.5%BSA 
in PTwH. The sample were incubated in 4 different ways (37°C, under shaking): 1) 6 days and 2) 
14 days in the solution containing the 1.Ab premixed with the 2.Nb, 3) 3 days and 4) 7 days with 
the 1.Ab followed by a washing step of 1 day in PTwH at room temperature and the incubation of 
the 2.Ab for 3 and 7 days respectively. Before the clearing procedure, the samples were washed in 
PTwH for 1 day at room temperature. Finally, samples were dehydrated in an increasing methanol 
dilution series (20, 40, 60, 80, 100 and 100% Methanol in ddH2O, one hour each), incubated in 
66% Dicloromethane/33% Methanol for 3 hours plus two consecutive incubation in 100% DCM 
for 15 minutes each for lipid extraction, and immerse in Dibenzylether, as a refractive index 
matching solution.  
 
Cochlear probe penetration quantification 
The original stack was resampled by a factor of 2.15x2.15x2 and converted to 8-bits in FIJI36. 
Then, the ganglion was coarsely segmented manually with TrakEM237 and imported to 
3DSlicer38,39. There, a median filter with a kernel of 10x10x1 pixel was applied and the resulting 
image was threshold segmented, converted to a 3D closed surface or mesh and stored as a .stl file, 
as it is the input format needed for the following step. Centerlines of the ganglion were then 
calculated using the vmtkcenterline function of the open source software VMTK (the Vascular 
Modelling Toolkit, Orobix Srl) and then imported to MATLAB for further analysis. For every 
sample, the mesh, centerline and raw stack were imported to MATLAB. The centerline was fitted 




positions, 14 radii of 200 µm were positioned, 6 orthogonal to the rest. The chosen orientation was 
parallel to the apical-basal axis formed by the most apical and most basal coordinate of the 
centerline. Those radii that were inside of the mesh, checked by the function inpolyhedron, or 
outside of the original image space, were removed. Radii were mapped in the image space and the 
pixel values in their coordinates were used to obtain the line profiles. The minimum of each 
profiles was subtracted for each to have a comparable baseline. 
 
Microscopy Setups 
Fluorescent imaging of Supp Fig.5.1 was done with Nikon inverted epifluorescence microscope. 
The microscope was equipped with an HBO 100‐W lamp and an IXON X3897 Andor Camera. 
For all samples, a 60X Plan apochromat oil immersion objective (NA 1.4) was used (from Nikon). 
The filter sets and time course (if applicable) used for imaging are shown in Table 3. Images were 
obtained using the image acquisition software NiS‐Elements AR (Nikon). STED microscopy 
images were obtained using STED Expert line microscope (Abberior Instruments, Göttingen, 
Germany) composed of a IX83 inverted microscope (Olympus, Hamburg, Germany) with a 
UPLSAPO 100x 1.4 NA oil immersion objective (Olympus). Confocal images were obtained from 
the same setup without using the STED depletion laser. DNA-PAINT imaging was carried out on 
an inverted Nikon Eclipse Ti microscope (Nikon Instruments) with the Perfect Focus System, 
applying an objective-type TIRF configuration with an oil-immersion objective (Apo SR TIRF 
100x, NA 1.49, Oil). Two lasers were used for excitation: 561nm (200 mW, Coherent Sapphire) 
or 488 nm (200 mW, Toptica iBeam smart). The laser beam was passed through a clean-up filter 
(ZET488/10x or ZET561/10x, Chroma Technology) and coupled into the microscope objective 
using a beam splitter (ZT488rdc or ZT561rdc, Chroma Technology). Fluorescence light was 
spectrally filtered with two emission filters (ET525/50m and ET500lp for 488 nm excitation and 
ET600/50 and ET575lp for 561 nm excitation, Chroma Technology) and imaged on a sCMOS 
camera (Andor Zyla 4.2) without further magnification, resulting in an effective pixel size of 130 
nm after 2x2 binning. Camera Readout Sensitivity was set to 16-bit, Readout Bandwidth to 540 
MHz. Light-sheet images of the cochleae were done using a light-sheet microscope (LaVision 
Biotec Ultramicroscope II). The laser power was constant for all the samples except for the sample 
incubated with 1.Ab-2.Ab for 14 days, which was 6.75 times lower (13.5% vs. 2%). The stacks 




body), a step size of 3 µm, with a light-sheet of 30% width and a thickness of 5 µm (NA: 0.148, 
unidirectional illumination and 11-12 steps of dynamic horizontal focus.  The images were 
imported to FIJI36 for calculating the maximum intensity projection image and to generate the 
RGB tif files with a mpl-magma look-up-table. 
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Supplementary Figure 5.1: Pre-mixing antibodies in a centrifuge tube prior incubation on the 
cell. Immunostaining is commonly done by sequential incubation of the primary probe and the 
secondary probe. Pre-mixing the two probe in a centrifuge tube prior incubation leads to no 
staining for 1.Ab-2.Ab while staining is maintained for 1.Ab-2.Nb. Hoechst staining (nucleus) 




Supplementary Figure 5.2: Pre-mixing 1.Ab-2.Nb for Western Blot. COS-7 cell lysate blotted 
on nitrocellulose membrane. A) Pre-mixing allows shorter protocol by one single step staining. 
The membrane was stained with 1.Ab beta actin pre-mixed with 2.Nb anti Mouse coupled to 
IRDye680RD and 1.Ab anti Lamin B pre-mixed with 2.Nb anti Rabbit-IRDye800CW B) Pre-




stained with 1.Ab beta actin pre-mixed with 2.Nb anti Mouse-IRDye800CW and 1.Ab anti 
alpha tubulin pre-mixed with 2.Nb anti Mouse-IRDye680RD. 
 
 
Supplementary Figure 5.3: Assessment of cross-contamination of 2.Nbs if pre-mixtures of 
same species are co-incubated on the sample simultaneously. (A) Top-left panel shows the 
epifluorescence images of COS-7 cells co-incubated for 1h at room temperature with the 




with 2.Nb-Star635p. The other top panels are controls. From left to right: anti-GM130 with 
2.Nb-Star635p, without the anti-tubulin primary antibody; only anti-tubulin premixed with 
2.Nb-Star635p; only the fluorescently labeled secondary nanobody (2.Nb-Star635p). The lower 
panels show the zoom areas depicted with dashed squares. Gray levels were equally set for all 
images (depicted with the gradient bar shown on the left). Scale bar for top and zoomed panels 





Supplementary Figure 5.4: The presence of homer signal in pre-synapses. (A) Example 
synapse taken from Fig. 3I. Analysis of homer DNA-PAINT localizations on the bassoon-rich 
localization area (pre-synapses) where the low frequency of visits by imager (shown in c & d) 
suggest that these “homer” localizations are non-specific events caused by the imager 
“stickiness”. In contrast, homer localizations on the post-synaptic area can be clearly attributed 
to specific and repeated annealing of imager to the docking DNA strand present on the 2.Nb (a 
& b). (B) 2-Color STED microscopy images of primary hippocampal neurons stained with a 
guinea pig anti-Synaptotagmin1 antibody (pre-synaptic marker found in synaptic vesicles) and 
the same anti-homer or anti-bassoon used for the DNA-PAINT in Fig. 3H. (C) An analysis of 




can be found within Syt1-marked pre-synapses. An average of ~14.45±1.6% (mean±SD) of the 
homer signal is present there. Bassoon, which is a bona fide pre-synaptic protein, shows a 
stronger correlation to Syt1-marked synaptic vesicles, as expected. The graph displays the 
mean±sem with an N = 5.  
 
 
Supplemental Figure 5.5: Method to investigate the sample penetration of different labelling 
approaches in cochlear staining. A) Maximal intensity projection of a cleared cochlea stained 
with 1.Ab against parvalbumin- premixed with 2.Nb anti-guinea pig. B) Coarse manual 
segmentation of the ganglion. C) Median filtered image of the ganglion (kernel: 10x10x1). D). 
2D projection of the mesh created from a threshold segmentation of C), its centerline, the apex-
base axis, the center positions where the radii fan out and the used and discarded radii. Only 6 
out of the 100 center positions and their corresponding radii used are displayed for clarity. E) 
Maximal intensity projections of a sub-stack of the slices that contains only the ganglion. In 
magenta, all the radii mapped back in the image space. F). Mean line profile per position (n=100 
positions) and mean line profile for this sample is plotted against the distance from the center 







Supplemental Figure 5.6: Line profile from individual cochlear samples. Mean profile per 
position (n= 100 per sample, grey thin traces) and mean profile per sample (N=2 per staining 
method and incubation time, color thick traces) are displayed against distance from center 
position from  A) Samples stained with a 1.Ab against parvalbumin-  premixed with 2.Nb 
against guinea pig, labeled with Alexa Fluor 546, and B) Samples stained with a 1.Ab against 




Supplementary Figure 5.7: Diffraction limited images (confocal microscope) of B cells 




of the BCR receptor. In green a membrane staining is performed (R18) to show the integrity of 
the membrane. Scale bar represents 50 µm 
 
Supplementary Figure 5.8: B cells fixed in different conditions and subsequently stained with 




Supplementary Figure 5.9: Autocorrelation curve of B cells fixed prior staining with different 










Supplementary Table 5.1 | Antibodies  




affibody® anti-IgM coupled to 
the Star635P 
Abcam, Cambridge, UK ab36088 1:25 























BD bioscience 610822 1:62,5 
Monoclonal mouse anti-NPC Abcam, Cambridge, UK ab24609 1:200 





FluoTag-X2 anti-Mouse kLC 


















































Supplementary Table 5.2 | Handle sequences 
Handle Name Sequence 5’-mod 3’-mod Company 
P1 TTATACATCTATTTT  Azide Atto488 Biomers.net 
P3 TTTCTTCATTATTTT Azide Atto488 Biomers.net 
P5 TTTCAATGTATTTTT Azide Atto488 Biomers.net 
 
 
Supplementary Table 5.3 | Imager sequences 
Imager name Sequence 5’-mod 3’-mod Company 
P1* CTAGATGTAT None Cy3b 
Eurofins 
Genomics 
P3* GTAATGAAGA None Cy3b 
Eurofins 
Genomics 







Supplementary Table 5.4| Imaging parameters 
Dataset  Parameters  Power @561 
nm 
Figure 2: DNA-PAINT Microtubule with 
2.Nbs 
200ms, 2D, 60k Frames, 
2nM. P1* 
1 kW/cm2 
Figure 2: DNA-PAINT Microtubule with 
2.Abs 
200ms, 2D, 60k Frames, 
2nM. P1* 
1kW/cm2 
Figure 3: bassoon 150ms, 3D, 30k Frames, 
3nM, P5* 
1 kW/cm2 










Supplementary Table 5.5 | Statistics on BCR autocorrelation Analysis. One-way ANOVA 
with Tukey Multiple Comparison Test. ns= non-significant, *= p ≤ 0.05, **= p ≤ 0.01, ***= p 









From Figure 5 
polyFab live  ns **** ** 
Affibody live    **** ns 




10 min 4% 
PFA 
1.Ab+2.Ab 30 
min 4% PFA 
1.Ab+2.Ab 30 
min 4% PFA+ 
0.1% GLU 
From Figure 6a 
1.Ab+2.Ab live  ns *** **** 
1.Ab+2.Ab 10 min 4% 
PFA 
   * ns 
1.Ab+2.Ab 30 min 4% 
PFA 




10 min 4% 
PFA 
1.Ab+2Nb 30 
min 4% PFA 
1.Ab+2Nb 30 min 
4% PFA+ 0.1% 
GLU 
From Figure 6b 
1.Ab+2Nb live  ns ns ns 
1.Ab+2Nb 10 min 4% 
PFA 
   ns ns 
1.Ab+2Nb 30 min 4% 
PFA 







min 4% PFA 
polyFab 30 min 
4% PFA+ 0.1% 
GLU 
From Supp. Figure 8 
polyFab live  ns ns ns 
polyFab 10 min 4% 
PFA 
   ns ns 
polyFab 30 min 4% 
PFA 































6. General discussion  
Over the last few years, the advent of super resolution microscopy enabled imaging objects 
beyond the diffraction limit, such as sub-cellular elements in the neuronal synapse. However, 
the difficulty of imaging several targets in super resolution within the same synapse persists 
and synaptic proteins are usually addressed separately in different samples. In addition, 
conventional immunostaining approaches use antibodies that are a source of artefacts such as 
target induced clustering, fluorophore delocalization and lack of sample penetration (Maidorn 
et al., 2016). Hence, there is a need of artefact-free affinity binders for different synaptic targets 
working in a highly multiplexed super resolution microscopy technique. In my doctoral 
research, I developed and optimized a set of tools to image multiple targets in super resolution 
microscopy using alternative probes. First, I established a pipeline for the production and 
validation of nanobodies targeting different proteins in the synapse. Then, I characterized and 
showed the advantages of using secondary nanobodies as an alternative to secondary antibodies 
in imaging applications. Finally, I developed a robust protocol to couple nanobodies to a single-
stranded DNA for Exchange PAINT.  
 
An optimized pipeline for the generation of multiple synaptic nanobodies  
Nanobodies have proven to be a superior alternative to conventional antibodies. Their smaller 
size enables reduced fluorophore delocalization in microscopy, enhanced sample penetration 
and access to cryptic epitopes (Ingram, Schmidt, & Ploegh, 2018). They are composed of a 
single domain with no posttranslational modifications, except for one or two disulfide bridges. 
They can be easily produced as a recombinant protein in prokaryotes, enabling cheap and 
animal independent production, and guarantying batch to batch uniformity (Muyldermans, 
2013). However, in comparison to conventional antibodies, the diversity in available 
nanobodies is low. The Institute collection and analysis of nanobodies (Ican) database counts 
2391 nanobodies from which 2131 appear in patents and 260 in publications. Out of those, 1863 
are used in clinical practice and 130 in basic research mainly targeting fluorescent and tag 
proteins. (Zuo et al., 2017). Hence, there is an urgent need for a fast and simple selection 
procedure of nanobodies against endogenous mammalian targets, to target the synaptic proteins 
for example. In this thesis, I achieved this by first minimizing the amount of immunizations 
required for generating nanobodies against different antigens. By immunizing alpacas with a 




different synaptic targets (Chapter 3). To investigate if the animal produced hcAbs against a 
particular target, I created the preELISA (Fig. 3.1). preELISA enables to assess the possibility 
of finding nanobodies against a specific synaptic target before starting the selection process.  
This approach of immunization of a camelid with a cocktail of immunogen combined with the 
preELISA would allow the generation of many nanobodies in a shorter time. This approach 
could be applied to any other kind of preparation. For example, a whole cellular organelle could 
be purified and injected in the camelid and the preELISA used to assess which protein of this 
organelle generated hcAbs. 
Another caveat in nanobodies identification is the laborious and extensive validation of the 
nanobodies clone candidates obtained by the selection. In fact, every type of selection (phage 
display, NGS-MS approach, etc.) leads to many nanobody candidates that needs to be validated 
for their specificity to their target and for the applicability in the method they are required for. 
In this thesis, I established a validation pipeline to validate to test the specificity of the nanobody 
directly in the phagemid without needing further subcloning at early steps. I assessed at an early 
stage the binding ability of the nanobody candidates in immunofluorescence by using the 
bacterial cell lysate and indirect immunostaining of 3xFLAG tag present on the phagemid (Fig. 
3.4). I established a rampELISA estimating the affinity of the nanobody to its antigen (Fig. 3.5, 
3.6). This approach drastically reduces the number of nanobodies to be processed in the 
downstream validation steps.  
Phage display versus other techniques  
From synaptosome-immunized alpacas, I created a nanobody library and screened for 
nanobodies against endogenous synaptic targets using phage display technique (Smith, 1985) 
(Chapter 3). This method  is a simple technique and is the most used approach for the selection 
of nanobodies (Arbabi Ghahroudi et al., 1997; Li et al., 2017; Maidorn et al., 2019). In this 
technique, the nanobody library is infected with helper phages leading to the production of fully 
formed phages displaying the nanobody on their surface. Phages are then extracted by PEG 
precipitation and the selection of antigen specific nanobodies is done by “panning” the phages 
onto an immobilized antigen. Two to three panning rounds are usually performed to enrich the 
binding clones. The ability of the clones to bind to the antigens is verified by phageELISA and 
further validation process. The positive clones are then sequenced to derive their aminoacidic 
composition (Pardon et al., 2014). Using phage display I successfully obtained nanobodies 




Low affinity nanobodies could be useful for certain therapeutic applications because of their 
fast clearance and elution (Liu et al., 2018). However, immunofluorescence, requires binders 
with high affinity to withstand the washings necessary in immunostaining protocol for 
guarantying low background staining. Therefore, some protein engineering approach could be 
used to enhance the affinity of the nanobodies. Affinity maturation has been performed by 
others by random and site directed mutagenesis of the CDR of the nanobody increasing up to 
100 fold the affinity of the nanobodies (Koide et al., 2007; Yau et al., 2005). However, the 
mutagenesis and consecutive display methods necessary are laborious and require validation of 
many candidates. To circumvent this, in silico affinity maturation has been proven a valuable 
tool. Both ab initio (Mahajan et al., 2018) and homology modeling were used to increase the 
nanobody affinities (Cheng et al., 2019).   
 
In this project, we tested another screening method that supposedly allows the rapid generation 
of high affinity nanobody using a combination of NGS and MS (Fridy et al., 2014). As 
discussed in Chapter 3, this method is too expensive and laborious and was not successful for 
the identification of high affinity binding nanobodies from a complex immunogen. Alternative 
screening methods for nanobodies are the one using cell surface display (Ueda et al 2016). 
Instead of using a filamentous phage to display the nanobody, yeast or bacteria cell surface is 
used (Fleetwood et al., 2013; Ryckaert, Pardon, Steyaert, & Callewaert, 2010). The advantage 
here compared to a phage display approach, is that flow cytometry detection of the cell is 
possible, due to its bigger size than the phage. Therefore, fluorescence-based analysis and 
sorting of displayed libraries can be performed  (Boder & Wittrup, 1997; Daugherty, Chen, 
Olsen, Iverson, & Georgiou, 1998).  This also allows to measure the  binding affinity of the 
nanobodies selected by measurement with flow cytometry without the need of subcloning and 
further processing (Adams, Mora, Walczak, & Kinney, 2016; Chao et al., 2006). Compared to 
our method, this achieve the same result obtained using the rampELISA established in this 
thesis (Fig. 3.1), giving an estimation of the binding affinity of the nanobody clone by 
subjecting it to different amount of antigen.  
 
Yeast display compared to phage display, guarantees proper folding and secretion of 
nanobodies which might not be able to be expressed in prokaryotes (Ryckaert et al., 2010). 
However, as it is the case for the NGS and MS approach, the yeast display does not involve a 
prokaryotic step. Therefore, nanobodies might be selected that might not be properly expressed 




display techniques seem, therefore, a better alternative. However, displaying the nanobodies on 
the surface of Gram-negative bacteria such as E. coli requires overcoming the nanobody 
challenge of translocation to the surface. The nanobody needs to cross different areas of the 
bacteria: the inner membrane, the periplasm and the outer membrane (Dalbey & Kuhn, 2012). 
This is why this approach, even if combining the advantages of yeast display and phage display, 
has not been, up to this date, leading to the selection of many nanobodies (Salema & Fernández, 
2017). To circumvent the difficult crossing of the outer membrane, bacterial display has also 
been performed by using Gram-positive bacteria that are composed of a simple cell envelope. 
This has allowed for example the generation of a library of 107  clones displayed on 
Staphylococcus carnosus and selection of nanobodies against GFP (Kronqvist, Lofblom, 
Jonsson, Wernerus, & Stahl, 2008). 
The limited transfection/transformation efficiency of those cells (yeast and Gram positive 
bacteria) compared to the transformation efficiency of E. coli limits the size of the resulting 
library (Salema & Fernández, 2017). The size of the library has been shown to correlate to the 
diversity of the nanobodies represented but also to the affinity of the nanobody selected 
(Vaughan et al., 1996; Waterhouse, Griffiths, Johnson, & Winter, 1993). In this regard E. coli 
remains a good alternative, exhibiting library size of up to 109 clones (Galán et al., 2016). The 
synaptosome library I generated by Gibson cloning into the “minimal phagemid” has a library 
size of 107 clones (Fig. 3.3). The estimation of the library diversity in phage display is 
conventionally done by calculating the colonies of E. coli obtained after transformation of the 
library (Pardon et al., 2014). However, this estimate assumes that there is no more than one 
inserted gene in each E. coli colony and that every colony contains a different DNA sequence 
coding for a different nanobody. Indeed, the NGS of the nanobodies resulted in 106 non-
redundant nanobodies, confirming that counting colonies is not precise for the diversity 
determination of the library (Fig. 3.2).   
Our synaptosome library led to the identification of nanobodies against five different synaptic 
targets (Chapter 3). This library can be stored for years at -80 degree and used for selection of 
nanobodies against other synaptic targets.   
 
Probes for multiplexed super resolution microscopy  
Due to the lack of available nanobodies targeting endogenous proteins in immunofluorescence, 
I have tested alternative approaches to avoid using the standard primary-secondary complex.  




(Chapter 4) to target recombinant protein fused to fluorescent proteins and use them in DNA-
PAINT. Next, I have tested secondary nanobodies as an alternative to secondary antibodies in 
microscopy (Chapter 5). I observed that the use of secondary nanobodies reduces the linkage 
error in STED microscopy and DNA PAINT (Fig. 5.1, 5.2). Those results confirm the one 
obtained using secondary nanobodies in STORM microscopy (Pleiner, Bates, & Görlich, 2018). 
Smaller linkage error corresponds to better attainable resolution. I have for example imaged 
microtubules with DNA-PAINT using secondary nanobodies and obtained a diameter size of 
30 nm, close to the microtubule size of 25 nm reported in the literature (Ledbetter & Porter, 
1964). I have also shown that premixing the primary antibody to the secondary nanobody prior 
incubation on the sample (Fig 5.3) reduces the incubation necessary in thick biological samples 
and guarantee homogenous staining (Fig 5.4). Finally, I have shown how antigen clustering 
induced by the affinity probe in live and poorly chemically fixed samples can be rescued by the 
use of secondary nanobodies (Fig 5.5 and Fig. 5.6). The advantages obtained using secondary 
antibodies could also be obtained by direct labelling of the primary antibody and no use of a 
secondary probe (Mikhaylova et al., 2015). However, the available labelling chemistry of 
antibody is not site directed and can hence interfere with the binding capability of the antibody. 
On the other hand, secondary nanobodies have the convenience to be purchased and working 
for a big majority of primary antibodies.  
After characterizing the probes to be used for the imaging of the synapse, I focused on the 
microscopy technique. As discussed in the introduction, Exchange-PAINT is the method of 
choice for imaging multiple targets in super resolution microscopy (Jungmann et al., 2014). 
This method relies on the sequential imaging of orthogonal imager strands binding to different 
docking strands attached to different targets through affinity probes (Jungmann et al., 2014). In 
this thesis, a protocol was established to link the nanobodies to docking strands (Fig. 4.2). I 
used a click and thiol-based strategy to couple an azide-DNA to an ectopic C terminal cysteine 
of the nanobody through a maleimide-DBCO cross-linker. In comparison to a previously 
published approach labelling the amino group of the nanobody (Agasti et al., 2017), our 
protocol allows a site-directed coupling to only the C-terminus of the nanobody. In addition, 
the purification of the labelled nanobody by size exclusion chromatography (Fig. 4.2 C) 
guarantees no free-floating docking strand that could increase signal background during 
imaging. Towards completion of this project, a similar site directed coupling approach was 
published by Fabricius et al.. In their approach, they use a SortaseA-mediated conjugation to 
couple an azide-DNA to the C terminus of the nanobody through an ammine-DBCO cross linker 




production of Sortase A, which for standard imaging laboratories might need to be outsourced. 
Our approach instead uses commercially available components, which however are comparably 
expensive. Another advantage of their approach is the possibility to assess the correct 
occurrence of the first step of the reaction (coupling of the nanobody to the cross-linker) by size 
reduction of the nanobody losing the SortaseA signal visible on SDS-PAGE.  
 
Future work: characterization of the synapse in super resolution  
I have successfully generated a Stg1 nanobody working in immunostaining (Fig. 3.7). The 
affinity of the nanobodies selected against VAMP2, Homer and Bassoon (Fig. 3.3, 3.4, 3.5) will 
be in the future enhanced with approaches described above to make them suitable for 
immunostaining as well. These newly selected nanobodies might enable by imaging the 
discovery of structural organization which was not known before, as it was done by previously 
identified nanobodies against Syntaxin 1a (stx1a) and SNAP25 (Maidorn et al., 2019). Those 
two nanobodies identified population of stx1a and SNAP25 outside of the synaptic area that 
could not be revealed by antibody staining and that the extra-synaptic stx1a population was 
recruited to the synapse upon neuronal stimulation (Maidorn et al., 2019). To stain synaptic 
proteins for which no functional nanobodies in immunofluorescence yet exist, I will use primary 
antibodies already validated and commercially available. The primary antibodies will be 
detected by the secondary nanobodies that have been shown in Chapter 5 to be a better 
alternative than the secondary antibodies. As shown in Chapter 5 (Fig. 5.3), multiple primary 
antibodies originating from the same animal species can now be used in the same sample by 
premixing to secondary nanobodies conjugated to a reporter. Therefore, the species limit is 
lifted and the number of targets that can be imaged is no longer limited by the use of secondary 
probes. All those nanobodies can be coupled to a single strand DNA by using the site targeted 
labeling method developed in Chapter 4. Using the custom-built microfluidic setup I described 
in Fig. 4.3, I will be able to perform Exchange-PAINT in an automatized fashion with injection 
and removal of liquid with up to 24 inlet channels. Altogether, our tools will enable the imaging 
of multi-synaptic targets in the same synapse in super resolution. These tools will help, for 
example, to characterize the spatial organization of the different synaptic and their relative 
position to one another. This can be done by the analysis of the size, shape, intensity and 
distance between molecules and can be automatized with statistical methods such as Statistical 
Object Distance Analysis (SODA). SODA analyses the morphology and performs coupling 




illuminated microscopy and 3D STORM and showed for the first time that two postsynaptic 
markers, PSD95 and Homer, are arranged in different nanodomains and form an asymmetric 
triangle with the presynaptic protein Synapsin (Lagache et al., 2018).  
An additional common question that can be answered using the tools developed in this thesis is 
how the synapse rearrange their molecular components during plasticity. A recent study has 
shown how pre and postsynaptic proteins are arranged in nanomodules and that those rearrange 
during plasticity (Hruska, Henderson, Le Marchand, Jafri, & Dalva, 2018). However, those 
findings were obtained with 3-color STED microscopy, limiting the amounts of proteins to be 
analyzed in the same synapse.  
Our approach could, therefore, be used to expand that knowledge to the reorganization of other 
synaptic proteins respectively. Hippocampal neurons in basal condition could be compared to 
high frequency stimulated neurons (chemical or electrical), or exposed to synaptic activity 
blocked by neurotoxins such as Tetrodotoxin.   
A further important question, which could be answered using our tools, is how the protein 
reorganization during synaptic plasticity is associated with gene expression. Local translation 
at the nerve terminal has been shown to exist (Scarnati, Kataria, Biswas, & Paradiso, 2018). 
However, it has not been shown in concomitance related to protein localization and amounts. 
Using Exchange- PAINT and the tools developed in this thesis, this could be easily achievable.  
DNA-PAINT has been successfully applied to single molecule mRNA by using fluorescent in 
situ hybridization (FISH) probes containing docking sites for imager strand (Wade et al., 2019). 
Staining the synapse with both FISH probes and protein binders (nanobodies and secondary 
nanobodies) would give a description of how gene expression and protein activity are related 
in the synapse. Quantification of the molecules, both protein and mRNA, can be performed 
using quantitative PAINT imaging (qPAINT) (Jungmann et al., 2016). qPAINT determines the 
number of molecules imaged by using the predictable binding kinetics between the imager and 
docking strand. It has been shown that qPAINT is able to quantify molecules separated by as 
little as 3 nm which corresponds to the size of the DNA strand used (M. A. B. Baker et al., 
2019).  
However, one limitation of our approach is that each target imaged in DNA PAINT image to 
reach high resolution, requires at least 20’000 frames corresponding to a minimum of 30 min 
at least of acquisition time (Fig. 4.4). Therefore, imaging both protein target and mRNA could 
take a long time, and considering that many synapses needs to be imaged to have a 




variable in their composition and morphology. For example, the synaptic vesicle volume has 
been shown to vary up to 5 folds between neighboring synapse in rat hippocampal neurons (Hu, 
Qu, & Schikorski, 2008). To circumvent the image acquisition time, multiple targets could be 
acquired at the same time by using different fluorophores on different imager strands present in 
the solution at the same time (Gómez-García, Garbacik, Otterstrom, Garcia-Parajo, & 
Lakadamyali, 2018). Another approach would be spectral barcoding, meaning using the same 
imager strand binding to different targets with different binding kinetics (Wade et al., 2019).  
Finally, it is of capital importance to expand the variety of high affinity nanobodies available 
against synaptic proteins but also against other targets. This year a nanobody was approved for 
the first time by the FDA as drug against acquired thrombotic thrombocytopenic purpura, 
(Morrison, 2019), opening the doors to the therapeutic market. Considering the abilities of the 
nanobodies to reach cryptic epitopes and potentially to cross the blood brain barrier, there will 





















Abbe, E. (1873). Beiträge zur Theorie des Mikroskops und der mikroskopischen 
Wahrnehmung. Archiv Für Mikroskopische Anatomie, 9(1), 413–418. 
https://doi.org/10.1007/BF02956173 
Adams, R. M., Mora, T., Walczak, A. M., & Kinney, J. B. (2016). Measuring the sequence-
affinity landscape of antibodies with massively parallel titration curves. ELife, 5. 
https://doi.org/10.7554/eLife.23156 
Agasti, S. S., Wang, Y., Schueder, F., Sukumar, A., Jungmann, R., & Yin, P. (2017). DNA-
barcoded labeling probes for highly multiplexed Exchange-PAINT imaging. Chemical 
Science, 8(4), 3080–3091. https://doi.org/10.1039/C6SC05420J 
Arbabi Ghahroudi, M., Desmyter, A., Wyns, L., Hamers, R., & Muyldermans, S. (1997). 
Selection and identification of single domain antibody fragments from camel heavy-chain 
antibodies. FEBS Letters, 414(3), 521–526. https://doi.org/10.1016/s0014-
5793(97)01062-4 
Baker, M. (2015). Reproducibility crisis: Blame it on the antibodies. Nature, 521(7552), 274–
276. https://doi.org/10.1038/521274a 
Baker, M. A. B., Nieves, D. J., Hilzenrat, G., Berengut, J. F., Gaus, K., & Lee, L. K. (2019). 
Stoichiometric quantification of spatially dense assemblies with qPAINT. Nanoscale, 
11(26), 12460–12464. https://doi.org/10.1039/C9NR00472F 
Balzarotti, F., Eilers, Y., Gwosch, K. C., Gynnå, A. H., Westphal, V., Stefani, F. D., … Hell, 
S. W. (2017). Nanometer resolution imaging and tracking of fluorescent molecules with 
minimal photon fluxes. Science (New York, N.Y.), 355(6325), 606–612. 
https://doi.org/10.1126/science.aak9913 
Benson, D. L., Watkins, F. H., Steward, O., & Banker, G. (1994). Characterization of 
GABAergic neurons in hippocampal cell cultures. Journal of Neurocytology, 23(5), 279–
295. https://doi.org/10.1007/BF01188497 
Betzig, E. (2015). Single Molecules, Cells, and Super-Resolution Optics (Nobel Lecture). 
Angewandte Chemie International Edition, 54(28), 8034–8053. 
https://doi.org/10.1002/anie.201501003 
Boder, E. T., & Wittrup, K. D. (1997). Yeast surface display for screening combinatorial 
polypeptide libraries. Nature Biotechnology, 15(6), 553–557. 
https://doi.org/10.1038/nbt0697-553 
Bradbury, A., & Plückthun, A. (2015). Reproducibility: Standardize antibodies used in 
research. Nature, 518(7537), 27–29. https://doi.org/10.1038/518027a 
Chaikuad, A., Keates, T., Vincke, C., Kaufholz, M., Zenn, M., Zimmermann, B., … Müller, S. 
(2014). Structure of cyclin G-associated kinase (GAK) trapped in different conformations 
using nanobodies. The Biochemical Journal, 459(1), 59–69. 
https://doi.org/10.1042/BJ20131399 
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. W., & Prasher, D. C. (1994). Green fluorescent 
protein as a marker for gene expression. Science (New York, N.Y.), 263(5148), 802–805. 
https://doi.org/10.1126/science.8303295 
Chao, G., Lau, W. L., Hackel, B. J., Sazinsky, S. L., Lippow, S. M., & Wittrup, K. D. (2006). 




1(2), 755–768. https://doi.org/10.1038/nprot.2006.94 
Cheng, X., Wang, J., Kang, G., Hu, M., Yuan, B., Zhang, Y., & Huang, H. (2019). Homology 
Modeling-Based in Silico Affinity Maturation Improves the Affinity of a Nanobody. 
International Journal of Molecular Sciences, 20(17), 4187. 
https://doi.org/10.3390/ijms20174187 
D’Huyvetter, M., Xavier, C., Caveliers, V., Lahoutte, T., Muyldermans, S., & Devoogdt, N. 
(2014). Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of 
cancer. Expert Opinion on Drug Delivery, 11(12), 1939–1954. 
https://doi.org/10.1517/17425247.2014.941803 
Dai, M. (2017). DNA-PAINT Super-Resolution Imaging for Nucleic Acid Nanostructures. In 
Methods in molecular biology (Clifton, N.J.) (Vol. 1500, pp. 185–202). 
https://doi.org/10.1007/978-1-4939-6454-3_13 
Dalbey, R. E., & Kuhn, A. (2012). Protein Traffic in Gram-negative bacteria – how exported 
and secreted proteins find their way. FEMS Microbiology Reviews, 36(6), 1023–1045. 
https://doi.org/10.1111/j.1574-6976.2012.00327.x 
Dani, A., Huang, B., Bergan, J., Dulac, C., & Zhuang, X. (2010). Super-resolution Imaging of 
Chemical Synapses in the Brain. Neuron, 68(5), 843–856. Retrieved from 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057101/pdf/nihms259099.pdf 
Daugherty, P. S., Chen, G., Olsen, M. J., Iverson, B. L., & Georgiou, G. (1998). Antibody 
affinity maturation using bacterial surface display. Protein Engineering, 11(9), 825–832. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9796833 
Desmyter, A., Farenc, C., Mahony, J., Spinelli, S., Bebeacua, C., Blangy, S., … Cambillau, C. 
(2013). Viral infection modulation and neutralization by camelid nanobodies. Proc Natl 
Acad Sci U S A, 110(15), E1371-9. https://doi.org/10.1073/pnas.1301336110 
Fabricius, V., Lefèbre, J., Geertsema, H., Marino, S. F., & Ewers, H. (2018). Rapid and efficient 
C-terminal labeling of nanobodies for DNA-PAINT. Journal of Physics D: Applied 
Physics, 51(47), 474005. https://doi.org/10.1088/1361-6463/aae0e2 
Fleetwood, F., Devoogdt, N., Pellis, M., Wernery, U., Muyldermans, S., Ståhl, S., & Löfblom, 
J. (2013). Surface display of a single-domain antibody library on Gram-positive bacteria. 
Cellular and Molecular Life Sciences : CMLS, 70(6), 1081–1093. 
https://doi.org/10.1007/s00018-012-1179-y 
Fornasiero, E. F., Mandad, S., Wildhagen, H., Alevra, M., Rammner, B., Keihani, S., … 
Rizzoli, S. O. (2018). Precisely measured protein lifetimes in the mouse brain reveal 
differences across tissues and subcellular fractions. Nature Communications, 9(1), 4230. 
https://doi.org/10.1038/s41467-018-06519-0 
Fridy, P. C., Li, Y., Keegan, S., Thompson, M. K., Nudelman, I., Scheid, J. F., … Rout, M. P. 
(2014). A robust pipeline for rapid production of versatile nanobody repertoires. Nature 
Methods, 11(12), 1253–1260. https://doi.org/10.1038/nmeth.3170 
Fukuda, M., Moreira, J. E., Liu, V., Sugimori, M., Mikoshiba, K., & Llinás, R. R. (2000). Role 
of the conserved WHXL motif in the C terminus of synaptotagmin in synaptic vesicle 
docking. Proceedings of the National Academy of Sciences of the United States of 
America, 97(26), 14715. https://doi.org/10.1073/PNAS.260491197 
Galán, A., Comor, L., Horvatić, A., Kuleš, J., Guillemin, N., Mrljak, V., & Bhide, M. (2016). 





Gallagher, S. R. (2012). SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE). In Current 
Protocols Essential Laboratory Techniques (Vol. 6, pp. 7.3.1-7.3.28). Hoboken, NJ, USA: 
John Wiley & Sons, Inc. https://doi.org/10.1002/9780470089941.et0703s06 
Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, C. A., & Smith, H. O. 
(2009). Enzymatic assembly of DNA molecules up to several hundred kilobases. Nature 
Methods, 6(5), 343–345. https://doi.org/10.1038/nmeth.1318 
Gibson, T. J., Seiler, M., & Veitia, R. A. (2013). The transience of transient overexpression. 
Nature Methods, 10(8), 715–721. https://doi.org/10.1038/nmeth.2534 
Gomes de Castro, M. A., Wildhagen, H., Sograte-Idrissi, S., Hitzing, C., Binder, M., Trepel, 
M., … Opazo, F. (2019). Differential organization of tonic and chronic B cell antigen 
receptors in the plasma membrane. Nature Communications, 10(1), 820. 
https://doi.org/10.1038/s41467-019-08677-1 
Gómez-García, P. A., Garbacik, E. T., Otterstrom, J. J., Garcia-Parajo, M. F., & Lakadamyali, 
M. (2018). Excitation-multiplexed multicolor superresolution imaging with fm-STORM 
and fm-DNA-PAINT. Proceedings of the National Academy of Sciences of the United 
States of America, 115(51), 12991–12996. https://doi.org/10.1073/pnas.1804725115 
Götzke, H., Kilisch, M., Martínez-Carranza, M., Sograte-Idrissi, S., Rajavel, A., Schlichthaerle, 
T., … Frey, S. (2019). A rationally designed and highly versatile epitope tag for nanobody-
based purification, detection and manipulation of proteins. BioRxiv, 640771. 
https://doi.org/10.1101/640771 
Greenberg, A. S., Avila, D., Hughes, M., Hughes, A., McKinney, E. C., & Flajnik, M. F. (1995). 
A new antigen receptor gene family that undergoes rearrangement and extensive somatic 
diversification in sharks. Nature, 374(6518), 168–173. https://doi.org/10.1038/374168a0 
Gupta, S., Thirstrup, D., Jarvis, T. C., Schneider, D. J., Wilcox, S. K., Carter, J., … Baird, G. 
S. (2011). Rapid Histochemistry Using Slow Off-rate Modified Aptamers With Anionic 
Competition. Applied Immunohistochemistry & Molecular Morphology, 19(3), 273–278. 
https://doi.org/10.1097/PAI.0b013e3182008c29 
Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hamers, C., Songa, E. 
B., … Hamers, R. (1993). Naturally occurring antibodies devoid of light chains. Nature, 
363(6428), 446–448. https://doi.org/10.1038/363446a0 
Hardman, R. (2006). A Toxicologic Review of Quantum Dots: Toxicity Depends on 
Physicochemical and Environmental Factors. Environmental Health Perspectives, 114(2), 
165–172. https://doi.org/10.1289/ehp.8284 
Hayashi, M. K., Tang, C., Verpelli, C., Narayanan, R., Stearns, M. H., Xu, R.-M., … Hayashi, 
Y. (2009). The Postsynaptic Density Proteins Homer and Shank Form a Polymeric 
Network Structure. Cell, 137(1), 159–171. https://doi.org/10.1016/J.CELL.2009.01.050 
Hell, S. W., & Wichmann, J. (1994). Breaking the diffraction resolution limit by stimulated 
emission: stimulated-emission-depletion fluorescence microscopy. Optics Letters, 19(11), 
780–782. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19844443 
Helma, J., Cardoso, M. C., Muyldermans, S., & Leonhardt, H. (2015). Nanobodies and 
recombinant binders in cell biology. The Journal of Cell Biology, 209(5), 633–644. 
https://doi.org/10.1083/jcb.201409074 
Hruska, M., Henderson, N., Le Marchand, S. J., Jafri, H., & Dalva, M. B. (2018). Synaptic 
nanomodules underlie the organization and plasticity of spine synapses. Nature 




Hu, Y., Qu, L., & Schikorski, T. (2008). Mean synaptic vesicle size varies among individual 
excitatory hippocampal synapses. Synapse, 62(12), 953–957. 
https://doi.org/10.1002/syn.20567 
Huston, J. S., Levinson, D., Mudgett-Hunter, M., Tai, M. S., Novotny, J., Margolies, M. N., … 
Crea, R. (1988). Protein engineering of antibody binding sites: recovery of specific activity 
in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proceedings of 
the National Academy of Sciences, 85(16), 5879–5883. 
https://doi.org/10.1073/pnas.85.16.5879 
Ingram, J. R., Schmidt, F. I., & Ploegh, H. L. (2018). Exploiting Nanobodies’ Singular Traits. 
Annual Review of Immunology, 36(1), 695–715. https://doi.org/10.1146/annurev-
immunol-042617-053327 
Ivanova, D., Dirks, A., Montenegro‐Venegas, C., Schöne, C., Altrock, W. D., Marini, C., … 
Fejtova, A. (2015). Synaptic activity controls localization and function of Ct BP 1 via 
binding to B assoon and P iccolo. The EMBO Journal, 34(8), 1056–1077. 
https://doi.org/10.15252/embj.201488796 
Jank, L., Pinto-Espinoza, C., Duan, Y., Koch-Nolte, F., Magnus, T., & Rissiek, B. (2019). 
Current Approaches and Future Perspectives for Nanobodies in Stroke Diagnostic and 
Therapy. Antibodies, 8(1), 5. https://doi.org/10.3390/antib8010005 
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A 
Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity. 
Science, 337(6096), 816–821. https://doi.org/10.1126/science.1225829 
Jungmann, R., Avendaño, M. S., Dai, M., Woehrstein, J. B., Agasti, S. S., Feiger, Z., … Yin, 
P. (2016). Quantitative super-resolution imaging with qPAINT. Nature Methods, 13(5), 
439–442. https://doi.org/10.1038/nmeth.3804 
Jungmann, R., Avendaño, M. S., Woehrstein, J. B., Dai, M., Shih, W. M., & Yin, P. (2014). 
Multiplexed 3D cellular super-resolution imaging with DNA-PAINT and Exchange-
PAINT. Nature Methods. https://doi.org/10.1038/nmeth.2835 
Jungmann, R., Steinhauer, C., Scheible, M., Kuzyk, A., Tinnefeld, P., & Simmel, F. C. (2010). 
Single-Molecule Kinetics and Super-Resolution Microscopy by Fluorescence Imaging of 
Transient Binding on DNA Origami, 10, 43. https://doi.org/10.1021/nl103427w 
Köhler, G., & Milstein, C. (1975). Continuous cultures of fused cells secreting antibody of 
predefined specificity. Nature, 256(5517), 495–497. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/1172191 
Koide, A., & Koide, S. (2007). Monobodies: antibody mimics based on the scaffold of the 
fibronectin type III domain. Methods in Molecular Biology (Clifton, N.J.), 352, 95–109. 
https://doi.org/10.1385/1-59745-187-8:95 
Koide, A., Tereshko, V., Uysal, S., Margalef, K., Kossiakoff, A. A., & Koide, S. (2007). 
Exploring the Capacity of Minimalist Protein Interfaces: Interface Energetics and Affinity 
Maturation to Picomolar KD of a Single-domain Antibody with a Flat Paratope. Journal 
of Molecular Biology, 373(4), 941–953. https://doi.org/10.1016/j.jmb.2007.08.027 
Kronqvist, N., Lofblom, J., Jonsson, A., Wernerus, H., & Stahl, S. (2008). A novel affinity 
protein selection system based on staphylococcal cell surface display and flow cytometry. 
Protein Engineering Design and Selection, 21(4), 247–255. 
https://doi.org/10.1093/protein/gzm090 




Naive Camelidae Libraries and Selection of Single-Domain Antibodies Against Peptide 
Antigens. In Single Domain Antibodies (Vol. 911, pp. 105–124). Totowa, NJ: Humana 
Press. https://doi.org/10.1007/978-1-61779-968-6_7 
Lagache, T., Grassart, A., Dallongeville, S., Faklaris, O., Sauvonnet, N., Dufour, A., … Olivo-
Marin, J.-C. (2018). Mapping molecular assemblies with fluorescence microscopy and 
object-based spatial statistics. Nature Communications, 9(1), 698. 
https://doi.org/10.1038/s41467-018-03053-x 
Lam, A. Y., Pardon, E., Korotkov, K. V, Hol, W. G. J., & Steyaert, J. (2009). Nanobody-aided 
structure determination of the EpsI:EpsJ pseudopilin heterodimer from Vibrio vulnificus. 
Journal of Structural Biology, 166(1), 8–15. https://doi.org/10.1016/j.jsb.2008.11.008 
Lauwereys, M., Ghahroudi, M. A., Desmyter, A., Kinne, J., Hölzer, W., De Genst, E., … 
Muyldermans, S. (1998). Potent enzyme inhibitors derived from dromedary heavy-chain 
antibodies. EMBO Journal, 17(13), 3512–3520. 
https://doi.org/10.1093/emboj/17.13.3512 
Ledbetter, M. C., & Porter, K. R. (1964). Morphology of Microtubules of Plant Cell. Science 
(New York, N.Y.), 144(3620), 872–874. https://doi.org/10.1126/science.144.3620.872 
Lee, Y. J., & Jeong, K. J. (2015). Challenges to production of antibodies in bacteria and yeast. 
Journal of Bioscience and Bioengineering, 120(5), 483–490. 
https://doi.org/10.1016/J.JBIOSC.2015.03.009 
Li, T., Vandesquille, M., Bay, S., Dhenain, M., Delatour, B., & Lafaye, P. (2017). Selection of 
similar single domain antibodies from two immune VHH libraries obtained from two 
alpacas by using different selection methods. Immunology Letters, 188, 89–95. 
https://doi.org/10.1016/j.imlet.2017.07.001 
Limsakul, P., Peng, Q., Wu, Y., Allen, M. E., Liang, J., Remacle, A. G., … Wang, Y. (2018). 
Directed Evolution to Engineer Monobody for FRET Biosensor Assembly and Imaging at 
Live-Cell Surface. Cell Chemical Biology, 25(4), 370-379.e4. 
https://doi.org/10.1016/j.chembiol.2018.01.002 
Lipman, N. S., Jackson, L. R., Trudel, L. J., & Weis-Garcia, F. (2005). Monoclonal Versus 
Polyclonal Antibodies: Distinguishing Characteristics, Applications, and Information 
Resources. ILAR Journal, 46(3), 258–268. https://doi.org/10.1093/ilar.46.3.258 
Liu, W., Song, H., Chen, Q., Yu, J., Xian, M., Nian, R., & Feng, D. (2018). Recent advances in 
the selection and identification of antigen-specific nanobodies. Molecular Immunology, 
96, 37–47. https://doi.org/10.1016/j.molimm.2018.02.012 
Longo, P. A., Kavran, J. M., Kim, M.-S., & Leahy, D. J. (2013). Transient mammalian cell 
transfection with polyethylenimine (PEI). Methods in Enzymology, 529, 227–240. 
https://doi.org/10.1016/B978-0-12-418687-3.00018-5 
Lvov, A., Greitzer, D., Berlin, S., Chikvashvili, D., Tsuk, S., Lotan, I., & Michaelevski, I. 
(2009). Rearrangements in the Relative Orientation of Cytoplasmic Domains Induced by 
a Membrane-anchored Protein Mediate Modulations in Kv Channel Gating. Journal of 
Biological Chemistry, 284(41), 28276–28291. https://doi.org/10.1074/jbc.M109.028761 
Mahajan, S. P., Meksiriporn, B., Waraho-Zhmayev, D., Weyant, K. B., Kocer, I., Butler, D. C., 
… DeLisa, M. P. (2018). Computational affinity maturation of camelid single-domain 
intrabodies against the nonamyloid component of alpha-synuclein. Scientific Reports, 
8(1), 17611. https://doi.org/10.1038/s41598-018-35464-7 




synaptic population of SNAP-25 and Syntaxin 1A in hippocampal neurons. MAbs, 11(2), 
305–321. https://doi.org/10.1080/19420862.2018.1551675 
Maidorn, M., Rizzoli, S. O., & Opazo, F. (2016). Tools and limitations to study the molecular 
composition of synapses by fluorescence microscopy. The Biochemical Journal, 473(20), 
3385–3399. https://doi.org/10.1042/BCJ20160366 
Mattson, G., Conklin, E., Desai, S., Nielander, G., Savage, M. D., & Morgensen, S. (1993). A 
practical approach to crosslinking. Molecular Biology Reports, 17(3), 167–183. 
https://doi.org/10.1007/BF00986726 
Mikhaylova, M., Cloin, B. M. C., Finan, K., van den Berg, R., Teeuw, J., Kijanka, M. M., … 
Kapitein, L. C. (2015). Resolving bundled microtubules using anti-tubulin nanobodies. 
Nature Communications, 6, 7933. https://doi.org/10.1038/ncomms8933 
Modi, S., Higgs, N. F., Sheehan, D., Griffin, L. D., & Kittler, J. T. (2018). Quantum dot 
conjugated nanobodies for multiplex imaging of protein dynamics at synapses. Nanoscale, 
10(21), 10241–10249. https://doi.org/10.1039/C7NR09130C 
Morrison, C. (2019). Nanobody approval gives domain antibodies a boost. Nature Reviews 
Drug Discovery, 18(7), 485–487. https://doi.org/10.1038/d41573-019-00104-w 
Muyldermans, S. (2013). Nanobodies: Natural Single-Domain Antibodies. Annual Review of 
Biochemistry, 82(1), 775–797. https://doi.org/10.1146/annurev-biochem-063011-092449 
Nilsson, F. Y., & Tolmachev, V. (2007). Affibody molecules: new protein domains for 
molecular imaging and targeted tumor therapy. Current Opinion in Drug Discovery & 
Development, 10(2), 167–175. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/17436552 
Pardon, E., Laeremans, T., Triest, S., Rasmussen, S. G. F., Wohlkönig, A., Ruf, A., … Steyaert, 
J. (2014). A general protocol for the generation of Nanobodies for structural biology. 
Nature Protocols, 9(3), 674–693. https://doi.org/10.1038/nprot.2014.039 
Pleiner, T., Bates, M., & Görlich, D. (2018). A toolbox of anti-mouse and anti-rabbit IgG 
secondary nanobodies. The Journal of Cell Biology, 217(3), 1143–1154. 
https://doi.org/10.1083/jcb.201709115 
Pleiner, T., Bates, M., Trakhanov, S., Lee, C.-T., Schliep, J. E., Chug, H., … Görlich, D. (2015). 
Nanobodies: site-specific labeling for super-resolution imaging, rapid epitope-mapping 
and native protein complex isolation. ELife, 4, e11349. 
https://doi.org/10.7554/eLife.11349 
Plückthun, A. (2015). Designed ankyrin repeat proteins (DARPins): binding proteins for 
research, diagnostics, and therapy. Annual Review of Pharmacology and Toxicology, 55, 
489–511. https://doi.org/10.1146/annurev-pharmtox-010611-134654 
Porter, R. R. (1959). The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. 
The Biochemical Journal, 73, 119–126. Retrieved from 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1197021&tool=pmcentrez&r
endertype=abstract 
Qu, L., Akbergenova, Y., Hu, Y., & Schikorski, T. (2009). Synapse-to-synapse variation in 
mean synaptic vesicle size and its relationship with synaptic morphology and function. 
The Journal of Comparative Neurology, 514(4), 343–352. 
https://doi.org/10.1002/cne.22007 
Ries, J., Kaplan, C., Platonova, E., Eghlidi, H., & Ewers, H. (2012). A simple, versatile method 





Rizzoli, S. O. (2014). Synaptic vesicle recycling: steps and principles. The EMBO Journal, 
33(8), 788–822. https://doi.org/10.1002/embj.201386357 
Rust, M. J., Bates, M., & Zhuang, X. (2006). Sub-diffraction-limit imaging by stochastic optical 
reconstruction microscopy (STORM). Nature Methods, 3(10), 793–796. 
https://doi.org/10.1038/nmeth929 
Ryckaert, S., Pardon, E., Steyaert, J., & Callewaert, N. (2010). Isolation of antigen-binding 
camelid heavy chain antibody fragments (nanobodies) from an immune library displayed 
on the surface of Pichia pastoris. Journal of Biotechnology, 145(2), 93–98. 
https://doi.org/10.1016/j.jbiotec.2009.10.010 
Sakamoto, Y., Tanaka, N., Ichimiya, T., Kurihara, T., & Nakamura, K. T. (2005). Crystal 
Structure of the Catalytic Fragment of Human Brain 2′,3′-Cyclic-nucleotide 3′-
Phosphodiesterase. Journal of Molecular Biology, 346(3), 789–800. 
https://doi.org/10.1016/J.JMB.2004.12.024 
Salema, V., & Fernández, L. Á. (2017). Escherichia coli surface display for the selection of 
nanobodies. Microbial Biotechnology, 10(6), 1468–1484. https://doi.org/10.1111/1751-
7915.12819 
Scarnati, M. S., Kataria, R., Biswas, M., & Paradiso, K. G. (2018). Active presynaptic 
ribosomes in the mammalian brain, and altered transmitter release after protein synthesis 
inhibition. ELife, 7. https://doi.org/10.7554/eLife.36697 
Schenck, S., Kunz, L., Sahlender, D., Pardon, E., Geertsma, E. R., Savtchouk, I., … Dutzler, 
R. (2017). Generation and Characterization of Anti-VGLUT Nanobodies Acting as 
Inhibitors of Transport. Biochemistry, 56(30), 3962–3971. 
https://doi.org/10.1021/acs.biochem.7b00436 
Schermelleh, L., Ferrand, A., Huser, T., Eggeling, C., Sauer, M., Biehlmaier, O., & Drummen, 
G. P. C. (2019). Super-resolution microscopy demystified. Nature Cell Biology, 21(1), 72–
84. https://doi.org/10.1038/s41556-018-0251-8 
Schlichthaerle, T., Eklund, A. S., Schueder, F., Strauss, M. T., Tiede, C., Curd, A., … 
Jungmann, R. (2018). Site-Specific Labeling of Affimers for DNA-PAINT Microscopy. 
Angewandte Chemie International Edition, 57(34), 11060–11063. 
https://doi.org/10.1002/anie.201804020 
Schnitzbauer, J., Strauss, M. T., Schlichthaerle, T., Schueder, F., & Jungmann, R. (2017). 
Super-resolution microscopy with DNA-PAINT. Nature Protocols, 12(6), 1198–1228. 
https://doi.org/10.1038/nprot.2017.024 
Schueder, F., Lara-Gutiérrez, J., Beliveau, B. J., Saka, S. K., Sasaki, H. M., Woehrstein, J. B., 
… Jungmann, R. (2017). Multiplexed 3D super-resolution imaging of whole cells using 
spinning disk confocal microscopy and DNA-PAINT. Nature Communications, 8(1), 
2090. https://doi.org/10.1038/s41467-017-02028-8 
Seitz, K. J., & Rizzoli, S. O. (2019). GFP nanobodies reveal recently-exocytosed pHluorin 
molecules. Scientific Reports, 9(1), 7773. https://doi.org/10.1038/s41598-019-44262-8 
Shashkova, S., & Leake, M. C. (2017). Single-molecule fluorescence microscopy review: 
shedding new light on old problems. Bioscience Reports, 37(4). 
https://doi.org/10.1042/BSR20170031 
Skerra, A. (2008). Alternative binding proteins: anticalins - harnessing the structural plasticity 




275(11), 2677–2683. https://doi.org/10.1111/j.1742-4658.2008.06439.x 
Smith, G. (1985). Filamentous fusion phage: novel expression vectors that display cloned 
antigens on the virion surface. Science, 228(4705), 1315–1317. 
https://doi.org/10.1126/science.4001944 
Soler, M. A., Fortuna, S., de Marco, A., & Laio, A. (2018). Binding affinity prediction of 
nanobody–protein complexes by scoring of molecular dynamics trajectories. Physical 
Chemistry Chemical Physics, 20(5), 3438–3444. https://doi.org/10.1039/C7CP08116B 
Stack, E. C., Wang, C., Roman, K. A., & Hoyt, C. C. (2014). Multiplexed 
immunohistochemistry, imaging, and quantitation: A review, with an assessment of 
Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods, 
70(1), 46–58. https://doi.org/10.1016/J.YMETH.2014.08.016 
Takei, K., Mundigl, O., Daniell, L., & De Camilli, P. (1996). The synaptic vesicle cycle: a 
single vesicle budding step involving clathrin and dynamin. The Journal of Cell Biology, 
133(6), 1237–1250. https://doi.org/10.1083/jcb.133.6.1237 
Terry-Lorenzo, R. T., Torres, V. I., Wagh, D., Galaz, J., Swanson, S. K., Florens, L., … Garner, 
C. C. (2016). Trio, a Rho Family GEF, Interacts with the Presynaptic Active Zone Proteins 
Piccolo and Bassoon. PLOS ONE, 11(12), e0167535. 
https://doi.org/10.1371/journal.pone.0167535 
Thastrup, O., Tullin, S., Kongsbak Poulsen, L., & Bjørn, S. (n.d.). Fluorescent proteins. US 
patent 6172188. Retrieved from 
https://worldwide.espacenet.com/publicationDetails/biblio?CC=US&NR=6172188&KC
=&FT=E&locale=en_EP# 
Tiede, C., Tang, A. A. S., Deacon, S. E., Mandal, U., Nettleship, J. E., Owen, R. L., … 
McPherson, M. J. (2014). Adhiron: a stable and versatile peptide display scaffold for 
molecular recognition applications. Protein Engineering, Design and Selection, 27(5), 
145–155. https://doi.org/10.1093/protein/gzu007 
Vaks, L., & Benhar, I. (2014). Production of Stabilized scFv Antibody Fragments in the E. coli 
Bacterial Cytoplasm (pp. 171–184). Humana Press, Totowa, NJ. 
https://doi.org/10.1007/978-1-62703-586-6_10 
Vangindertael, J., Camacho, R., Sempels, W., Mizuno, H., Dedecker, P., & Janssen, K. P. F. 
(2018). An introduction to optical super-resolution microscopy for the adventurous 
biologist. Methods and Applications in Fluorescence, 6(2), 022003. 
https://doi.org/10.1088/2050-6120/aaae0c 
Vaughan, T. J., Williams, A. J., Pritchard, K., Osbourn, J. K., Pope, A. R., Earnshaw, J. C., … 
Johnson, K. S. (1996). Human Antibodies with Sub-nanomolar Affinities Isolated from a 
Large Non-immunized Phage Display Library. Nature Biotechnology, 14(3), 309–314. 
https://doi.org/10.1038/nbt0396-309 
Von Pawel-Rammingen, U., Johansson, B. P., & Björck, L. (2002). IdeS, a novel streptococcal 
cysteine proteinase with unique specificity for immunoglobulin G. EMBO Journal, 21(7), 
1607–1615. https://doi.org/10.1093/emboj/21.7.1607 
Wade, O. K., Woehrstein, J. B., Nickels, P. C., Strauss, S., Stehr, F., Stein, J., … Jungmann, R. 
(2019). 124-Color Super-resolution Imaging by Engineering DNA-PAINT Blinking 
Kinetics. Nano Letters, acs.nanolett.9b00508. 
https://doi.org/10.1021/acs.nanolett.9b00508 




imaging. International Journal of Molecular Sciences, 10(2), 441–491. 
https://doi.org/10.3390/ijms10020441 
Waterhouse, P., Griffiths, A. D., Johnson, K. S., & Winter, G. (1993). Combinatorial infection 
and in vivo recombination: a strategy for making large phage antibody repertoires. Nucleic 
Acids Research, 21(9), 2265–2266. https://doi.org/10.1093/nar/21.9.2265 
Weng, J., & Ren, J. (2006). Luminescent quantum dots: a very attractive and promising tool in 
biomedicine. Current Medicinal Chemistry, 13(8), 897–909. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/16611074 
Wiedenmann, J., Oswald, F., & Nienhaus, G. U. (2009). Fluorescent proteins for live cell 
imaging: Opportunities, limitations, and challenges. IUBMB Life, 61(11), 1029–1042. 
https://doi.org/10.1002/iub.256 
Wilhelm, B. G., Mandad, S., Truckenbrodt, S., Kröhnert, K., Schäfer, C., Rammner, B., … 
Rizzoli, S. O. (2014). Composition of isolated synaptic boutons reveals the amounts of 
vesicle trafficking proteins. Science (New York, N.Y.), 344(6187), 1023–1028. 
https://doi.org/10.1126/science.1252884 
Xu, C., Yang, Y., Liu, L., Li, J., Liu, X., Zhang, X., … Liu, X. (2018). Microcystin-LR 
nanobody screening from an alpaca phage display nanobody library and its expression and 
application. Ecotoxicology and Environmental Safety, 151, 220–227. 
https://doi.org/10.1016/j.ecoenv.2018.01.003 
Yan, J., Li, G., Hu, Y., Ou, W., & Wan, Y. (2014). Construction of a synthetic phage-displayed 
Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic 
applications. Journal of Translational Medicine, 12(1), 343. 
https://doi.org/10.1186/s12967-014-0343-6 
Yau, K. Y. F., Dubuc, G., Li, S., Hirama, T., MacKenzie, C. R., Jermutus, L., … Tanha, J. 
(2005). Affinity maturation of a VHH by mutational hotspot randomization. Journal of 
Immunological Methods, 297(1–2), 213–224. https://doi.org/10.1016/J.JIM.2004.12.005 
Zimmermann, I., Egloff, P., Hutter, C. A., Arnold, F. M., Stohler, P., Bocquet, N., … Seeger, 
M. A. (2018). Synthetic single domain antibodies for the conformational trapping of 
membrane proteins. ELife, 7. https://doi.org/10.7554/eLife.34317 
Zrazhevskiy, P., & Gao, X. (2013). Quantum dot imaging platform for single-cell molecular 
profiling. Nature Communications, 4(1), 1619. https://doi.org/10.1038/ncomms2635 
Zuo, J., Li, J., Zhang, R., Xu, L., Chen, H., Jia, X., … Xie, W. (2017). Institute collection and 
analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for 























































Green fluorescent protein 
Heavy chain antibody 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
Highly inclined and laminated optical sheet 
Horseradish peroxidase 
Kanamycin 




Point Accumulation for Imaging in Nanoscale Topography 
Photo-activated localization microscopy 
Phosphate-buffered saline 
Phenylmethylsulfonylfluorid 
Reversible Saturable optical Fluorescence Transitions 
Ribonucleic acid 
Revolutions per minute 
Room temperature 
Sodium dodecyl sulfate 
Standard deviation 
Standard error of the mean 
Single domain Antibody 

















Stimulated emission depletion microscopy 
Stochastic optical reconstruction microscopy 


















First, I would like to thank my two supervisors Prof. Silvio Rizzoli and Dr. Felipe Opazo. Silvio, 
thank you for giving me the opportunity to work in this project, for the instructive advice on 
how to build a scientific career and navigate through the academic world. Felipe, thank you for 
your supervision, for sharing your knowledge and experience and giving me a great 
environment for my PhD, I could not have hoped for a better supervisor.  
I would like to extend my gratitude to Prof. Peter Rehling and Prof. Blanche Schwappach-
Pignataro for their time and advice throughout my whole PhD. I would like to thank the IMPRS  
Molbio and the GGNB office shaping us as scientists and beyond and giving us such incredible 
opportunities Thank you Kerstin Grüniger and Kirsten Pöhlker for their help and availability. 
A special thank you goes to Dr. Steffen Burkhardt without his presence, the graduate program 
would not be the same. Thank you for being a great mentor and taking great care of us.    
I would also like to thank my collaborators Dr. Roman Tzukanov and Nazar Oleksiievets for 
putting together and realizing a great project, Prof. Ralf Jungmann and Thomas Schlichthaerle 
for welcoming me in their team and being great collaborators, Dr. Steffen Frey for his help and 
Carlos Duque Afonso for his creative and good work.  
I would like to thank all the lab members. In particular, Dr. Manuel Maidorn for his invaluable 
initial training and constant support throughout the years. I would also like to thank Dr. Eugenio 
Fornasiero and Dr. Martin Helm for being extremely helpful and giving me great advices. I 
would like to thank Dr. Sebastian Jähne for his help in proofreading and microscopy expertise. 
I would like to thank Dr. Mihai Alevra for his help with data analysis.  
Thanks to Dr. Selda Kabatas, for her constant support in every lab and life challenge. I could 
not have wished for a better office mate. I would like to thank Sinem Sertel for her constant 
moral support, encouragement and friendship.  
I would like to thank Dr. Carlo Breda and Prof. Flaviano Giorgini for being the best first 
supervisors one could wish for. Thank you for making it such a pleasant first dive in the 
academic world and thank you for believing in me.  
Grazie a Professoressa Lucia Palmieri, che educandomi e crescendomi, mi ha trasmesso la 
passione per la scienza e l’infastidimento per le cose illlogiche.  
For all my beloved people, who supported me and loved me throughout this work and beyond. 





































10. List of pubblications 
Sograte-Idrissi S. et al. “Circumvention of common labelling artefacts using secondary 
nanobodies” Nanoscale,12, 10226-1023 (2020).  
 
Götzke H, Kilisch M, Martínez-Carranza M, Sograte-Idrissi S et al. “The ALFA-tag is a highly 
versatile tool for nanobody-based bioscience applications”. Nature Communications 10, 4403 
(2019).  
 
Sograte-Idrissi S. et al. “Nanobody Detection of Standard Fluorescent Proteins Enables Multi-
Target DNA-PAINT with High Resolution and Minimal Displacement Errors”. Cells mdpi 8, 
48 (2019).  
 
Gomes de Castro M.A, Wildhagen H, Sograte-Idrissi S. et al. “Differential organization of 
tonic and chronic B cell antigen receptors in the plasma membrane”. Nature Communications. 
10, 820 (2019). 
 
Breda C., Sathyasaikumar K.V, Sograte Idrissi S. et al. “Tryptophan-2,3-dioxygenase (TDO) 
inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites”. 
Proceedings of the National Academy of Sciences of the United States of America, 113(19), 
5435–5440 (2016). 
 
 
 
 
